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ABSTRACT
Due to their biocompatibility and parallel data processing, DNA computational devices
are highly desired for applications in diagnosis and treatment of cancer, infectious and genetic
diseases. Much like in modern electronic devices, DNA computation is based on the logic gates by directly interacting with DNA or RNA input molecules, they produce a specific output
depending on their embedded logic function. This work is devoted to the development of
functional parts of a future DNA nanorobot for biomedical applications. Specifically, we used
DNA nanotechnology and the concept of multicomponent DNA probes to develop three parts of
the DNA nanorobot: computing, actuating, and sensing.
The computation function was addressed by developing construct with two integrated
NAND gates, capable of processing three different DNA or RNA inputs. The second “smart”
construct produces actuating function – cleavage of RNA for housekeeping gene in response to
recognition of RNA inputs, generated by cancer cells. The third construct is an original DNA
“Cephalopod-tile”, with improved sensing function, capable of recognizing highly structured
biological analytes, such as 16S rRNA of E.coli, as well as increasing hybridization kinetics with
targets up to 465 times. These nanoconstructs contributed to development of original DNA
nanomachine with OR logic function for treatment of cancer.

Theses for Defense
1. Computing: It is possible to design tile-associated DNA NAND logic gates that can be
integrated in communicating circuits.
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2. Actuating: It is possible to create a DNA nano-construction that can cut out a marker
fragment from a longer RNA sequence and use it as an activator for triggering cleavage of another
RNA sequence.
3. Sensing: A DNA probe equipped with analyte capture function can increase
hybridization rates between DNA and RNA analytes.
4. Sensing, computation, and actuating: It is possible to design multifunctional DNA
nanomachines with sensing, computation, and therapeutic modules.
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complementary ‘capturing’ fragments and direct it to the MB probe for detection. Dashed lines are
all the same sequences, which can attract up to eight 5’-TS. Dotted lines are complementary to 3’TS. B. Analysis of tile association in 2.5 % agarose gel. Lanes 2-5 contained tile-associated MB
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CHAPTER 1: INTRODUCTION
Many human diseases can be accurately pinpointed to a presence of specific nucleic acid
sequence. For example, single nucleotide polymorphism (SNP) can contribute to a genetic disease,
such as sickle cell anemia1 or it can turn protooncogene into oncogene and contribute to the
developing of cancer, such as in case of KRAS gene2; the presence of bacterial nucleic acids can
indicate an infection, and overexpression or under expression of certain genes in the form of
mRNA sequences3-5, as well as miRNA sequences can has been also linked to diseases6. DNA
molecules, due to predictability of its base-pairing with DNA or RNA targets makes an ideal and
reliable tool for diagnostics of such diseases.
Traditional methods of detection with DNA utilize molecular beacon (MB) probes, which
are single- stranded DNA sequences, that form self-complimentary stem-loop structure, where
fluorophore and a quencher are in a close proximity to each other, resulting in a low fluorescence
in the absence of target. However, when DNA or RNA sequence of interest is present, MB probe
hybridizes with it and assumes bright conformation with high fluorescence7 (Figure 1A). Some of
the shortcomings of MB-based detection is its inability to detect single nucleotide mutations and
necessity to produce new MB sequence for each new target, which drives up cost of the analysis.
Multicomponent probes can alleviate some of these limitations. General strategy for designing
these types of probes includes addition of two or more adaptor strands, that contain constant
domain, complimentary to the MB probe and a variable domain, designed with complementarity
to the target, where sequence, responsible for the recognition of SNP is relatively short (Figure
1B).

1

Figure 1. Detection of nucleic acid targets with DNA probes. A. MB probe exhibits dark (low
fluorescence) conformation in the absence of target and bright (high fluorescence) when the target
is present. B. Addition of adaptor strands α and β improves selectivity of MB probes. High
fluorescent complex is formed only in the presence of the fully matched analyte. C. Detection of
nucleic acid targets using split DNAzyme. Deoxyribozyme was split into Dz-A and Dz-B parts,
which are catalytically inactive. DNA or RNA target hybridizes to two halves of split Dz, bringing
2

them in proximity and restoring its catalytic activity. Active DNAzyme can then hybridize with
fluorescent substrate, cleaving it between RNA bases, resulting in high fluorescence.
This approach allows sensitive and specific detection of sequences different in one nucleotide,
which could be done even at ambient temperatures8.
Additional methods for nucleic acids detection include use of DNAzymes, which are
single-stranded catalytically active DNA sequences, identified using SELEX technology9,10.
DNAzymes can catalyze a variety of reactions, such as RNA and DNA cleavage and ligation,
peroxidation reactions among others11-13. Splitting catalytic sequence of DNAzymes14 into
multiple components inhibits its catalytic activity. However, when target is present, the
components of DNAzyme sequence will hybridize with it, bringing them into proximity and
restoring catalytic activity. Catalytically active DNAzyme can then be used to produce fluorescent
or colorimetric response14,15 (Figure 1C). This method of detection is also sensitive and capable of
discriminating targets, that differ in single nucleotide.
Another method for detection of nucleic acid targets includes use of aptamers, which are
NA sequences isolated from NA libraries using SELEX procedure, and have high binding affinity
for specific ligands, such as small molecules, dyes, proteins, or even tissues16-20. The mechanisms
of attraction between aptameric sequences and their targets are based on specific tertiary structure
of the sequences with high affinity for the ligand. Aptamers for fluorescent dyes increase their
fluorescence upon binding and generally have high on/off ratios, which makes them very useful
for sensitive detection of NA targets. To achieve that, aptamer sequences can be split into multiple
components, where full aptamer sequence, capable of binding and enhancing fluorescence, is
formed only, when hybridized to the NA analyte of interest21-23.
3

DNA Logic gates and DNA Computation
Many pathological conditions are often associated with multiple NA markers or a
complex pattern of markers, which could be analyzed by DNA computation. Much like operation
of conventional processors, DNA computation is based on the logic gates. Logic gates recognize
inputs, process it, according to the predesigned logic, and produce an output (either high output
“1” or low output “0”). In DNA computation inputs and outputs, as well as logic gates, are
represented by DNA or RNA sequences. Described above methods of detection, can be viewed as
acts of DNA computation with YES logic (Table 1), one of the simplest computational operations.
Various DNA logic gates, such as AND, NOR, XOR and combination of gates were previously
designed, as well as more complex circuits, such as half24,25 and full-adders26, half-subtractor24 and
a square root computing function27.
Table 1. Truth table for YES and NOT functions. 1 and 0 represent high or low values respectively.
Logic gate function

Input

Output

YES gate

0

0

1

1

0

1

1

0

NOT gate

There are a number of different approaches to the design of DNA logic gates, but all could
be separated into two broad categories of enzymatic and non-enzymatic mode of operations.
Enzymatic logic gates often employ catalytic DNA sequences (DNAzymes), that catalyze cleavage
of RNA or DNA substrates or colorimetric reactions. A common approach to enzymatic logic gates
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includes catalytic core sequence, whose activity is either impeded or restored when the gates
process its oligonucleotide inputs, generating a binary output of 0 or 1 respectively. A high output
is represented by fully operational Dz sequence, while low output is generated by an enzyme with
a low activity, for example by distorting the catalytic core. Stojanovic et al. reported Yes, NOT,
AND and XOR Boolean logic gates (see Tables 1 and 2), based on the activity of E6 and 8-17
deoxyribozymes28. YES and AND logic gates were designed by adding self-complimentary
sequences that formed in the absence of input and blocked binding sites for fluorescent substrate,
resulting in low fluorescent output. Addition of inputs would cause their binding to these inhibitory
portions and opening up substrate binding sites, resulting in high fluorescent output. In NOT gate,
where high output is produced in the absence of input, the input was complimentary to the catalytic
core sequence, disturbing its activity when present and resulting in low fluorescence.
Table 2. Truth table for AND and XOR logic gates. 1 and 0 represent high or low values
respectively.
Logic

gate

InputA

InputB

Output

0

0

0

1

0

0

0

1

0

1

1

1

0

0

0

1

0

1

0

1

1

funciton
AND gate

XOR gate
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Logic

gate

InputA

InputB

Output

1

1

0

funciton

Non-enzymatic logic gates rely on hybridization to a hairpin-like fluorescent reporter
(molecular beacon) or on a strand displacement- generated cascade mechanism29. In a study by
Seelig et al., Boolean logic gates with AND, OR, and NOT functions were generated by toeholdmediated strand displacement mechanism (THMSD). THMSD is observed, when doublestranded
DNA, formed by 2 or more strands, in addition to the double-stranded region, contains single
stranded regions, or toe-holds, with base complimentarity to a different strand (invader strand). In
the presence of the invader strand, it will bind to the single stranded region first, unziping and
displacing the strand from duplex, which in turn would generate another single stranded region,
that could be used as a toe-hold by the next invader strand and so on (Figure 2). Addition of a
single invader strand can initiate a cascade of binding events. Seelig et al. designed logic gates,
that could operate by this principal. For example, AND gate was generate by two inputs, sequtially
displacing two DNA strands from a 3 strand DNA complex, which result in separation of
fluorophore and a quencher and a high fluorecent output in agreement with AND logic.

Figure 2. Mechanism of THMSD. Double-stranded DNA complex is generated by strands A,B,
and C, where strand B contains single stranded toe-hold region (highlighted in blue). In the
6

presence of invader strand D, with base complementarity to strand B, it can hybridize with the toehold region first, and then form full complex with strand B. This leaves A and C as part of the
original complex, with strand C now having single-stranded region, that can be used as a tor-hold
for a subsequent hybridization event with a different strand.
Between enzymatic and non-enzymatic methods, an advantage of enzymatic method is an
accumulation of signal due to the catalytic turnover, resembling powering of a tradional circuits.
However both approaches are subject to a number of limitations, such as slow response time in the
order or several hours, relatively high concentration requirements of computing units (up to μM
scale), as well as imperfect digital behavior, that can arise in complex systems.
One way to bypass some of the limitations of solution-based logic gates, is to connect them
to a common platform, an action resembling collection of cmputing units on a traditional silicon
chip. One way to achieve such connection is by using Dx tiles, stable building block in DNA
nanotechnology, that are based on DNA double-crossover motif30, where DNA forms 4-way
junction structure (4J)31 and allows positioning of logic units with precision relative to each other.
Gerasimova and Kolpashchikov reported combination of AND and NOT gates, to generate
INHIBIT and NOR functions, using 4J structures32. This approach allowed to produce reusable
logic gates with predictable digital behaviour and significantly reduced reaction times. Some other
motifs that are used for connection of units include Y-DNA33 and DNA tetrahedrone structures34.

DNA Logic Gates in Diagnostics
DNA logic gates could be successfully implemented for detection of diseases, such as
bacterial or viral infections, cancers, where determination about diagnosis and/or course of
treatment is based on analysis of a complex set of inputs. In case of DNA logic gates-based
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diagnostics, these inputs are bacterial or viral nucleic acid material, cell surface markers, mRNA
or miRNA expression profiles of cells.
DNA logic gates for detection of infectious diseases
DNA logic gates were successfully used for diagnostics of Mycobacterium tuberculosis
(Mtb) infection, and moreover determining if the bacteria is susceptible or resistant to antibiotic
Rifampin. In study by Cornett et al. this objective was achieved with the use of two logic gates,
with a YES and an OR logic functions35. The YES logic gate was needed to determine if Mtb
infection is present, whereas 5 input logic gate could detect any of the 5 rifampin-resistant strains.
The output of two logic gates was represented by fluorescence of two MB probes, with emission
at different wavelength, and could be recorded simultaneously (Figure 3A)35.
A different approach to a similar task was taken by Connelly et al. By using a combination
of 5 different logic gates (OR, NOR, NOT, PASS 0, and PASS 1) they were able to design
alphanumeric display for visual detection of Mycobacterium tuberculosis and determination of its
antibiotic susceptibility36. The colorimetric response was produced by designing logic gates based
on activity of peroxidase-like DNAzyme, which could catalyze oxidation of organic compounds
(in this case ABTS) to produce colorimetric outputs. The display reads O (if no Mtb infection is
present), letter P form pass, if infection is present, but is susceptible to rifampin, or F for fail, if
the infection is a rifampin-resistant strain (Figure 3B)36. The latest is a great example, how DNA
logic gates for diagnostics, could be used in point-of-care settings.

8

Figure 3. Examples of logic gates for detection of Mycobacterium tuberculosis. A35. YES gate
gives high fluorescent output of UMB 1 if Mtb infection is present. 5 input logic gates gives high
fluorescent output by UMB 2 in the presence of any of the 5 rifampin-resistant strains. B36. A
combination of logic gates to generate alphanumeric display for detection of Mtb. 0 indicates no
infection, F and P indicate infection with rifampin resistant or susceptible strands respectively.
DNA logic gates for detection of cell surface markers
Oftentimes the diseased vs healthy cell can be differentiated from each other by a set of
cell surface markers. In a proof -of-concept study, Rudchenko et al. were able to separate and
fluorescently label cells of interest (B cells) from closely related group of cells (T cells) by
employing Boolean AND logic37. According to the truth table for a 2 input AND gate (Table 2), a
9

high output (in this case fluorescence) will be produced only in the presence of both inputs. In the
study, inputs were represented by cell surface markers or clusters of differentiation (CD), where B
cells contained CD 45 and CD 20 markers, but T cells only contained CD 20. Antibodies against
CD 45 and CD20 were conjugated with DNA duplexes and incubated with the cells. In the event
when both inputs were present, two duplexes ended up in the close proximity, which resulted in
toehold mediated strand displacement and oligonucleotide transfer with the addition of initiator
strand. The transfer cascade resulted in hybridization of fluorescently labeled oligonucleotide with
oligonucleotide on the cell with both markers present37.
Gao et al. were able to fluorescently label leukemia cancer cells using 3 input AND gate38.
They made use of aptameric sequences for 3 surface markers associated with leukemia cells:
aptamer TCO1 against receptor tyrosine kinase-like receptor 7 (PTK 7), aptamers Sgc8c and
Sgc4f, associated with multiple blood cancer cell lines and leukemia cells respectively. Aptameric
sequences had additional nucleotides extensions, which when all 3 surface markers are present,
would be placed in proximity and with the addition of connector strand would form nano scaffold
for binding od circular DNA template (Figure 438). Addition of T4ligase/phi 29 DNA polymerase
would initiate rolling circle amplification (RCA) and amplicon can be detected with the addition
of fluorescent reported. Using this system, they were able to achieve 20 times signal increase when
all 3 inputs are present.
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Figure 438. 3 input AND gate for detection of leukemia cells. Aptamers Sgc8c, Sgc4f, TCO1 bind
to cell markers on the surface of leukemia cells. The output of the logic gate is formation of
nanoscaffold, that serves as binding site for circular template and initiates RCA reaction. The
output is detected when produced amplicon is hybridized with the fluorescent reported molecule.
Both methods however rely on hybridization of nucleic acids, attached to components,
recognizing different cell surface markers, which makes them suitable only for analysis of markers,
that are in a close proximity to each other on the membrane, which is not always the case. Also,
amplification method requires addition of protein enzymes, which could be expensive.
Additionally, both methods rely on addition of single stranded oligonucleotide components and
reporters to help carry out computation, further complicating the assay and making it most likely
not be suitable for analysis in more complex matrices, such as in vivo computation.
DNA logic gates for detection of mRNA and miRNA
Both mRNA and miRNA can be used to differentiate between diseased and healthy cells.
mRNA levels correlate with gene expression levels, they also carry over mutations from DNA
templates, resulting in a gene product with altered function and other pathologies. MiRNA are
small (~22 nt) noncoding RNAs, that alter gene expression levels by binding to mRNA. Many
miRNA sequences have been recently identified, that can contribute to development of cancer. For
11

example, miRNA-21 is known to downregulate expression of tumor suppressor genes, and its
altered expression levels are associated with many cancer types39.
DNA logic gates can be designed to analyze complex patterns of mRNA and miRNA
inputs inside cells and make a diagnosis on diseased vs healthy cells. One of the caveats, however,
is relatively high requirement of inputs, whereas concentrations of inputs in the cellular
environment is a lot lower. Zhou et al. were able to bypass this limitation. They have implemented

Figure 540. Two input AND gate for miRNA detection. The correct output (displacement of strand
E2) occurs only when both inputs (T1=miRNA-21 and T2=miRNA-let7a) are present. Displaced
E2 serves as a template for RCA reaction, producing amplicon that can bind fluorescent dye.

2 input AND logic gate, based on strand-displacement (THMSD) and RCA techniques40. The
output of the gate, which occurs only in the presence of both inputs, is displacement of strand E2,
which serves as a template for RCA reaction (Figure 540). The amplicon is then added by addition
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of fluorescent dye. Using this technique, they were able to detect miRNA-21 and let-7a from total
RNA extract of Hela cells.

DNA Nanomachines
The growing need for development of more efficient, precision therapies with little or no
side effects can be achieved with the help of DNA computation. DNA nanomachines or DNA
nanorobots, which are the next step from DNA logic gates, can help achieve this goal. We define
DNA nanomachines as multifunctional DNA constructs, that at the minimum possess the
following functions: (i) recognition/sensing function, (ii) computing function, (iii) actuating
function. Sensing function is ability to recognize disease-causing inputs in a complex matrix, such
as specific nucleic acid sequence, mutation in the DNA or RNA, overexpression of certain genes,
presence of certain biomarkers etc. After recognition and /or processing of the inputs, they would
be analyzed by a computational unit, which would produce an output, based on the predesigned
logic. The output, which could be a conformational change, formation of specific DNA or RNA
sequence, activation of the enzyme etc., triggers actuating or therapeutic function of the
nanodevice. The actuating function can involve destruction of disease-causing stimuli or
destruction of the diseased cell among others (Figure 6). Nanodevice can also possess additional
features, making its performance more effective, such as unwinding arms, aiding in binding of

13

natural targets with complex secondary structures, elements, helping its cellular uptake, elements,
improving kinetics of the reactions etc.

Figure 6. Schematic of a DNA nanomachine. In this schematic inputs 1 and 2 (I1 and I2) are being
recognized and processed by sensing/processing element of the device before being analyzed by
computing unit (DNA computer). DNA computer additionally processes inputs 3 and 4 (I3 and
I4). When the correct combination of inputs is present, the output of the computer triggers
actuating function. Actuation (therapeutic function) is achieved through formation of output
sequence, allowing to bind and cleave mRNA target, resulting in downregulation of the gene or
cell death.
DNA nanomachines can be broadly divided based on where computation occurs, into
performing computation inside cells and the ones that target extracellular inputs, such as cell
surface markers. Nanoconstructs with cell surface inputs perform computation outside the cell and
only then deliver therapeutic output, which is often a drug or a small molecule, inside the cell.
DNA nanomachines with operation inside cells analyze expression levels and mutations in mRNA
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and miRNA molecules, and often use oligonucleotide-based gene therapeutics (OGT), such as
siRNA, antisense, CRISPR/cas9 or Dz-based methods for downregulation of mRNAs41,42.
DNA nanomachines operating in the cellular environment
Beneson et al. proposed an in vitro molecular computer, that is able to analyze a set of
mRNA expression levels associated with specific disease and produce a ss DNA for antisense
suppression of a specific gene, as an output of a positive diagnosis43. For example, a positive
diagnosis for a prostate cancer will be achieved if an overexpression of PIM1 and HPN genes,
combined with low expression of GSTP and PPAP2B genes is detected, resulting in release of
antisense oligonucleotide for targeting of MDM2 gene. The system process one input at a time,
and in the event that not all required conditions are met, an antidrug sequence, that would bind
OGT is released, to ensure that no active drug is available.
In above example, authors used OGT to target gene, that is overexpressed in diseased
cells44, which is often a common approach in the oligonucleotide-based therapeutics. Perhaps a
better approach might be to target a gene, that is present in all cells and is essential for the cell
survival, but only in response to a specific set of markers, associated with disease. This approach
was taken by Nedorezova et al. Designed nanomachine targets antiapoptotic gene DAD-1
(therapeutic function), but only in the cells, containing cancer marker RNA N-Myc45. Activity of
the nanomachine is based on split deoxyribozyme 10-23 design, that can be designed to bind and
cleave specific RNA sequence. The computation logic of the nanodevice represents YES gate, and
a high output in the presence of the cancer marker is represented by catalytically active Dz core,
that in turn can bind and cleave mRNA for DAD-1 essential gene45 (Figure 7A)45. Additionally,
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nanomachine is equipped with RNA unwinding arms, that can help with hybridization of Dz halves
to the natural mRNA.

Figure 7. DNA nanomachines with oligonucleotide-based therapeutic function. A45. Example of
nanomachine with DZ-based therapeutic function. In response to cancer marker RNA molecules,
the output of the nanomachine is represented by formation of catalytic core, that can bind and
cleave mRNA for housekeeping gene. Arms 3 and 4 are accessory arms, that help in binding of
mRNA. B48. Example of DNA nanomachine, that releases siRNA molecules to target cancer
marker gene in response to AND gated opening of the DNA nanoprism, which is triggered by Bcl
and Bcl-xL mRNA binding.
Inspired by designs of DNA origami structures, such as DNA box with lid46 and hexagonal
DNA barrel47, that can be unlocked in response to specific input keys and expose their cargo, DNA
16

nanoprism offers a conceptually similar approach48. In the study by Bujold et al. DNA nanoprism,
that contained siRNA cargo against fatty acid synthase, a gene that is known to be overexpressed
in Hela cancer cells, can be unlocked inside cells in the presence of mRNA antiapoptotic genes
Bcl-2 and Bcl-xL, representing AND logic (Figure 7B)48. Although the authors didn’t use cellular
mRNA transcripts for Bcl genes as inputs but used a short synthetic instead, release of siRNA
inside cells resulted in double amount of cell death compared to controls. Interestingly enough,
this nanomachine has potential for a dual therapeutic function since binding of mRNA molecules
not only unlocks the prism and initiates therapeutic release of siRNA molecules, but is in itself a
therapeutic event, resulting in depletion of mRNA molecules by antisense oligonucleotide
technology. It can potentially be optimized to produce therapeutic siRNA for essential genes in
response to a cancer marker gene.
Some of the issues hindering the progress of DNA nanomachines for intracellular analysis
and activation of therapeutic function, include potential for off-target effects49, low therapeutic
efficacy under physiological conditions due to Mg2+ requirement and due to stability of mRNA
secondary structures50, as well as cell permeability and nuclease stability51.
Nanomachines operating on the cell surface
Unlike DNA nanomachine with intracellular computation and therapeutic output, this class
of nanomachines performs its recognition and computation in the extracellular environment.
Common approach includes recognition of specific set of cell surface marker by the nanodevice,
which triggers uptake of nanodevice by the cell. This approach can be illustrated by DNA
icosahedra nanostructure, containing aptamer sequences for recognition of MUC1 cell surface
marker, which is often associated with various epithelial cancers52. Upon recognition of the
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receptor, DNA icosahedra, containing doxorubicin chemotherapy drug, were delivered inside
MCF7 breast cancer cells, exhibiting this cell surface protein, resulting in selective cytotoxicity52.
A more common approach to DNA nanomachines operating on cell surfaces includes
structure-switching aptameric sequences, which are bound to the complimentary DNA strand in
the absence of its ligand but releasing it when the target is present53. A number of works have been
targeting PTK7 receptor, that is often associated with colon cancer and is upregulated in many
cancer cell lines54. Wang et al. used structure-switching aptamers for imaging and therapy of PTK7
expressing cells, with LOD for receptor concentration of 1 pM. In addition to structure-switching
aptamer for PTK7, bound to complimentary DNA fragment, they added two more selfcomplimentary DNA sequences, one dually labeled with fluorophore and a quencher and the other
carrying a cisplatin prodrug. In the presence of PTK7-positive cells, the aptamer sequence would
bind its ligand, exposing single stranded region and triggering hybridization event for the other
two strands, after which the whole complex is able to be internalized within cell for its visualization
and therapy55 (Figure 8A55).
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Figure 8. DNA nanomachines operating in extracellular environment, based on the structureswitching aptamer sequences. A55. Structure-switching aptamer for detection and therapy of
PTK7-positive cells. IN the presence of the cell surface marker, aptamer changes conformation
and triggers hybridization events with fluorophore-labeled strand and strand, containing prodrug.
The complex is released inside cells for their fluorescent labelling and therapy. B57. Design and
operation of nanoclaw. Structure-switching aptamers Sgc8c (PTK7 receptor), TC01, AND Sgc4f
on the capture toes, release their complimentary DNA sequences in the presence of their respective
ligand. cDNA sequences hybridize with the effector toe, facilitating THMSD of oligonucleotide
strand with drug.
DNA nanomachines, where recognizing, computation and therapeutic components are
represented by separated single and double stranded DNA components, would run into the same
problems as solution-based logic gates, including slow response time, imperfect digital behavior
and risk of components getting separated in complex matrices. For example, in the solution-based
system, that used 3 cell surface markers for detection and therapy of leukemia cells, Weihong Tan
group reported difficulty distinguishing between high and low outputs and diminished diagnostics
and therapeutic effects with higher order logic (AND-AND And AND-NOT combinations)56. On
the contrast, the same group achieved more predictable behavior with the DNA nanoconstruct
named “Nanoclaw”, containing recognition, computing and actuating elements within one
nanostructure57. This structure is based on Y-DNA motif and contains capture toes and effector
19

toe. Capture toes are structure-switching aptamers for recognition of PTK 7 and 2 more unknown
targets, overexpressed on the cell surface of human acute lymphoblastic leukemia cells. When the
aptamers bind to their targets, they release complimentary DNA sequences, which in turn are
recognized and processed by effector toe. Effector toe designed to perform AND computation,
will release drug or fluorescent label in the event that all 3 inputs are present54 (Figure 8B54). The
same group recently reported of a nanorobot of similar design but equipped with integrated
computation (AND-AND gate) for recognition of 3 cellular markers (Muc1, EpCAM and PTK7).
The robot first recognizes and processes two surface markers (EpCAM and MUC1) with an AND
logic, which liberate single stranded sequence conjugated with prodrug, as in previous design. This
output sequence also contains aptameric sequence for PTK7 receptor and serves as one of the
inputs for a second AND gate, where the second input necessary for therapeutic function is
presence of PTK758.
Overall, design and performance of DNA nanomachines operating in extracellular
environment, is based on recognition of cell surface proteins by aptameric sequences. This limits
potential targets to the sequence of aptamers that are currently isolated. Some of the ligands for
the isolated aptamers, represent cell surface markers, that are exhibited by both healthy and
diseased cells, increasing chance for off-target toxicity. Additionally, for nanodevices recognizing
multiple inputs, the performance of the device will be limited by the proximity of the targets on
the cell surface, which is not always the case, or in the designs, where recognition components are
not attached to the same scaffold, by their diffusion and separation in the biological matrices.
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Research questions
Although recent years marked several efforts towards design and implementation of DNA
nanomachines, a lot of this work remains as a proof-of-concept and hasn’t been developed for
clinical applications. Some of the questions, that need to be answered to move from concept to
clinical applications, are the following: (1) can we design DNA computational units, that would
be able to produce predictable outputs in complex matrices, have fast response times (in the order
of minutes), require low concentration of computing units and be integrateable to accommodate a
variety of computational tasks; (2) how can we increase specificity and decrease potential offtarget events for theranostic DNA nanomachines; (3) what type of targets do we need to select to
achieve these precise theranostics; (4) how can we improve binding efficiency and therapeutic
efficiency of DNA nanomachines operating under physiological conditions or within cells; (5)
how do we achieve efficient cell permeability and release of DNA nanodevices within cytoplasm.
This are just a few questions, and this work aimed to provide answer to some of them. In
this work we were able to design integrateable logic gates, that feature novel operational strategies,
not relying on self-inhibiting structures or on THMSD cascades. We have developed nanodevice,
capable of efficient and selective cleavage of SNP-containing mRNA for KRAS oncogene under
physiological conditions with low nanomolar concentration of nanodevice, which in turn activates
therapeutic cleavage of a housekeeping gene. We have also developed strategies, that allow
efficient hybridization of nanodevices with targets containing extensive secondary structures,
improving hybridization kinetics up to 240 times. We have combined these strategies in the design
of nanomachine, that is capable of recognizing two different SNP-containing mRNA for KRAS
oncogene, perform computation based on OR logic function, and produce therapeutic output for
21

cleavage of housekeeping gene with the aid of adaptor sequence. The design of this nanomachine
is not final. It can be further optimized for cellular uptake and nuclease protection.
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CHAPTER 2: MANUFACTURING REUSABLE NAND GATES AND
THEIR INTIAL CIRCUITS
Reproduced in part with permission from Molden, T. A., Grillo, M. C., & Kolpashchikov,
D. M.: Manufacturing reusable NAND logic gates and their initial circuits for DNA
nanoprocessors. Chemistry – A European Journal, 2020, 27(7), 2421–2426.
. Copyright 2020 Wiley-VCH Verlag GmbH & Co. KGaA.
Abstract
DNA-based computers can potentially analyze complex sets of biological markers,
thereby advancing diagnostics and treatment of diseases. Despite extensive efforts, DNA
processors have not yet been developed due to, in part, the limitations in ability to integrate
available logic gates into circuits. Here, we designed a NAND gate, which represents one of the
functionally complete set of logic connectives. The gate’s design avoids stem-loop folded DNA
fragments, and capable of reusable operations in RNase H-containing buffer. The output of the
gate can be translated in RNA cleaving activity or fluorescent signal produced either by a
deoxyribozyme or molecular beacon probe. Furthermore, three NAND gate-forming DNA strands
were cross-linked by click chemistry and purified in a simple procedure, which allowed
manufacturing ~1013 gates in 16 h, with hands-on time of about 30 min. Two NAND gates can be
joined in one association, performing new logic function simply by adding a DNA linker strand.
Approaches developed in this work may contribute to the development of biocompatible DNA
logic circuits for biotechnological and medical applications.
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Introduction
Since Adleman’s solution of a Hamiltonian path problem,1 DNA became an attractive
candidate to serve as a material for molecular computation.2-4 Its parallel data processing
capabilities and predictability of Watson-Crick base pairing poses an intriguing possibility for
performing computation on a nanoscale.1-4 Moreover, biocompatibility of such devices would
enable analysis of complex sets of biomarkers including those found in individual cells. This
promises to advance diagnostics and treatment of infectious diseases, genetic disorders, and
cancers.4-7
Traditional computers operate using logic gates – devices that recognize a limited number
of inputs, process them according to the embedded Boolean logic, and produce a single output.8
The electronic logic gates are integrated in circuits of communicating logic gates of required
architecture to solve a particular computational task. The operational power is provided by electric
inputs, which can pass multiple times through the circuits, thus enabling multiple operational
rounds. Following this functional pattern, the stages of a DNA computer development would
include (i) designing individual DNA logic gates able to communicate with each other; (ii)
integrating the gates in complex circuits; (iii) powering DNA circuits; (iv) achieving multiple
rounds of operation. DNA gates with a variety of logic functions have been developed to date,9-16
of which those that operate by recognizing oligonucleotide inputs and produce oligonucleotide
outputs are of interest. Such gates can be integrated in chains to execute pre-designed operations.17
Despite achieving up to 4-8 levels of integration, there is still a lack of a universal set of DNA
logic gates practically useful for building complex DNA circuits.17
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One reason for poor DNA gate integration and their slow response is the usage of DNA
structures containing self-inhibited fragments: inputs and outputs of upstream gates must unwind
the predesigned double-stranded (ds) DNA fragments prior to triggering gate response. For
example, the deoxyribozyme (Dz) two-input AND gate is an RNA-cleaving Dz with a catalytic
function inhibited by two stem-loops (Figure 9A).18 Binding two oligonucleotide inputs (one to
each loop) are required to unblock the substrate-binding arms and/or the catalytic core, which leads
to F_sub cleavage, corresponding to digital 1. The need to unwind short stem-loops in DNA can
significantly slow hybridization rates.19 Moreover, the active Dz association (Figure 9A, right) has
single-stranded overhangs complementary to Dz, which can interfere in computation by
intermolecular interactions. Strand displacement gates20 lack the undesired overhangs but suffer
from slow communication due to the competition of the input and inhibitory strand (strands 3 and
2, respectively, in Figure 9B) for binding of the same complement (strand 1). Here, we aimed at
creating a gate with minimum pre-designed structures to alleviate input binding and gate-to-gate
communication.
Following our previously reported strategy,21 the gates were attached to a DNA platform
for positioning several logic units close to each other within a single nanostructure to facilitate
cross-communication, minimize undesired crosstalk, and reduce operational time. DNA crossover
tiles (X tiles) are stable building blocks used in DNA nanotechnology.22 In this work, we designed
a tile-integrated, reusable NAND gate of an original design (Figure 9, C-E, see detailed description
in Results and discussion). According to Boolean logic, a two input NAND (negative AND) gate
produces low output only when two inputs are present (Figure 9F). The importance of NAND logic
comes from its universality: NAND gate alone can be used to generate an entire processor.8,23
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Much like the development of electronic computers was boosted with the invention of the NAND
gate transistor–transistor logic (TTL),23 the development of connectable NAND gate may advance
DNA-based molecular computation.

Results and Discussion
NAND Gate Design
NAND1 gate is an association of four DNA strands: forward strand (FS), back strand (BS),
and strands 1a and 1b (Figure 9C and Figure 30 Appendix B). The NAND function is fulfilled by
the four functional fragments: BiDz-a, BiDz-b, Bridge a and Bridge b (dashed lines), each of which
were covalently tethered to the DNA crossover tile (shaded area in Figure 9C). The two ‘bridging‘
sequences are slightly different (Figure 30, App. B), but hybridization of either of the two to BiDza and BiDz-b brings the two halves of Dz catalytic core together and thus restores the RNAcleaving activity of Dz, which results in F_sub cleavage (digital 1). This fluorescent reporting
mode is known as a binary or split Dz (BiDz) sensor.24,25 The ‘bridge’ fragments are fully
complementary to Input 1 and 2, while only partially complementary to BiDz-a and BiDz-b (Figure
30 App. B). This makes ‘bridge’/input hybrids energetically more favorable than their complexes
with BiDz-a and BiDz-b. In the absence of inputs, the NAND1 population should be roughly
evenly split between the associations, in which either Bridge a or Bridge b stabilize the catalytic
Dz core (Figure 9C), since the predicted stabilities of the ‘bridge’/BiDz arms hybrids for both
‘bridge’ sequences are similar. When only one of the two inputs (I1 or I2) is present, it hybridizes
and inactivates its cognate ‘bridge’, while the second bridging fragment is still available to stabilize
Dz catalytic core, thus ensuring high output (Figure 9D). At this stage, each input does not have
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to compete for binding the ‘bridge’, as there is always ~ 50% of NAND1 population containing
one or the other ‘bridge’ fragment in a single-stranded form. Hybridization of the 2nd input,
however, should proceed through the DNA strand displacement (Figure 9B), which is a
competitive process. When both inputs are bound to their cognate ‘bridges’, BiDz-a and BiDz-b
turn into inactive split state (low fluorescence, digital 0, Figure 9E). In our opinion, this is so far
the most structurally relaxed system that may contribute to shortening the response time and
increasing gate communication efficiency.
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Figure 9: Design and operation of NAND1 gate. A) Deoxyribozyme AND gate.[18] B) Strand
displacement Yes gate.[20] C) NAND1 gate is an association of four oligonucleotide strands: front
strand (FS), 1a, 1b, and the back strand (BS). High output (digital 1) is produced when the
fragments Bridge a or Bridge b (blue and green dashed lines) hybridize to BiDz-a and BiDz-b
(blue and green solid lines). The Bridge fragments including toeholds (red) are complementary to
Inputs 1 and 2, respectively. High output (digital 1) is generated in the absence of inputs. D) High
output of the NAND1 gate is produced when one input is present. E) In the presence of both inputs,
fragments Bridge a and Bridge b are hybridized to Input 1 and input 2, respectively, resulting in a
catalytically inactive Dz, and low output. Dx-tile platform is shaded. Single-stranded DNA
sequences are attached to the X-tile platform via triethylene glycol linkers (dashed lines). F) The
NAND gate truth table.
35

NAND Gate Performance
The system discriminates between the high and low output states (Figure 10). The ratio
between the fluorescent intensities corresponding to high and low outputs increases significantly
with time due to signal accumulation resulting from cleaving multiple F-sub molecules by a single
catalytically activity Dz core.24,25 High and low output could be distinguished in 5 min after input
addition (Figure 31B, App B).

Figure 10: Fluorescent response of the gate in the presence of DNA or RNA inputs. NAND1 gate
(10 nM) in Buffer 1 was mixed with 100 nM of DNA or RNA inputs (grey or white bars
respectively) and 200 nM of the fluorogenic substrate (F sub). Fluorescence was recorded after 15
min of incubation at 22oC. Fluorescence of the system above or below the threshold corresponds
to an output of 1 or 0, respectively, which is in the agreement with the NAND truth table. Data
represents an average of three trials, with standard deviations as error bars. Signal produced by the
fluorescent substrate F-sub in solution (in the absence of the gate) is provided as a reference. The
threshold line is at the fluorescence level that corresponds to the highest intensity triggered by both
inputs together (average plus at least one standard deviation).
The logic gate processed both DNA and RNA inputs with outputs of similar fluorescent
intensities (Figure 10). When two functional stands NAND_1a and NANA_1b were mixed
without forward (NAND_FS) and back (NAND_BS) strands, they failed to produce any
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fluorescent response (Figure 32, App. B), which indicates the need for the formation of the fourstrand association to achieve NAND gate function.
Multiple Rounds of Operation
Ideally, DNA logic circuits should be reusable: they should be able to complete multiple
rounds of operation.26,27 We demonstrated that the NAND1 gate can be reused several times
(Figure 11). Processing RNA inputs by the system results in the formation of an RNA-DNA duplex
between the inputs and the ‘bridge’ fragment. Addition of RNase H to the system resulted in
selective degradation of the RNA inputs in this duplex. For the NAND1 gate, the fluorescence
could not be reduced as fluorescent F_sub cleavage product irreversibly accumulates in solution
during the gate operation. Therefore, we observed a continuous fluorescence increase. However,
the rate of the fluorescent signal accumulation can serve as a measure of the gate’s output: low
increase rate would correspond to digital 0; high rate – to digital 1. Figure 3 demonstrates that after
each new addition of I1 and I2, the NAND gate immediately reduced the slope of the fluorescence
increase (indicated by the horizontal line), while reaching its highest slope in 5-7 min after input
addition (dashed line), thus indicating complete gate resetting. The immediate gate response to the
presence of inputs proves our hypothesis of alleviated interactions of the stem loop-free constructs
with inputs. Importantly, NAND1 reduced response to zero (low slope) in seconds after input
addition (during mixing). This is much shorter time than that of stem-loop containing tile-attached
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gates, which required 5-10 min for full restoration of the signal after input addition.[21] This
observation proves the hypothesis that stem-loop-free DNA constructs have faster response rates.

Figure 11: Processing multiple rounds of input addition by the NAND1 gate. Fluorescence of the
system was recorded at 22° C as a function of time. NAND1 gate (10 nM) in buffer 1 was initially
mixed with 100 nM of both RNA inputs I1 and I2. After 5 min, RNase H was added to the final
concentration of 0.01 U/µL. A new portion of the inputs was added every 13 min (as indicated by
the vertical arrows). The high slope (dashed line) of the fluorescence time-dependence represents
the high output (1), while the low slope (straight line) represents the low output (0).
Isolation of NAND Gate Using Click Chemistry
Placing DNA gates on a tile allows for a modular approach to circuit assembling, in which
logic units can be produced separately and stored for extended time before being integrated in
more complex circuits.5 In this paradigm, each NAND gate can be chemically cross-linked to
minimize the risk of strand separation and miss-hybridization in complex mixtures of DNA strands
during assembling complex circuits.
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Figure 12: Characterization and performance of a cross-linked NAND gate. A) Design of the
NAND1 gate tile with chemically modified tile strands. Alkyne modifications were added to both
the 5’- and 3’-terminal nucleotides of the FS strand. The reaction, initiated with the addition of
Cu+, produced covalent crosslinks between FS and 1a and 1b strands. The biotinylated BS strand
was used to separate the unit from the unreacted strands using a streptavidin-agarose affinity
column, followed by washing the cross-linked strands by 0.2 M NaOH. B) Analysis of the reaction
using 10% denaturing PAGE. From left to right, lane 1 contains the purified cross-linked product
with an expected length of 176 nt; lanes 2-4 contain strands 1a (82 nt), 1b (62 nt), and FS (32 nt);,
lane 5: a 114 nt DNA strand, used as a control. C) Fluorescent response produced by the crosslinked NAND gate. Following purification, the “click” unit was annealed to a stoichiometric
amount of the BS strand. Fluorescent response of 10 nM cross-linked NAND1 gate was obtained
in the presence of 200 nM F_sub and 100 nM inputs upon 180-min incubation at 22oC. Data
represents an average of three trials, with standard deviations shown as error bars. The threshold
dashed line represents the upper boundary of the 0 output and separates digital 1 from 0.
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The NAND gate manufacturing scheme includes the following stages: (1) annealing the 4
tile-forming strands with the BS stand being biotinylated, both strands 1a and 1b azide-modified,
and FS containing two alkyne modifications (Figure 12A); (2) copper-catalyzed ‘click’ chemistry
crosslinking of 1a and 1b to FS; (3) separation of the 1a/1b/FS crosslinking product using agarose
beads28. The scheme requires only 30 min of hands–on time and allows for obtaining a pure product
(Figure 12B, lane 1) without purification by gel electrophoresis.
After the purification step, the 1a/1b/FS conjugate was mixed with BS strand and tested in ability
to process inputs. The gate responded similar to the non-crosslinked tile and produced outputs in
agreement with the NAND logic (Figure 12C). The unit can be used in connection with other tiles
to generate different logic operations. An important advantage of the cross-linked gate at the stage
of development, is its ability to operate at low concentrations, higher temperatures and low Mg2+
concentrations without disassembling.

Integration of NAND Gates
Next, we demonstrated that the NAND gates can be connected into communicating
circuits. We, therefore, designed and characterized NAND2 gate (Figure 33, App.B). NAND2
operated using the same principle as NAND1, processing different inputs, I3 and I4. However,
instead of producing a catalytically active Dz, NAND2 produced the sequence of I2 as the high
output. The I2 sequence was composed of two separate fragments, parts of 2a and 2b strands.
These two fragments (green in Figure 13A) can be brought in proximity by one of the two NAND2
‘bridge’ sequences (Bridge 2a and 2b in Figure 13A), unless both bridge 2a and 2b are sequestered
by the inputs (I3 and I4, respectively, Figure 13B). Prior to the gate integration, the correct digital
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performance of NAND2 was verified using a molecular beacon (MB) probe for sensing the output
(Figure 33B, App. B).
Integration of the two gates was achieved by introducing Linker 1+2 strand (orange in
Figures 13). This strand placed the two gates in proximity for efficient communication. The
integrated NAND1 and NAND2 gates processed 8 possible combinations of the 3 inputs (I1, I3
and I4) according to the truth table (Figure 13C). Low outputs were achieved in the presence of I1
alone, or when I1 was combined with either I3 or I4. For example, in the presence of both I1 and
I4, bridge 2a brings in proximity the two output-forming fragments (green in Figure 13A) to form
the I2 sequence thus producing the high output for NAND2. This inactivates bridge 1b, while
bridge 1a is inactivated by I1 input. As a result, Dz catalytic core is not formed (low fluorescence,
digital 0). The high output is triggered by the absence of inputs, presence of I3 and/or I4 (alone or
in combination), or presence of all three inputs (Figure 13C). For example, in the presence of all
three inputs (Figure 13B), the NAND2 gate is in the low output state due to the complexation of
both bridge 2a and 2b with I3 and I4, respectively. This releases bridge 1b for binding BiDza and
BiDzb strands, thus producing the high output.
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Figure 13: Integration of two NAND gates. A. The integrated system in one of the low output
states. NAND2 processes inputs I3 and I4, which are complementary to “bridge” sequences of the
2a and 2b tile-forming strands. The true output of NAND2 is achieved when one of the bridge
fragments of NAND2 (e.g. bridge 2a, while bridge 2b is sequestered by I4) bring in proximity two
fragments of otherwise split “I2 sequence”. The united “I2 sequence” serves as one of the inputs
for NAND1. The “I2 sequence” and I1 sequester bridge 1b and bridge 1a, respectively, thus
disabling the Dz core formation and maintaining low fluorescence of the intact F_sub. The shaded
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region represents the DX-tile platform. The single-stranded DNA sequences are attached to the
platform via peg-linkers (dashed lines). Figure S5 shows integrated gates with complete sequences.
B. The integrated system in one of the high output states. In the presence of all three inputs, the
system should produce “1” output due to stabilization of the F_sub cleaving Dz core by bridge 1b.
In the presence of I3 and I4, NAND2 produces low output, and no “I2 sequence” complementary
to “bridge” of 1b is formed. The input I1 sequesters bridge 1a. C. Truth table of the integrated 3input NAND gates. D. Fluorescent response of the system containing integrated NAND1 and
NAND2 (10 nM) annealed in Buffer 1, was obtained in the presence of 200 nM F sub and 100 nM
inputs upon incubation at 22oC for 6 hr. Data represents an average of three trials. A dashed
threshold line represents the upper boundary of the “0” output and separates the high and low
output signals.
Figure 13D demonstrates the expected logical response of the two integrated NAND gates.
the high output generated in the presence of all three inputs produced a fluorescent signal only
about 1.6 times higher than the signal corresponding to “0” output. Other high-outputs were 4
times higher than low-output signals.
Discussion
Several technological problems should be solved before a DNA processor becomes
available for biomedical applications. Earlier, we 21 and others

31

placed communicating DNA

logic gates on a DNA tile aiming at increasing the efficiency of inter-gate communication by
bringing the interacting DNA sequences in close proximity. This helped reducing possible nonspecific associations and increasing the hybridization rates, thus accelerating the response. Most
importantly, each tile-localized circuit turns into a unit independent on its inter-unit interactions
(except input recognition), and thus can be referred as an individual molecular circuit. However,
previously reported tile-bound gates required unwinding of stem-loop elements for input
recognition, which slowed down the response despite high local concentrations of the
communicating units. Here, we designed NAND logic gate omitting the stem-loop architecture.
When performing multiple rounds of operation the gates respond immediately to the addition of
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inputs, which is a significant improvement over several min response found in pervious designs,
thus proving the hypothesis of facilitated response of stem-loop-free DNA gates.21
The output of the NAND gates can be detected either by an RNA-cleaving Dz activity
(Figure 10) or by a molecular beacon probe (Figure 33), which provides versatility in application.
For example, the RNA-cleaving function can be tailored for suppressing mRNA in gene therapy
applications,32,3] while the MB probe can be used for monitoring the gate’s outputs in a re-usable
format.21 Indeed, the designed NAND gates could be re-used at least 5 times in an RNase Hcontaining buffer with the reset time of 5-7 min, which is limited by the catalytic activity of RNase
H. The NAND gates could be stabilized by a covalent cross-link and isolated in a simple and robust
procedure, which preserved the accurate digital response.
The response of the individual NAND gates was observed shortly after input addition
(Figure 10 and 11). However, when the two gates were connected, longer time was required to
trigger the response. This indicates that the connection of the two gates within a single association
requires further optimization.

Conclusion
This study contributes to the development of DNA circuits by introducing a stem-loop-free
design for universal NAND gates, and a procedure for stabilization of the gate-forming DNA
associations by simple cross-linking followed by a quick and efficient isolation protocol. The intergate communication within a single association was achieved only between two NAND gates,
which indicates that integration requires further optimization, or alternative designs.
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Experimental Section
Materials. All oligonucleotides (Table 7) were custom synthesized by Integrated DNA
Technologies (Coralville, Iowa). F_sub was synthetized by TriLink biotechnologies (San Diego,
CA). All chemicals were purchased from Sigma-Aldrich or Fisher.
Annealing DNA strands to assemble the tile-associated NAND gates. The four NAND gateforming strands were mixed in Buffer 1 (50 mM HEPES-NaOH, pH 7.4, 50 mM MgCl2, 20 mM
KCl, 120 mM NaCl, 1 % DMSO, 0.03 % Triton X 100, pH 7.4) to a final concentration of 200
nM, heated for 5 min at 90⁰C and allowed to cool down to room temperature over 16 h.
Deoxyribozyme florescent assay. For the fluorescent experiments, the assembled NANDcontaining tile (10 nM) was mixed with F_sub (200 nM) and DNA or RNA inputs (100 nM). The
samples were incubated at 22oC for different time intervals (1-180 min) followed by measuring
the samples’ fluorescence using a Perkin Elmer LS 55 Fluorescence Spectrometer with Xenon
lamp (excitation at 485 nm, emission at 517 nm).
Resettable NAND gate. The assembled NAND-containing tile (10 nM) tile was mixed with
F_sub (200 nM). RNA inputs (100 nM) were added initially and then every 13 min 4 times. RNase
H (New England Biolabs, 5000 U/mL) was added to the input-containing samples upon a 5-min
incubation, to the final concentration of 0.01 U/µL. Fluorescence was recorded continuously using
the kinetics program on a Gary Eclipse Fluorescence Spectrophotometer with Xenon flash lamp
(excitation at 485 nm, emission at 517 nm).
DNA tile crosslinking using “click” chemistry. The reaction was performed by adding
CuSO4 (0.1 mM), Tris(3-hydroxypropyltriazolmethyl)amine (0.5 mM) and sodium ascorbate (5
mM) to a 500-µL solution of the NAND1 gate (500 nM) modified with azido and alkyne groups
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at specific positions (Table 7) in 50 mM HEPES-NaOH, 50 mM MgCl2 buffer, pH 7.4. Reaction
was carried out at 22oC for 16 h, and the cross-linked product was purified by affinity
chromatography using a streptavidin-agarose resin (Thermo-Fisher), as detailed in SI.
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CHAPTER 3: CUT AND PASTE FOR CANCER TREATMENT: A DNA
NANODEVICE THAT CUTS OUT AN RNA MARKER TO ACTIVATE A
THERAPEUTIC FUNCTION
Reproduced in part with permission from Molden, T. A., Niccum, C. T., &
Kolpashchikov, D. M. (2020). Cut and paste for cancer treatment: A DNA nanodevice that
cuts out an RNA marker sequence to activate a therapeutic function. Angewandte Chemie
2020, 132(47), 21376–21380. Copyright 2020 Wiley-VCH Verlag GmbH & Co. KGaA.

Abstract
DNA nanotechnology uses oligonucleotide strands to assemble molecular structures
capable of performing useful operations. Here, we assembled a multifunctional prototype DNA
nanodevice, DOCTR, that recognizes a single nucleotide mutation in a cancer marker RNA
followed by cutting out a signature sequence and using it as an activator for a ‘therapeutic’
function: cleavage of another RNA sequence. The proposed design is a prototype for a gene
therapy DNA machine that cleaves a housekeeping gene only in the presence of a cancer-causing
point mutation and suppresses exclusively cancer cells with minimal side effects to normal cells.

Introduction
Programmable and autonomous computing machine made of biomolecules can become a
tool for manipulating nature at the molecular and atomic levels and thus help controlling both
human health and materials’ properties1. DNA nanotechnology deals with assembling a broad
variety of functional molecular structures including DNA machines2. Recently, DNA associations
capable of intracellular detection of cancer markers3-5, and delivery of therapeutic payloads inside
cells6-8 have been designed. We undertake a seemingly logical step of applying DNA
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nanotechnology to improve oligonucleotide gene therapy (OGT). Conventional OGT agents
include antisense, siRNA, CRISPR/cas9 and deoxyribozymes (Dz)9,10. However, none of them has
produced a clinically significant anti-cancer treatment so far. Indeed, among the 6 anti-cancer gene
therapy drugs approved by August 2019, there is not a single OGT11. We believe that sophisticated
oligonucleotide-based nanodevices can be more effective in anticancer treatment than traditional
OGT agents. In our definition, therapeutic oligonucleotide nanodevices are multifunctional
nanoconstructs, which at a minimum must include the following functionalities: ability to
recognize an aberrant signal, process it, and take an action, such as destruction of a molecule or a
cell12. DNA nanodevices containing a built-in “processor” capable of analyzing the signals can be
called “DNA nanorobots”12. Our long-term goal is to design a DNA nanorobot that can (i)
penetrate into cytoplasm of a targeted cell; (ii) analyze a complex pattern of cancer markers to
ensure high selectivity of cancer cell recognition; (iii) autonomously activate its cleaving function
upon target recognition; (iv) be able to unwind an RNA target secondary and tertiary structure; (v)
cleave multiple copies of a vital (presumably housekeeping gene) RNA target. One advantage of
such approach in comparison with traditional OGT agents, is cancer cells-specific activation thus
eliminating a risk of damaging healthy cells13. Another advantage is the possibility to target
mRNAs of the genes other than cancer markers, which should increase efficiency of cancer cell
suppression.14. We previously described a nanodevice, that would target mRNA vital for cell
survival upon activation by cancer marker14, with the goal to trigger cancer cell death. In
intracellular environment, however, a cancer marker-bound nanorobots can lose their intracellular
mobilities required for finding RNA targets. In this paper, we describe a DNA nanodevice that
recognizes an RNA cancer marker with high selectivity, cuts a short fragment from the context of
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longer RNA sequence, which is followed by cleaving a housekeeping gene mRNA. We achieved
single nucleotide selectivity of marker RNA recognition under near physiological conditions.

Results and Discussion
The principle of the DNA nanodevice, named here ‘the Deoxyribozyme-Operated CancerTargeting nanoRobot’ (DOCTR), is shown in Figure 14A. The construct is based on an RNAcleaving deoxyribozyme (Dz) - short DNA that can cleave specific RNA sequences15.
It consists of the two cancer marker-cleaving Dz (Dz1 and Dz2) and strands Dz-a and Dzb, attached to a double-stranded (ds) DNA platform (Figure 14A). DOCTR-1 recognizes a
fragment of a cancer marker RNA characterized by a single base cancer-causing mutation. This
leads to cutting out short activating fragment (bold in Figure 14A), which ‘bridges’ Dz-a and Dzb fragments of DOCTR-1. It is speculated that the now ‘active’ DOCTR can freely migrate inside
the cell searching for its cognate mRNA targets. Brought together, Dz-a and Dz-b re-form a Dz
catalytic core that cleaves a targeted RNA (e.g. a housekeeping gene mRNA). Cleavage of mRNA
target will trigger cancer cell death.
As a cancer marker, we chose the KRAS gene mRNA. Ras proteins, encoded by HRAS,
NRAS and KRAS genes, are GTPases involved in cellular growth and proliferation16. Mutation
hotspots at codons 12, 13, and 61 have been found in ~ 25 % of all human cancers.16 Moreover,
about 87 % of all Ras mutations occur within KRAS isoform almost exclusively at codon 12,
where G→A nucleotide substitution is the most common12. Mutations in Kras has been previously
targeted using Dz 10-2317 and siRNA technologies18. However, despite significant efforts in
targeting Kras, no clinically significant therapy has been reported to date. Kras was dubbed an
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“undruggable target” due to retention of cancer cell viability even after Kras was knocked down19.
In this study, DOCTR-1 was designed to recognize the G →A nucleotide substitution followed by
cleaving of a vital housekeeping gene thus providing a principle solution of the ‘undruggability’
problem. We used synthetic RNA K58G as a marker of healthy cells, and mutated RNA K58A as
a marker of cancer cells (Figure 14B and Table 8).
DOCTR-1’s recognition/processing function was carried out by Dz1 and Dz2 (in Figure
14B), both of which a based on Dz10-23 core20. The actuating function was carried out by the split
Dz21 consisting of Dz-a and Dz-b fragments. In the absence of RNA cancer marker, the actuating
function was inactive. In the presence of a 21-nt fragment (NF-21) of the mutated RNA K58A,
Dz-a and Dz-b were brought together, thus forming Dz 10-23 catalytic core to enable the actuating
function. We initially tested the actuating function by fluorescence, where Dz-a and Dz-b cleaved
a fluorophore- and quencher-labeled F sub (Figure 14B), and then tailored DOCTR-1 to cleave a
fragment of a housekeeping gene.
Figure 14C demonstrates formation DOCTR-1 complex with a mobility of ~ 75 bp/ 150
nucleotides (nt) in agreement with the predicted size of 151 nt (Figure 14C, lane 2). The position
of the band was sifted up in the presence of K-58A RNA due to the formation of 209 nt DOCTR1/ K-58A RNA complex (Figure 14C, lane 3).
The objective of the next stage was to achieve selective release of NF-21 (Figure 14B)
from the cancer marker K-58A, but not from normal K-58G. All RNA cleaving experiments were
performed at 37oC in the buffer containing 2 mM [Mg2+] to mimic intracellular conditions, in
which RNA K-58A folds in a stable secondary structure (Figure 35, Appendix C). We compared
several DOCTR constructs in their ability to selectively cleave K-58A, but not K-58G (Figure 36
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App.C). DOCTR-1 was equipped with Dz1 containing 9-nt and 8-nt RNA-binding arms (Dz1 9/8),
and Dz2 with 9-nt and 13-nt RNA-binding arms (Dz2 9/13), see Table 10 for the melting
temperatures).

Figure 14: Design and assembling of Deoxyribozyme-Operated Cancer-Targeting nanoRobot
(DOCTR). A) Principle design: DOCTR cuts out a fragment of an RNA cancer marker (bold)
followed by its transferring to actuating function which cleaves mRNA target. ║indicates cleavage
sites. B) DOCTR-1 cuts out a 21-nt fragment (NF-21A) from K58A RNA. Shaded region
represents the dsDNA platform. Dashed lines are triethylene glycol linkers. The g>a mutation
differentiates cancer marker K58A from normal K58G. Dz-a and Dz-b form active Dz core after
binding NF-21A followed by cleavage of a fluorogenic substrate (F sub). C) Analysis of DOCTR1 assembling by agarose gel electrophoresis. Lanes 1 and 2 contained K58A and DOCTR-1. Lane
3 contained mixture of 42 nM DOCTR-1 and 420 nM RNA K58A. Arrows indicate positions of
K58A, DOCTR-1 and DOCTR-1/K58A complexes. Lane L contains double stranded (ds) DNA
ladder indicate in base pairs (bp).
The cleavage efficiency of DOCTR-1 was compared with that of the tile-free Dz1 and Dz2
using fluorescein-labeled K-58A-FAM as a substrate. Dz1 produced a 40-nt fluorescent fragment
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(F-40) and an 18-nt non-fluorescent fragment (NF-18); Dz-2 produced a 19-nt fluorescent
fragment (F-19) and a 39-nt non-fluorescent fragment (NF-39). Cleavage of K-58A-FAM by both
Dz1 and Dz2 would produce NF-18, F-19, and NF-21 activator sequence (Figures 14B and 35A,
App.C).
NF-21 was selectively cut out only by DOCTR-1, but not by the detached pair of Dz1 and
Dz2. Indeed, DOCTR-1 produced NF-21 when was incubated with cancer marker K-58A, (Figure
15, lane 2). NF-21 fragment was not observed when DOCTR-1 was incubated with normal K-58G
RNA (Figure 15, lane 6) suggesting the lack of DOCTR1 activation in healthy cells (Figure 14A
and B). This can be explained by the inability of Dz2 to bind K-58G when Dz1/K-58G complex
is mismatched. This suggests cooperativity between Dz1 and Dz2 in binding folded RNA. The
ability of DOCTR-1 to recognize the least destabilizing G-T mismatch under near physiological
conditions is notable. At the same time, tile detached Dz1 and Dz2 of the same sequences (Dz1
9/8 and Dz2 9/13) failed to produce NF-21 fragment (Figure 15, lanes 3 and 7).

Figure 15: Selectivity of K-58A cleavage by DOCTR-1. Samples contained either 500 nM RNA
K-58A (lanes 1-4) or 500 nM K-58G (lanes 5-8). Lane 2-4, 3-8 contained 10 nM activating agents
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as indicated. All samples were incubated 20 h at 37oC in buffer 1 (50 mM HEPES, 15 mM NaCl,
150 mM KCl, 2 mM MgCl2, pH 7.4) followed by separation in 12.5 % urea polyacrylamide gel
(PAG). The images were taken under UV light after GelRed staining. Lane L had a single-stranded
(ss) DNA ladder indicated in nucleotides (nt). The position of a 21-nt NF-21 activating fragment
is indicated by the arrows.
This can be explained by the combination of the greater cleavage activity of Dz2 with the
dimerization of Dz2 cleavage product, NF39 (see discussion to Figure 35, App. C). To achieve
NF-21 release by tile-detached Dzs, we tested a series of Dz1 and Dz2 pairs with longer RNAbinding arms (Figure 37, App.C). Dz1 10/9 and Dz2 10/13 acting together were able to cut out
NF-21 with high efficiency (Figure 15, lane 4). However, they also cut out the same fragment from
the wild type K-58G, thus compromising selectivity, so crucial for cancer-specific recognition.
DOCTR-1 cleavage efficiency was, however, lower (3.8 h-1) than that of the tile-free Dz1
and Dz2 (6.1 h-1) under multiple turnover conditions. DOCTR-1‘s variation lacking Dz-a and Dzb (DOCTR-2) had cleavage efficiency like that of the tile detached Dz1 and Dz2 pair (Figure 38,
App. C). This suggests inhibition of the Dz1/Dz2 by the actuating function. Further optimization
of DOCTR’s structure is required to minimize interference of Dz-a and Dz-b to the processing
function.
RNA-58 should initially bind Dz1 and Dz2 due to more favorable binding (sum of ΔG for
4 binding arms is - 32.8 kcal/mol) than to Dz-a and Dz-b (sum of ΔG of 2 binding arms is Δ 26.7
kcal/mol). However, after NF-21 activator sequence is cut out, its binding to Dz1 and Dz2 remains
weak, causing the NF-21 fragment to be transferred to Dz-a and Dz-b. Nearest neighbor modelling
predicts at least 6.2 kcal/mol tighter binding of NF-21 to Dz-a and Dz-b than to Dz-1 and Dz-2
under the experimental conditions. The transfer of the NF-21 fragment to Dz-a and Dz-b should
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be facilitated by its proximity to the Dz-1 and Dz-2 within DOCTR nanostructure. We
hypothesized that the transfer of the NF-21 fragment occurred without its released in solution.
To test this hypothesis, DOCTR-1 was pre-incubated 2 h with K-58A-FAM RNA followed
by addition of RNA NF-21-Alexa, a red dye-labeled NF-21 fragment (Table 8, App.C). If NF-21
were released in solution after K-58A-FAM processing, NF-21-Alexa would (at least partially)
replace NF-21 in the complex with DOCTR-1 thus labeling it red. If there was no exchange,
DOCTR-1 would remain unlabeled. Indeed, there was no labeling of DOCTR-1 observed in this
sample (Figure 16A, lane 6, upper part). At the same time, RNA K-58A was processed by DOCTR1, as evident by the release of F-19 product (arrows in lanes 4 and 6). The DOCTR-1/NF-21
complex is evident by the slight decrease in the mobility of the corresponding band (Figure 16B,
lanes 4 and 6 and Figure 39, App. C). Interestingly, NF-21-Alexa did not efficiently bind DOCTR1 even in the absence of K-58A, as indicated by the absence of the red-labeled DOCTR-1 band
(Figure 16A, lane 5). This data indicates that under experimental conditions (2 mM MgCl2, 37
°C), DOCTR-1 did not tightly bind NF-21 from solution due to low affinity (melting temperatures
of 35.7 and 35.8°C for Dz-a and Dz-b, respectively). For the tight binding to DOCTR-1, NF-21
needed to be cut out from K-58A first, and then transfers it to closely located the Dz-a and Dz-b
portion of the same DOCTR-1. In contrast, at 50 mM Mg2+ melting temperatures of Dz-a and Dzb fragments with NF-21 increase to 43.1°C and 42.8°C, respectively, which led to the formation
of DOCTR-1/NF-21-Alexa complex (Figure 39, App.C).
Transfer of the NF-21 fragment to Dz-a and Dz-b stabilizes the catalytic Dz core and thus
activates DOCTR-1 actuating function. The actuating function response was first monitored by
fluorescence, where Dz-a and Dz-b fluorogenic F sub (Figure 17A).
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Figure 16: Once cut out from RNA K-58A, NF-21 does not exchange with the solution-residing
NF-21-Alexa. DOCTR-1 (100 nM) was pre-incubated with 100 nM K-58A-FAM for 2 h followed
by addition of 100 nM NF-21-Alexa (lane 6). K-58A or RNA NF-21-Alexa were incubated with
DOCTR-1, lanes 4 and 5, respectively. Lanes 1, 2, 3 contained RNA K-58A, RNA NF-21-Alexa
or DOCTR-1 controls, respectively. After incubation 2 h at 37 °C, the reaction mixtures were
separated in 10% native 2 mM Mg2+ PAG. A) Image obtained under UV light without staining.
Arrow indicated F-19 cleavage product K-58A RNA. NF-21-Alexa migrated as a double band in
all samples because of imperfection of chemical DNA synthesis. B) Same gel imaged after GelRed
staining. Arrows indicate DOCTR-1/NF21 complex migrating slower than DOCTR-1 (for more
convincing image see Figure S5A).
Under this temperature, DOCTR-1 activated by either K-58A or NF-21A produced signal
~2 times above the background. The low signal was due to suboptimal binding of F sub to the Dza and Dz-b. We opted to conduct further optimization using a housekeeping gene mRNA fragment
rather than improving results with the model F sub. Neither addition of K-58G nor NF-21G
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triggered signal above the background (Figure 17A), thus proving high selectivity of DOCTR-1’s
actuating function.

Figure 17: The performance of DOCTR’s actuating function. (A) DOCTR-1 produced signal
above the background only in the presence of fully matched K-58A and K-21A. Samples contained
200 nM F sub, 10 nM DOCTR-1, and 10 nM activators K-58A, K-58G, NF-21A or NF-21G as
indicated. Fluorescent measurements were taken at 517 nm after 4 h incubation at 30oC in buffer
1. (B) Actuating function of DOCTR-1 targeting mRNA fragment of the PSMA3 gene (PA). All
lanes contained 500 nM PA-FAM (Table S1). Cleavage of PA-FAM by 100 nM DOCTR-PA in
the presence of 100 nM activators K-58A, K-58G, NF-21A or NF-21G as indicated. Samples were
analyzed in 12.5 % PAG after 16 h of incubation at 37 ⁰C in buffer 1. The photograph was taken
from unstained gel.
In contrast, tile-free Dz-a and Dz-b failed to produce fluorescent response in 2 mM Mg2+,
but were able to respond in 50 mM Mg2+ (Figure 40, App.C). The fluorescent responses of DOCTR
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version lacking Dz1 and Dz2 was almost identical to that of DOCTR-1 (Figure 40, App.C)
indicating that Dz1 and Dz2 did not interfere in the performance of actuating function.
Next, we adjusted DOCTR-1 for cleavage of a housekeeping gene sequence. As a cleavage
target, we selected PSMA3 gene coding for a subunit of 20S proteasomal core, which is essential
for cell survival.22 The target was represented by FAM-labeled fragment PA-FAM (Figure 41,
App.C). Cleavage of PA-FAM by DOCTR-PA generated expected 29-nt fluorescently labeled
fragment (F-29), upon activation by either K-58A or NF-21A (Figure 17B, lanes 3 and 6). No PAFAM cleavage was observed in the presence of single base mismatched K-58G or NF-21G thus
demonstrating excellent selectivity. Importantly, DOCTR-PA could not be activated by the
uncleavable analog of K-58Ad (Figure 17B, lane 4), which further verifies the importance of
cutting out the activator sequence NF-21 from the context of the long cancer marker sequence
prior achieving activation of the actuating function.
In this work, we addressed some problems of DNA-based anti-cancer OGT agents by
designing a multi-functional nanostructure that can accommodate several functional units acting
in cooperation with each other. This study makes a conceptual step toward improving traditional
anti-cancer OGT agents. Traditional OGT agents are designed to suppress cancer marker RNAs,
which may or may not affect cancer cell viability. Indeed, if a marker is expressed only in cancer
cells, it is not required for cell functioning. For example, some cancer cells bearing KRAS mutation
retain viability even after KRAS knock down19. On the other hand, if a gene is expressed in all
cells (overexpressed in cancer), suppression of this gene should inevitably affect normal cells. We
and others, proposed to activate an OGT agent by a cancer marker followed by targeting another
RNA, crucial for cell viability23. This approach promises both to increase efficiency and reduce
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side effects of the traditional OGT agents. Accordingly, DOCTR-1 was equipped with separate
recognition and cleavage functions.
A fundamental problem of all hybridization-based approaches is their low selectivity under
physiological conditions24. Split Dz probe can solve this problem21. DOCTR-1 equipped with split
Dz construct was able to differentiate RNA differing by a single nucleotide under near
physiological conditions. Importantly, in this study the least destabilizing G-T mismatch was
differentiated from A-T base pair under near physiological conditions.
All functional strands were attached to a common DNA scaffold, which ensured
cooperativity of all the components. For example, release of NF-21 was observed only by the tileattached but not tile-free Dz1 and Dz2. Another evidence of cooperativity is the fact that Dz-a and
Dz-b strands were active within DOCTR structure at 2 mM Mg2+ lost their activity in detached
form.
DOCTR-1’s recognition/processing unit (Dz1 and Dz2) cooperatively bind and unwind
RNA marker secondary structure, while lose their affinity to the short cleavage product (NF-21)
thus promoting its transfer to the neighboring Dza/Dzb actuating function. The complexity of this
multi-catalytic system is comparable with that of enzymatic supramolecular assemblies, while
accessibility via rational designed and custom oligonucleotide synthesis offers a hope for future
outperforming enzyme-based OGT strategies by DNA nanomachines.
In conclusion, we have introduced a DNA nano-construct with recognition/processing and
actuating functions. This device was able to selectively recognize an RNA sequence of mutated
KRAS gene, process it by cutting out a fragment, and use the fragment to activate cleavage of
another RNA. Both processing and actuating functions are highly selective, where only mutated
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sequence is cleaved or used as an activator. This development lays a foundation for the future anticancer drugs based on artificially designed nucleic acid nanostructures.
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CHAPTER 4: FACILITATING DNA AND RNA KINETICS WITH DNA
CEPHALOPOD TILE
Introduction
One of the obstacles hindering development of DNA nanomachines for operation inside
cells is their low binding efficiency with natural targets, exhibiting stable secondary structures1.
However, improving binding efficiency with longer analyte recognition arms, will necessarily lead
to decrease in selectivity against SNP-containing targets, resulting in off-target effects2. Another
approach involves equipping DNA nanomachines with unwinding arms, that would help
recognition/actuating unit interact with the highly structured targets without compromise in
selectivity3,4.
Additionally, performance of DNA nanomachines inside cells is subject to nuclease
degradation5. It is therefore desirable to make the devices fast-acting on their targets. Fast
hybridization kinetics of DNA nanodevice with their targets would be desirable in achieving this
goal. While hybridization thermodynamics has been well established for short oligonucleotides6,
the kinetic aspects of DNA hybridization received only limited attention7. Meanwhile,
hybridization kinetics act independently from thermodynamics and can affect the final outcome of
competitive hybridization reactions and time required for detecting or suppression of the nucleic
acid target. Hybridization rates can vary in broad ranges in solutions dependent on the conditions
and slowdown 40-400 times for surface-immobilized probes8. The major factors influencing
hybridization rates include (i) intramolecular folding of hybridization partners9 (ii) hybridization
temperature10(iii) nucleotide sequences of the hybridization partners11; (iv) buffer components
(including hydrophobic substances, crowding agents, and pH)12-14. Chemical modifications of
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nucleic acids including e.g. LNA15 or PNA16 can increase hybridization rates. It would have been
attractive to facilitate hybridization independent of buffer conditions using natural DNA or RNA
strands at ambient conditions (20-41C).
The work in this chapter aims at improving hybridization kinetics between DNA
nanomachines and highly structured natural targets. To achieve this task, we propose an alternative
approach for facilitating hybridization process – equipping a hybridization probe with diffusion
facilitator strands that would capture analyte molecules from solution and bring them closer to
hybridization site. We designed a hybridization probe construction equipped with diffusion
facilitators strands (tentacles) bound to a DNA tile (body) overall named ‘DNA cephalopod’,
which refers to the animal class that uses their tentacles to capture pray in aqueous environment.

The design of the DNA cephalopod tile
The construction consists of nine tile-forming strands (T1-T9), where each strand, except
for strand T5, consists of a tile-forming region and a single-stranded region at the 5’ or 3’ ends
(Figure 18A). All single stranded regions contain the same sequence and are free to hybridize with
the adaptor strands. Adaptor strands contain short sequences complimentary to the single stranded
portions of the tile-forming strands and to the fragments complimentary to the analyte, which aids
in the delivery of the analyte to the tile-associated molecular-beacon probe. Adaptors hybridizing
to the 3’ end of the tile-forming strands contain analyte-complimentary fragments on their 5’ ends
and were designated 5’ adaptors, whereas 3’ adaptors contain analyte-complimentary sequences
at their 3’ ends. There is a total number of eight available positions on the tile for hybridization
with 5’adaptors and eight positions for hybridization with 3’ adaptors (Figure 18A). Molecular
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beacon (MB) probe is hybridized with the single-stranded region of strand T5 at its 5’ “tail”, which
occurs without separating fluorophore and a quencher. Correct assembly of the tile and it’s
hybridization with the adaptor strands was confirmed by non-denaturing gel electrophoresis
(Figure 18B).

Figure 18. Design and assembling of the DNA cephalopod. A. Schematic representation of the
DNA cephalopod. Tile is formed by association of nine tile-forming strands (T1 – T9). MB probe
is hybridized with single-stranded end of T5. Tentacle strands (TS) capture the analyte by
complementary ‘capturing’ fragments and direct it to the MB probe for detection. Dashed lines are
all the same sequences, which can attract up to eight 5’-TS. Dotted lines are complementary to 3’TS. B. Analysis of tile association in 2.5 % agarose gel. Lanes 2-5 contained tile-associated MB
(strands T1-T9 + MB1); in addition, lane 2,4 contained 5’ tentacle strands; lanes 2 and 3 contained
An S4. Lane 1 contains 100 bp gene ruler DNA ladder (100 – 1000 bp ds DNA fragments).
Expected size of T1-T9 + MB-1 tile is 300 bp and 608 bp with the addition of 5’ tentacle strand.
Addition of An S4 is expected to increase the size by 10 bp. C. Secondary structure and the energies
of MB1 probe, An-16 and An-S4 under the experimental conditions (22oC, 50 mM monovalent
ions, 50 mM Mg+2) predicted by NUPACK. D. Hybridization kinetics of MB-probe and tileassociated MB probe with adaptors 5’ 9-9 (77) or 5’ ttt with An-S4.
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Our initial studies were conducted using a mostly linear model analyte with 16-nt sequence
complimentary to the MB (An-16, Figure 18C), and a structured version of this analyte with selfcomplimentary nucleotides on 5’ and 3’ ends, forming 4 nucleotides stem-loop structure (An-S4,
Figure 18D). The stem-loop containing analyte had slower hybridization kinetics with the MB
and thus larger region of linear rate increase.

Adaptor Selection
According to our hypothesis, tile with adaptor strands would have faster hybridization
kinetics, compared to the MB in solution. Adaptor strands with analyte-binding fragments would
first bind analyte from the solution transiently due to low melting temperatures of the fragments.
The analyte then would be funneled down the thermodynamic gradient, binding to the next
fragment of the adaptor with more base complementarity, and finally binding to the tile-associated
MB. To test this hypothesis a range of adaptor sequences that differ in length, number of fragments,
distance between fragments, and melting temperatures of the fragments, complementary to the
analyte were tested (see Tables 11 and 12, Appendix. D for complete list of all adaptors used).
The fluorescence of tile-associated MB with stoichiometric amounts of different adaptors,
in the presence of An-S4 was measured until fluorescent increase reached a plateau, and the initial
rate of hybridization was related to the fluorescent increase over the linear portion of the graph,
which was compared to the hybridization rate of MB in solution, measured as rate fold increase.
As a control, adaptor, consisting of polythymidine sequence, without sequence complementarity
to the analyte, was used, which produced fluorescent increase comparable to MB in solution (See
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Figure 44, App. D for complete list of rates with all adaptors used in study).We have tested 5’ and
3’ adaptors separately. Additionally, parameters, that may influence adaptor performance, such as
(i) number of fragments, (ii) melting temperature of fragments, (iii) distance between fragments,
(iv) length of adaptor’s single stranded region have been tested separately in systematic manner.
Dependence on the Melting Temperature of Fragments
All analyte-binding fragments used in the study had melting temperatures between 0 and
28 C. In general, it appeared that melting temperatures of fragments close to the reaction
temperature (22C) corresponded to faster hybridization rates. For a series of 5’ adaptors containing
analyte-binding fragments with 8-8 nt (Tm= 13.2 C), 9-9 nt (Tm= 22.6 C), 9-10 nt (Tm= 22.6C
and 28.4 C) and 10-10 (Tm= 28.4 )C, 5’ 9-9 adaptors exhibited the fastest hybridization rates (15.1
times increase, compared to MB-1 probe in solution), while 5’ 8-8 and 5’ 9-10 had similar rates
(10.4 and 10.3 times increase, respectively). Adaptor 5’ 10-10 with highest melting temperatures
of fragments exhibited the slowest kinetics from the series (4 fold increase, compared to MB-1
probe), which is likely due to analytes binding to the adaptors too tightly (Figure 19A). Similar
trend was observed for 3’ adaptors. For 3’ 5-8 (26), 3’7-9 (26) and 3’8-10 (26), that have all other
parameters, such as length of single stranded region and distance between the analyte-binding
fragments (5-7 nt) the same, increase in melting temperature of the fragments correlated with the
increase in rates (See Figure 45A, App.D ) . Adaptor 3’ 5-8(26) had melting temperatures of 0 and
13.2C, adaptor 3’ 7-9 (26) had melting temperatures equal 5.4 and 22.6, and adaptor 3’ 8-10 (26)
had melting temperatures equal to 13.2 and 28C, and their respective hybridization rates had 2.74, 3.27- and 5.77-fold improvement compared to MB in solution. (Figure 45A, App.D).
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We have also tried an approach, where the melting temperatures of fragments
complimentary to the tile strands, were reduced from 42C to 21C (the temperature of the
experiments). We wanted to test this more fluid approach, where the strands could dissociate freely
from tile into the solution, where they are able to capture the analytes, and then they could associate
back, thus bringing the analytes with them. However, the rates obtained by this method were lower
than for just MB in solution.

Figure 19. Selection of the most efficient tentacle strands. A. Effects of melting temperature
increase of analyte-binding fragments on hybridization rate kinetics (determined as change in
fluorescence of MB per second). B. Effects of the single nucleotide portion length of the tentacle
strands (determined as change in fluorescence of MB per second). Different shades represent
comparative pairs with different lengths. C. Effects of adaptors with 2, 3 or 4 analyte-binding
fragments on hybridization kinetics (determined as change in fluorescence of MB per second). D.
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Effects of the distance between analyte-binding fragments on the tentacle strands (determined as
change in fluorescence of MB per second). Different shades represent comparative pairs with
different distances between analyte-binding fragments. All slopes represent an average fluorescent
increase of 3 independent trials and were determined for the first 120 seconds after addition of the
analyte. Hybridization rates of tile-associated MB were compared with free MB in solution (MB).
Change in fluorescent intensity of 10 nM MB in the presence of 20 nM An-S4 was measured for
tile associated MB with stoichiometric amounts of different variations of 5’ adaptors. The number
of nucleotides complimentary to the analyte in each fragment is indicated by the numbers separated
by dashes; number in parenthesis indicates total adaptor length in nucleotides. 5’ ttt represents
control adaptor, that consists of polythymine sequence.
Dependence on the number of fragments complimentary to the analyte
Dependence on the number of fragments complimentary to the analyte was different
between 5’ and 3’ adaptors. For 5’ adaptors, it was determined that adaptors with two binding
fragments have faster hybridization kinetics, compared to adaptors with three or four analytebinding sequences, where 5’ 8-8 (77), 5’ 8-8-9 (77) and 5’ 6-8-8-9 (104) had decreasing trend in
the rate of reaction (Fig 19C). On the contrary, for 3’ adaptors, increase in numbers of fragments
appeared to positively influence the rate. For example, 3’ 5-8 (26) had 2.74-fold rate increase,
where addition of another fragment to the adaptor 3’ 5-8-10 (45) had rate fold increase of 4.10,
compared to solution MB. Similar trend was observed for 3’ 7-8 (45) and 3’ 6-7-8 (69), where
addition of fragment has changed rate increase from 2.08 to 4.24 (SI Figure 45B, App.D).
Dependence on the length of single stranded region.
Overall, we haven’t observed a definitive dependence of hybridization rates on the length
of single stranded region extending in solution. For example, a series of 3’ adaptors, differing in
length of single stranded region with 5 and 8- nt analyte-binding fragments, 3’ 5-8(26), 3’ 5-8 (45),
3’ 5-8 (73) all exhibited similar hybridization rates (2.74, 3.71 and 3.13 fold compared to MB
respectively) (See Figure 45C, App.D). For the 5’ series, adaptors 5’ 5-8 (26) and 5’ 5-8(45) had
similar rates (5.9 and 5.41 fold increase in rates compared to MB respectively). Similar behavior
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was observed for adaptor pairs with 3 analyte-binding fragments: 5’ 8-8-9 (57) and 5’ 8-8-9 (77)
had rate increases of 8.66 and 8. 57 folds respectively (Figure 19B). The only, outlier in the study
was represented by the pair of adaptors 5’ 8-8 (47) and 5’ 8-8 (77), where 5’ 8-8 (77) had
significant increase in rates compared to its counterpart (6.00 vs 10.48-fold increase respectively).
Dependence on the distance between analyte-binding fragments.
Much like distance of single stranded region, it appeared that the distance between analytebinding fragments doesn’t have large effect on the hybridization kinetics. Comparing the following
pairs, 5’ 5-8 (26) and 5’ 5-8 (45), 5’ 5-8 (45) with longer distance between analyte-binding
fragments (21 nt vs 10 nt), as expected had slightly lower rate (5.41 compared to 5.90-fold increase
respectively). Similarly, 5’ 8-8-9 (57) with 10 and 11 nt between fragments, compared to 5’ 8-8-9
(77) with 20 and 21 nt fragments, had slightly higher rate (8.66 compared to 8.57-fold increase
respectively). However, between 5’ 8-8 (47) with 20 nt distance and 5’ 8-8 (77) with 35 nt distance
between the fragments, 5’ 8-8 (77) had the highest hybridization rate from all adaptors (10.48-fold
improvement, compared to 6.00 fold for 5’ 8-8 (47) (Figure 19D). It is possible, that extra length
of the adaptor allows the strand to take a conformation, in which analyte is brought in closer
proximity to the MB.
Overall, it appears that the melting temperatures of the analyte-binding fragments, is the
main contributor to the hybridization rates between tile-bound MB and the analyte. Additionally,
it appears that our original hypothesis of thermodynamic funneling of the analyte is most likely
incorrect. It is more likely, that a different model, where analyte is captured by all available
fragments at the same time, which increases its concentration around tile-bound MB and increases
hybridization rates, is in place.
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Overall, 5’ adaptors had a much large influence on the rate, compared to the 3’, and
combining best performing 5’ and 3’ adaptors had worsened the effect. For comparison, the best
performing 5’adaptor had a rate of fluorescent increase of 0.12 RFU/sec, compared to 0.06
RFU/sec for the best performing 3’ adaptor. However, the tile with both 5’ and 3’ adaptors had a
fluorescent increase of 0.09 RFU/sec, while MB typical rate is 0.01 FU/sec (see Figure 45D,
App.D). This can be explained by increase in electron density around the tile in the presence of
both adaptors, which decreases analyte binding due to these electrostatic interactions.
Additionally, we believe, that higher rate increase in the presence of 5’ adaptors (12 times
compared to 6 times for best performing 3’ adaptor) is due to orientation of adaptor-bound analyte
relative to tile-associated MB. Overall, the best performing adaptors were 5’ 8-8 (77) and 5’ 8-9
(49), both with two analyte-binding fragments and melting temperatures between 13.2 and 22.8oC.
We selected adaptor 5’8-8 (77) for all consecutive experiments, (see figure 44A, App.D).

Adaptor strand stoichiometry
Since the tile contains eight possible positions for 5’ adaptors, we studied if the number of
the tile-associated adaptors influences the hybridization rates. The hybridization rate, indicated by
fluorescent increase, increases with the adaptors concentration, until all available positions on the
tile are occupied. The increase in fluorescence is consistent with a sigmoidal curve fit, where there
is a little change in hybridization rates at adaptor concentration below 25 % and above 87%, and
almost linear dependence between 25 % and 87% of positions occupied, The tile with all adaptor
positions occupied has fluorescent increase more than ten times faster compared to MB in solution,
additionally increase in adaptor concentration past the stoichiometric amounts of binding positions
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doesn’t further increase the hybridization rate (last bar in Figure 20A). Overall, the rate of
fluorescent increase is proportional to increase of adaptor concentration.

Figure 20. Number of the tentacle strand on the DNA cephalopod matters. A. Determination of
tentacle strands concentration on hybridization of tile-associated MB with An-S4. Determined as
increase in fluorescence of 10 nM tile-associated MB in the presence of 20 nM An-S4 and 0-100
nM adaptor 5’ 8-8 (77). 80 nM represents upper limit, where all available positions on the tile
should be occupied with the adaptors. 100 nM represents excess of stoichiometric amounts of
adaptors. B. LOD for An-16. 10 nM of MB in solution or tile-associated MB with 80 nM of
adaptor 5’ 8-8 (77) or 5’ ttt was incubated with 0 – 5 nM An-16 for 10 min and fluorescence of
each concentration was determined in triplicate. LOD was determined as concentration that
produced signal equal to the background plus three standard deviations. 5’ ttt represents control
adaptor, that consists of polythymine sequence. Orange, grey, yellow, and blue lines represents
thresholds, fluorescence above which indicates detection of An-16 by-tile-associated MB with the
adaptors 5’ ttt, 5’ 8-8 (77), 5’ 8-8- 9 (77) or by solution MB-1 probe respectively.
Comparison of LOD
Next, we investigated if tile-associated MB with full set of adaptors has lower LOD than
solution associated MB. For the linear An-16 the LOD was 1 nM for solution MB and 450 pM for
tile-associated MB with adaptors 5’ 8-8 (77), while tile with 5’ ttt adaptors had LOD of 1.9 nM.
Interestingly, the adaptor having 3-analyte binding fragments 5’8-8-9 (77) had even lower LOD,
equal to 62 pM (Figure 20B). LOD was significantly higher for the structured An-S4, which was
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determined to be 1.6 nM for tile with full set of 5’8-8 (77), while MB in solution has LOD about
7 times higher (10.5 nM), LOD for tile with control adaptors 5’ ttt was almost double of MB in
solution (19.6 nM) (Figure 46C, App.D). One possible explanation for lower LOD for tileassociated MB, is that the presence of adaptors increases local concentration of analyte around
MB, which potentially affects not just kinetics but also equilibrium of the hybridization reaction.
One argument supporting this hypothesis is increase in the final fluorescence of tile-associated MB
with the increase in adaptor concentration (Figure 46A, App.D). With both structured and
unstructured analytes, tile-associated MB with polythymine adaptors had LOD almost twice of the
MB in solution. We also determined LOD for the highly structured fragment of 16S rRNA (An16S-60), which was 0.75 nM in the presence of analyte-specific adaptor 5’ 6-9, 0.45 nM for control
adaptor 5’ ttt, while MB-2 probe in solution wasn’t able to detect this analyte under experimental
conditions (Figure 46B, App.D).

Detection of E.coli 16S rRNA
Having established the design principles using model An-16 and An-S4 analytes, we
applied DNA cephalopod for detection of natural E.coli 16S rRNA. This target has diagnostic
significance due to point mutations present in pathogenic strain O157:H717. Additionally, the of
~1500 nt sequence E.coli 16S rRNA has highly folded secondary structure, resulting in
exceptionally slow hybridization kinetics. We have first tested the performance of the tile with a
synthetic 61-120 nt 16S rRNA fragment (An-16S-60). This fragment contains secondary structure
with two stems (ΔG= –18.80 kcal/ mol) and is only detectable by the MB-2 probe after a 5 hrs
(Figure 21 D). Even after 5 hours, the fluorescent increased produced by MB in solution with An77

16S-60 was only about 20 % from the fluorescence of just MB. DNA cephalopod without
unwinding arms, produced similar fluorescence increase in the same amount of time, as solution
MB (See Figure 21C). Addition of just two unwinding arms to T4 and T6 strands improved
hybridization with the analyte Figure 21C). However, best hybridization was achieved in the
presence of additional unwinding arm on T3, which unwinds self-complimentary sequence, that
hybridizes with the MB (see Figure 21A and C). DNA cephalopod, equipped with three RNA
unwinding arms (attached to T3,T4, and T6 strands, figure 21A), and analyte specific adaptor, was
able to reach detection threshold in about 1 min (Figures 21C and 21D).

Figure 21. Design of DNA cephalopod tile and detection of 16S rRNA analyte fragment. A.
Schematic representation of hybridization 16S rRNA analyte with DNA cephalopod tile. Tile is
equipped with RNA unwinding arms, added to strands T3,T4, and T6. Dashed lines represent PEG
linkers, arrows represent 5’ to 3’ direction of oligonucleotide sequences. B. Analysis of tile
association in 2.5 % agarose gel. Lanes 2-5 contained tile-associated MB (strands T1-T9 + MB2);
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in addition, lane 2,4 contained 5’ tentacle strands; lanes 2 and 3 contained An-16S-60. Lane 1
contains 100 bp gene ruler DNA ladder (100 – 1000 bp ds DNA fragments). Expected size of T1T9 + MB-2 tile is 285 bp and 456 bp with the addition of 5’ tentacle strand. Addition of An 16S60 is expected to increase the size by 30 bp. C. Effects of tile and adaptors on hybridization kinetics
of tile-associated MB-2 with An-16S-60, represented as increase in fluorescent intensity of MB
with time. Tile without RNA unwinding arms (green curve), with 2 unwinding arms (gold curves)
or with 3 unwinding arms (navy curves) with adaptor 5’ 6-9 (47) (triangles) or with control adaptor
5’ ttt (squares) were incubated with An-16S-60 and increase in fluorescence of MB was recorded
as a function of time. Fluorescence of tile-free MB in the presence of An-16S-60 is represented by
the light blue curve. D. MB-2 probe reaches its maximum of fluorescent increase (20 %) in the
presence of An-16S-60 in 5 hrs. Tile with T3,T4,T6 unwinding arms reaches detection threshold,
determined as fluorescence equal to average background fluorescence plus its 3 standard
deviations, in 1.25 min for analyte-specific adaptor 5’ 6-9 (47) and in 1.68 min for adaptor 5’ ttt.
Tile with adaptors 5’ 6-9 (47) or 5’ ttt reaches signal plateau in 10 min, with S/B of 1.9 and 2.2
respectively. Data represents an average of three independent trials.

5’ 6-9 (47) adaptor sequence selected for this analyte, had two analyte-binding fragments
with melting temperature around 25 °C, and targets single-stranded region of the analyte, free of
any secondary structures. Interestingly, the control adaptor 5’ ttt required only slightly longer time
to reach detection threshold, compared to analyte-specific adaptor 5’ 6-9 (1.68 min compared to
1.25 min), but was able to facilitate higher fluorescent signal at the plateau (2.2 vs 1.93 for analytespecific adaptor) (Figure 21D). This effect can be attributed to extensive secondary structure of
RNA and by chance a string of six nucleotides, consisting of A’s and G’s, that are present in the
stem structure, complimentary to MB (see SI Figure 6A). We hypothesized that 5’ ttt adaptor is
capable of binding to this sequence and partially unwinding it, allowing for easier hybridization
with the MB. This unusual effect is diminished when RNA bases were changed to DNA, resulting
in less stable secondary structure (~ –14 kcal/mol) or when A-T substitution resulted in a less
stable stem structure (ΔG = –10.73 kcal/mol predicted by mFold). In both cases, there was faster
hybridization of MB in the presence of analyte-specific adaptor 5’6-9 compared to 5’ ttt (see Figure
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47. App.D). Additionally, less stable secondary structure improved ability of MB in solution to
hybridize with the analyte, resulting in modest increase of fluorescence. However, when one of
the G’s in the stem sequence was substituted for a C in a structure that preserved overall secondary
structure of the original analyte, adaptor 5’ ttt had the same rate of fluorescence increase as tile
without any adaptors, while adaptor 5’ 6-9 produced noticeable increase in fluorescence ( Figure
47, App.D).
Following the experiments with the 61-120 fragment of 16S rRNA, we have performed
kinetics experiments with tile-free or tile-associated MB for the full sequence of 16S rRNA,
extracted from E.coli cells. To achieve fluorescent increase in the presence of analyte,
concentration of the tile needed to be increased two times (from 20 to 40 nM), while concentration
of 16S rRNA needed to be around 98 nM (Figure 22). Additionally, longer incubation times with
the analyte were required for tile-bound and solution MB. Comparing with the An-16S-60
fragment, tile incubation times needed to be increased from 5 to 45 min, while solution MB had
increase in fluorescent signal only after 20 hrs, compared to 5 hrs for the shorter analyte.
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Figure 22. Extraction and kinetics of 16S rRNA of E.coli. A. RNA extraction was performed from
E.Coli cells using New England Bio Labs RNA extraction kit. Purity and integrity of extracted
RNA was determined by 1% agarose gel electrophoresis. Riboruler HR ladder was used to estimate
the sizes of RNA. B. Comparison of hybridization rates of tile-free MB, tile-associated MB with
T3, T4, T6 unwinding arms without adaptors or in the presence of 5’ ttt or 5’ 6-9 adaptors with
16S rRNA extract. 40 nM tile and 98 nM of 16S rRNA were used. Fluorescent increase was
determined over the period of 45 minutes for tile-associated MB. MB free in solution didn’t
produce any fluorescent increase over the same time period and needed to be incubated with the
16S rRNA extract for 20 hrs to produce fluorescent increase depicted in the graph.
Comparison of hybridization kinetics constants
We have determined that the rate of fluorescent increase for the tile-associated MB with
the adaptors present is about 10-12 times greater that for solution MB. To quantify hybridization
rate increase more accurately for the DNA cephalopod, the rate constants for hybridization reaction
were determined. For the following reaction MB + An ⇆ MB/An, the fluorescent increase can be
related to the rate of MB-analyte duplex formation. Then, assuming second order kinetics and
negligible rate of the reverse reaction, hybridization constant was determined as k=
Rate/([MB/An]), where the change in fluorescence was related to the change in concentration of
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fluorescent duplex by constructing calibration curve with various concentrations of MB/An (see
Figure 43, App.D for calibration curves).
Table 3 lists the kinetic constants for hybridization reaction of tile-associated MB with or
without analyte-binding adaptors, as well as for non-tile MB. Rate constants were determined for
solution systems and in heterogeneous format, where tile or MB were attached to the streptavidin
coated silica beads by biotinylated linker (see Figure 23A). Ratio of rate constants was then used
to determine fold increase in hybridization kinetics for tile-associated MB compared to tile-free
MB.
In solution with An-16, kinetic constant for tile with adaptors 5’ 8-8 (77) was 1.5 × 106 M1

sec-1 compared to 2.3 × 105 M-1 sec-1 for MB in solution, resulting in 6.5-fold increase in

hybridization rate. As expected, both constants decreased for more structured An-S4, 14 and 16
times for tile and for solution MB, respectively.
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Figure 23. Comparison of the rate constants for MB and tile-associated MB in solution and on
beads. A. Design for heterogeneous system. Biotin-conjugated strands T9 of the tile and MB probe
hybridized with biotinylated complimentary strand, are able to bind streptavidin-coated silica
beads, prior to addition of the analyte. Hybridization rates constants of tile-associated MB were
compared to MB without tile, and hybridization rate fold increase was determined as the ratio of
the kinetics constants averages for An-16 (B), An-S4 (C) and An-16S-60 (D). Rate fold increase
was determined for tile-associated MB without adaptors, with 5’ ttt control adaptors, and with best
performing adaptors. The structure for each analyte was predicted using Mfold software. For An16S-60 MB probe wasn’t able to achieve hybridization in heterogeneous format.

However, overall increased in the rate remained similar to the An-16, 7.4 times (see Figure
23C). The rates for both tile-associated MB without adaptors and tile with control adaptors 5’ ttt
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were slightly lower than for solution MB for both linear and structured analytes, possibly due to
the increased electron density and electrostatic interactions between tile and analyte.
As expected, kinetics constants were much lower for the heterogeneous system, since
heterogeneous hybridization kinetics are known to be much slower than solution-based systems.
Specifically, the hybridization rate for An-16 has decreased 35 times for the MB and 22 times for
the tile with adaptors. For the folded An-S4, MB experienced 78 times drop- off in rate, but for
tile with adaptors decrease in rate remained roughly the same as for linear analyte (22 times).
Overall, the rate increase for tile-associated MB with adaptors was much more pronounced in
heterogeneous format, and resulted in 10 and 28 times increase in the rate for An-16 and An-S4,
respectively (Figure 23). Additionally, in heterogeneous experiments, the rate for hybridization of
tile without analyte binding adaptors and for tile with nonspecific adaptors 5’ ttt, was slightly
higher than for MB. This could possibly be explained by extension of tile-bound MB further in the
solution from the solid support, compared to just MB.
We have calculated the kinetics constants for hybridization of tile-associated MB with An16S-60 rRNA fragment for the tile with T3,T4,T6-unwinding arms (see Table 3) Resulting
constants are 1.5 ± 0.4 X 104 M-1 sec-1, 4.3 ± 1.7 X 104 M-1 sec-1, 4.1 ± 6.1 X 104 M-1 sec-1 for
tile without adaptor, tile with 5’ ttt and tile with adaptor 5’ 6-9, respectively, while tile-free MB
had a rate constant of 88 ±36 M-1 sec-1, resulting in ~ 465 times rate improvement for the tile with
unwinding arms and adaptor 5’6-9. Comparing this data to hybridization rates with An-S4,
indicates that for highly structured analytes, unwinding arms have a bigger effect, than analyte
adaptors. For comparison, the rate for hybridization of tile-associated MB with An-S4 (ΔG = –
4.88 kcal/mol, predicted by mFold) was 1.2 ± 0.2 × 104 M-1 sec-1 without addition of adaptors,
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whereas rate of tile hybridization with unwinding arms for much more stable analyte 16S (61-120
nt) (ΔG= –18.80 kcal/mol) is about the same or even faster (1.5 ± 0.4 ×104 M-1 sec-1).
Table 3. Kinetics constants for hybridization reaction (k, M-1×sec-1)

MB
No
adaptors
Adaptors
5’ ttt
Adaptors
5’ 8-8 (77)

An-16
2.3 ± 0.4 ×
105
1.3 ± 0.6 ×
105
1.8 ± 0.3 ×
105
1.5± 0.3 ×
106

Solution
Sl-4
1.4 ± 0.2 ×
104
8.6 ± 0.2 ×
103
1.1 ± 0.1
× 104
1.1 ± 0.2
× 105

An-16S
8.8 ±3.9 ×
101
1.5 ± 0.4×
104
4.3 ± 0.2 ×
104
4.2 ± 0.6 ×
104

An-16
6.7 ± 2.7 ×
103
1.0 ±0.2 ×
104
7.4 ± 1.7 ×
103
6.7 ± 0.2 ×
104

On beads
Sl-4
1.8 ± 0.5 × 102

N/A

5.8 ± 1.0 × 102

2.1 ± 0.4 X 103

4.0 ± 1.3 × 102

6.7 ±3.0 X 103

5.0 ± 0.3 × 103

1.8 ±0.8 x 104

An-16S

Addition of adaptors to the tile for detection of An-S4 improved the hybridization rate
constant by almost a fold (1.1 ±0.2 × 104, compared to 1.5 ± 0.4 × 104 M-1 sec-1). However,
addition of the adaptors to the tile for the detection of analyte 16S only improves hybridization
kinetics by about 2.7 times (1.5 ± 0.4 × 104 vs 4.1 ± 6.1 × 104 M-1 sec-1). This data, also indicates,
that adaptor 5’ 6-9 (47) selected for 16S rRNA analyte was not the most optimal.
Additionally, we have performed kinetics experiments with An-16S-60 in heterogeneous
format, as described previously. The resulting constants were 2.1 ±0.4 X 103 M-1 s-1 for tile with
unwinding arms T3,T4,T6 and no adaptors, 6.7 ±3.0 X 103 M-1 s-1 for tile with 5’ ttt adaptors and
1.8 ±0.9 X 104 M-1 s-1 for tile with adaptors 5’ 6-9 (Table 1), whereas MB probe failed to detect
the analyte in this format. Heterogeneous format had decreased kinetics constants by about 7 folds
for tile without adaptors and tile with adaptor 5’ ttt, however tile with adaptor 5’ 6-9 had a decrease
in rate of only 2 times. Unlike solution experiments, this format also reduced non-specific
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interaction of adaptor 5’ttt with the analyte and improvement in rate in the presence of analytespecific adaptor 5’6-9 was greater than for 5’ ttt.

Conclusion
The proposed approach is an important step towards development of rapid hybridization of
DNA nanomachines with natural targets of clinical significance. Addition of analyte-specific
adaptors allows for increased local concentrations and decreased LOD for improved sensitivity.
More importantly, for highly structured targets, combination of analyte-specific adaptors and
unwinding arms allows to significantly reduce analysis time (from 20 hrs to 45 min), as well as
increasing hybridization kinetics ~ 465 times.
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CHAPTER 5: DOCTR-2: MULTIFUNCTIONAL DNA NANOMACHIINE
WITH IMPROVED CLEAVAGE FUNCTION AND ABILITY TO
PROCESS TWO MUTATIONS IN KRAS GENE
Introduction
Next, we wanted to design of multifunctional DNA nanorobot, DOCTR-2. We envisioned
to employ the principles described in Chapters 2-4 to develop a DNA nanomachine having the
following functions: (1) recognition of multiple target inputs, (2) ability to perform computational
operations based on the logic gates, (3) facilitate unwinding and hybridization of targets with
complex secondary structures; (4) facilitate its uptake inside the cell. Additionally, we wanted to
optimize nanodevice for detection and cleavage of biologically important targets, thus facilitating
development of the field from hypothetical towards real clinical applications.
In Chapter 2, DOCTR-1 nanodevice was designed for activation of therapeutic function in
the presence of G→A nucleotide substitution in codon 12. This mutation results in G12D
substitution in amino acid sequence of the protein and is known initiator of pancreatic cancer1.
Moreover, 95 % of all pancreatic cancer tumors have mutations in codon 12 of the gene, where
G12D is the most common (50 %), followed closely by G12V, resulting from G→U mutation2.
Design of DOCTR-1 nanodevice, which was based on two DNA strands, annealed to
generate ds DNA platform, didn’t provide sufficient flexibility for addition of multiple functions
other than recognition and actuation, since two DNA strands combined on a dsDNA platform
would yield a total of four single stranded attachments (one at the 5’ and 3’ ends of each strand).
Additionally, DOCTR-1, had low cleavage efficiency for the fragment of housekeeping
gene (PA-FAM), presumably due to low activity of split BiDz in the presence of near physiological
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2 mM Mg2+. Specifically, 10 nM DOCTR-1was incapable of cleaving PA-FAM, while 100 nM
DOCTR-1cleaved about 30 % of the target in 24 hrs (Table 10), resulting in 0.08 h-1 catalytic
turnover, which is about 48 times lower than that of Kras cleavage by tile-associated Dz-1 and Dz2 (Fig. 42, App. C).
We have tried several different designs, that would give us opportunity to generate multiple
functionalities within nanodevice scaffold and improve performance of DNA nanodevices under
physiological conditions (see Appendix E, Figures 48-50 for additional designs and results).
However, none of them yielded significant improvement in percent of RNA cleaved, presumably
due to incomplete tile association.
On the other hand, DNA cephalopod tile, is a stable and well characterized platform, that
at the minimum has 16 single stranded ends for attachment of functional elements. Additionally,
we hypothesized that since DNA cephalopod tile is large, (constructed from 9 tile-forming
strands), the presence of multiple phosphate groups might increase local concentration of Mg 2+
and improve catalytic efficiency of tile-associated deoxyribozymes. To test this hypothesis, we
attached Dz-2 (9/13) strand, previously used in DOCTR-1 design, to the DNA cephalopod tile and
checked for cleavage efficiency in physiological buffer. Compared to DOCTR-1, cleavage
efficiency of Dz-2, attached to the DNA cephalopod tile platform, has improved around 4 times
(from 3.8 h-1 to 13.7 h-1). Moreover, Dz-2 attached to DNA cephalopod tile, had higher percent of
RNA cleaved, than Dz-2 in solution, which was not the case for DOCTR-1 design (Table 4). We
have proceeded with DNA cephalopod tile platform to design multifunctional nanomachine for
recognition and treatment of two mutations in Kras gene, DOCTR-2.
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Table 4. Cleavage efficiency of Dz-2 in solution or attached to DNA platform
Tile type or Dz

Catalytic turnover (h-1)

Cleavage %

DNA cephalopod (Dz-2, 9/13) 41.2 %, 1.5 h

13.7

Dz-2 (9/13) in solution

10.4

31.4 %, 1.5 h

DOCTR-2 design and operation principles
We have modified DNA cephalopod tile with Dz-1 and Dz-2 strands attached to tile strands
T7 and T9 respectively, keeping previously optimized sequence for Dz-1 (9/8 nt binding arms)
and Dz-2 (9/13 nt binding arms). Binary Dz (Dz-a and Dz-b strands) were attached to strands T4
and T5 (Figure 24 ). The rest of the single stranded ends remained available for hybridization with
adaptor strands, that could facilitate diffusion of Kras target and PSMA3 housekeeping gene, or
for addition of other functionalities.
The therapeutic function, cleavage of the housekeeping gene, was activated in the same
manner as previously. After sensing and recognition of either of mutated Kras sequences by Dz-1
and Dz-2, the computational unit with OR logic function would produce 21 nt activator sequence
as its high output (cleavage product of cooperative action of Dz-1 and Dz-2). Presence of 21 nt
sequence activates therapeutic function of binary Dz by reassembling its catalytic core and making
it available to bind and cleave HK gene. While the sequence of 21-nt activator-binding fragment
on Dz-a and Dz-b were left same as in DOCTR-1, the sequences binding PSMA3 were changed.
We hypothesized, that low cleavage of PSMA3 occurs due to the location of Dz-a and Dz-b
binding sites within the PSMA3 stem region, which would lead to complementarity of binding
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arms and prevent efficient binding with PSMA3. We changed this location to more accessible sites
within PSMA3 (Figure 25).

Figure 24. Design of DOCTR-2 nanomachine. Design of DOCTR-2 is based on DNA cephalopod
scaffold and consists of tile-forming strands T1-T9. All tile-forming strands contain single
stranded ends on 5’ and 3’, which can be used for hybridization of target-specific adaptors or
modified to attach specific functions. Strands T7 (orange) and T8 (purple) were modified with
sequences of Dz-1 (9/8) and Dz-2 (9/13), while strands T4 and T5 were modified with Dz-a and
Dz-b respectively. Dashed lines represent polyethylene glycol linkers. SNP-selective arm on Dz1 (8 nt), as well as Dz-a actuator-binding arm were modified with inosine base for recognition of
U and A mutations.
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Figure 25. Design of binding arms for Dz-a and Dz-b actuator with housekeeping gene PSMA3.
A. Dz-a and Dz-b binding sites (blue and green curves respectively) aligned on the predicted
structure of PSMA3 fragment, that were used in DOCTR-1 design. B. New binding sides for Dza and Dz-b (blue and green curves respectively) aligned on the predicted structure of PSMA3
fragment, designed for DOCTR-2. PSMA3 structure is predicted with NUPACK software.
Computation function of DOCTR-2
To achieve activation of DOCTR-2 therapeutic function in the presence of both G12D
(G→A substitution) and G12V (G→U substitution) KRAS gene mutations, DNA nanodevice must
possess OR logic, producing 21 nt actuator sequence when either one of the mutations but not the
wild type are present (Table 5). We initially designed this computation with introduction of
universal base inosine in the SNP-recognizing arm of Dz-1 (Figure 24). Inosine can form stable
base pairs with A,C or U bases, but not with guanine3. .
DOCTR-2 nanodevice with inosine showed high cleavage of efficiency of Kras RNA (16.3
h-1 catalytic turnover, compared to 12.2 h-1 for Dzs mixture). However, no 21-nt actuator sequence
was generated, producing low outputs in the presence of either input Kras-58A or Kras-58U, which
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indicates incorrect logic (Table 5). Tile-free Dz-1 with inosine failed to produce any RNA cleavage
even after 24 hrs (Figure 26). Since cooperative function of Dz-1 and Dz-2 is required to produce
21-nt activator, we hypothesized that lack of this output stems from inability of Dz-1 with inosine
in its binding arm to bind Kras RNA. We suspected that inosine-containing arm has lower than
predicted melting temperature with RNA, preventing effective binding of Dz-1 and cooperative
cleavage by two Dzs.

Table 5. Truth table for 2 input OR logic function
Input

Output

0

0

I1

1

I2

1

I1, I2

1
*Kras-58A indicates I1
Kras-58U indicates I2
In order to achieve correct logic operation, we have modified the design of DOCTR-2 and

removed inosine from Kras binding arm. Instead, we opted out for two separate Dz-1, one for
recognition of Kras-58A and one for recognition of Kras-58U inputs. Dz-1 for recognition of
G→U mutation was attached to tile-forming strand T7, while Dz-1 for recognition of G→A
mutation was attached to T9. Both Dzs could cooperatively bind their targets with singular Dz-2,
when the correct input is present (Figure 27A). This design allowed to achieve correct
computation. High output (21-nt activator fragment) was produced when either Kras-58A or Kras95

58U were present (Figure 27B). No actuator sequence was produced in the presence of WT
fragment Kras-58G. Additionally, tile-free Dz-1 /Dz-2 pair with the same binding arms as Dzs on
tile failed to produce 21 nt activator sequence (Figure 27B).

Figure 26. Cleavage of Kras-58A by DOCTR-2 or solution Dzs. Top band indicates uncleaved
Kras, lower band is a product of cleavage reaction. Lanes 1-5 contain 500 nM of Kras-FAM,
incubated with 10 nM of DOCTR-2 or 10 nM of solution Dz-1, Dz-2 or combination of Dzs
respectively. No cleavage of Kras-FAM by Dz-1 (9/8) with inosine (lane 3) was observed.
Reaction mixtures were analyzed by 12.5 % dPAGE following 24 hrs incubation.
Actuating function of DOCTR-2
Actuating function of DOCTR-2 nanodevice is followed by computation, where generation
of 21-nt activator and assembly of binary actuator, allows for binding and cleavage of the fragment
HK gene PSMA3. Although RNA cleavage efficiency of DOCTR-2 nanodevice was higher,
compared to DOCTR-1 nanodevice (~ 4 times increase in the catalytic turnover), the efficiency of
the actuator function didn’t improve. 10 nM of nanodevice resulted in no cleavage of PSMA3FAM fragment even after long incubation, and 100 nM of nanodevice resulted only in modest
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cleavage, that compared to DOCTR-1 showed decreased value ( 22.6 % of PSMA3-FAM cleaved
after 24 hrs, compared to 37 % cleaved for DOCTR-1).

Figure 27. Design and implementation of OR computation by DOCTR-2. A. OR function is
generated by two different Dz-1 strands (attached to T7 and T9 strands), for recognition of G→U
or G→A mutations (green and orange Dz respectively). In the presence of their respective input
either Dz-1 is capable of cooperative binding with Dz-2, generating 21-nt activator sequence. Panel
A depicts state of the system, when Kras-58A input is present. Dz-1 recognizing this mutation,
Dz-2 and RNA input are in complex, while Dz for recognition of Kras-58U (green) doesn’t
participate in binding. Dashed lines represent polyethylene glycol linkers. B. Analysis of
computation function. Lanes 1-5 reaction mixtures contained Kras-58U (lane 1), incubated with
Doctr-2 (lane3), DOCTR-2 with only Dz-1 for recognition of Kras-58A (lane 2), solution based
Dz-1 (A)&Dz-2 (lane 4) or Dz-1 (U) & Dz-2 (lane 5). Lanes 6-10 reaction mixtures contained
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Kras-58G (lane 6), incubated with Doctr-2 (lane8), DOCTR-2 with only Dz-1 for recognition of
Kras-58A (lane 7), solution based Dz-1 (A)&Dz-2 (lane 9) or Dz-1 (U) & Dz-2 (lane 10). Lanes
11-15 reaction mixtures contained Kras-58A (lane 11), incubated with Doctr-2 (lane 13), DOCTR2 with only Dz-1 for recognition of Kras-58A (lane 12), solution based Dz-1 (A)&Dz-2 (lane 14)
or Dz-1 (U) & Dz-2 (lane 15). 10 nM of nanodevice or Dz pairs were incubated with 500 nM of
Kras-58U, Kras-58G or Kras-58A for 24 hr at 37C in buffer. Reaction mixture were analyzed by
12.5 % dPAGE following incubation and stained with Gel Red.
We hypothesized, that this low efficiency is in part due to inosine-containing arm of Dz-a (for
recognition of 21 nt activator sequences with G→U and G→A mutations) and applied the same
approach as for the recognition function. We attached two different Dz-a’s (one recognizing
activating sequence output from Kras-58A input and one recognizing activating sequence output
from Kras-58U), while maintaining a common Dz-b half for both cases.

Addition of adaptor sequences to facilitate hybridization with Kras inputs and HK gene RNA
Next, we wanted to see if approach utilized in Chapter 4, where addition of adaptors to
DNA cephalopod tile facilitated hybridization of tile with structured analytes, would improve
hybridization of DOCTR-2 with Kras inputs or PSMA3 HK gene. After addition of all
functionalities on a DNA cephalopod platform (two Dz-1s, Dz-2, two Dz-as, Dz-b), we still had
10 positions available for addition of adaptors. Following design principles developed in Chapter
4, to facilitated hybridization with Kras inputs, we have designed an adaptor with two binding
fragments (10 and 11 nt, Tm = 33.2C and 38oC, respectively). The adaptors were targeting sequence
common for both inputs (Kras-58A and Kras-58U, as well as the Kras-58G WT sequence).
However, addition of these adaptors didn’t seem to improve DOCTR-2 cleavage efficiency,
resulting in approximately the same percent RNA cleaved with or without adaptors (Figure 28).
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We have also designed two different adaptors to facilitate binding of DOCTR-2 with the
fragment of HK gene PSMA3. One of the adaptor sequences with 10 and 11 nt binding fragments
(Tm = 20oC and 22.o C, respectively) didn’t produced any difference in PSMA3 cleavage (no RNA
cleaved at 10 nM nanodevice, data not shown). This fact could be explained by inefficient binding
of the adaptor to PSMA3, due to melting temperature of PSMA3-binding fragments, that is below
37C reaction temperature. The other adaptor, containing 13 and 14 nt complementarity to PSMA3
(30.1 and 35.5C respectively) had unexpected and profound effect on ability of DOCTR-2 to
cleave PSMA3.

Figure 28. Addition of adaptors for facilitated hybridization of DOCTR-2 with Kras inputs. 10 nM
of DOCTR-2 with or without adaptors (was incubated in the presence of 500 nM of Kras-58A
lanes 3 and 2 respectively), Kras-58U (lanes 12 and 11 respectively) or WT Kras-58G (lanes 7 and
6 respectively). Lanes 4,8 and 12 have reaction mixtures containing 10 nM Dz-1&Dz-2 with Kras58A., Kras-58G and Kras-58U respectively. Lanes 1,5 and 9 indicate Kras-58A, -58G, and -58U
without addition of any cleaving agents. Position of intact RNA on the gel is indicated by purple
arrow, position of cleaved product is indicated by green arrow. DOCTR-2 with or without adaptors
appear to have the same intensity of cleaved product band. Reaction mixtures were analyzed
following 5 hrs incubation by 12.5 % dPAGE and stained using Gel Red.
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With the addition of this adaptor sequence, we were able to see cleavage of PSMA3-FAM
by 10 nM of DOCTR-2 within 2 hrs (Figure 51A, App.E). Additionally, it appeared that binding
of PSMA3 to Dz-a and Dz-b halves was independent on the presence of activator and occurs even
without any activators present (Figure 51A, App.E). This effect can be due to the increased local
concentration of PSMA3 around tile-associated Dz-a/Dz-b, which shifts equilibrium of the
hybridization reaction towards formation of more product. To check if this is the case, we have
incubated tile-free Dz-a/Dz-b pair in the presence of adaptor with PSMA3-FAM, in the presence
of short matched or mismatched activators (Kras-21A, Kras-21U or Kras-21G). Addition of
adaptors to solution even with tile-free Dz-a/Dz-b pair allowed activator-independent cleavage of
PSMA3. This data suggests that addition of PSMA3 adaptors with 13-14 nt binding fragments
binds to the structure of PSMA3, possibly unwinding its secondary structure and making it more
accessible for Dz-a and Dz-b binding (Figure 51B, App.E). With this information in mind, we
wanted to optimize the binding length of Dz-a and Dz-b that would trigger activator-dependent
cleavage of PSMA3.
The lengths of Dz-a and Dz-b studied, their melting temperatures with PSMA3 and
outcome of the reaction, are summarized in Table 6. Dz-a-11 and Dz-b-9 corresponded to the
length of Dz-a and Dz-b attached to the tile, which produced cleavage without activator present.
However, in solution this pair had no cleavage with or without activators. This effect can be
contributed to the proximity of Dz-a and Dz-b on the tile, allowing for their cooperative binding.
We have selected Dz-a-10 (24.8C) and Dz-b 9 (27.1C) to achieve activator-dependent binding and
cleavage of PSMA3.
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Table 6. Optimization of Dz-a and Dz-b lengths for cleavage of PSMA3 in the presence of adaptor
Dz length, nt

Melting temperatures, C

Combination

Outcome of reaction

Dz-a-11

28.4

Dz-a-11 +Dz-b-12

Cleavage

without

activator present
Dz-a-10

24.8

Dz-a-11 +Dz-b-9

No cleavage

Dz-a-9

17.2

Dz-a-11 +Dz-b-8

No cleavage

Dz-b-12

36.5

Dz-a-10 +Dz-b-12

Cleavage

without

activator present
Dz-b-9

27.1

Dz-a-10 +Dz-b-9

No cleavage

Dz-b-8

15.7

Dz-a-10 +Dz-b-9

No cleavage

Dz-a-9 +Dz-b-9

No cleavage

Dz-a-9 +Dz-b-8

No cleavage

101

Addition of PSMA3 unwinding arm
Additionally, we wanted to test the effects of unwinding arm on hybridization of DOCTR2 with PSMA3 housekeeping gene. Unwinding arm was hybridized to single-stranded portion of
strand T2 and hybridized to PSMA3 sequence on its 5’ end. It appears that unwinding arm is
necessary for cleavage of PSMA3 gene, since reaction cleavage products only appeared in the
lanes containing DOCTR equipped with unwinding arm (Figure 29). It also appears that cleavage
of HK gene PSMA3 occurred selectively only when mutated Kras-58A activator was present
(Figure 29).

Figure 29. Addition of unwinding arm for facilitated hybridization of DOCTR-2 with PSMA3. 20
nM of DOCTR-2 (lane 3-5), with addition of PSMA3-specific adaptors (lane 6-8), with addition
of PSMA3 unwinding arm (lane 9-11) or with adaptors and unwinding arm (lane 12-14) were
incubated with 20 nM of Kras-58A activator (lanes 4, 7,10 and 13) or with Kras-58G activator
(lanes 5,8,11, and 14). All lanes contain 500 nM pf PSMA3. Lane 2 additionally contains tile-fgree
Dz-a-10 and Dz-b-9 (20 nM each). Position of intact RNA on the gel is indicated by purple arrow,
position of cleaved product is indicated by green arrow. Reaction mixtures were analyzed
following 20 hrs incubation by 12.5 % dPAGE and stained using Gel Red.

Conclusions
We were able to design multifunctional DNA nanomachine DOCTR-2 for selective
recognition of two most common mutations in the sequence of Kras gene. In the presence of either
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of mutations, DNA nanodevice performed computation with OR logic, where 21-nt activator
sequence is produced as high output of the system with high efficiency. We have shown the
advantage and flexibility of larger DNA nanostructure for achieving multifunctionality. We have
also applied adaptor-facilitated approach for hybridization of nanodevice with its inputs and
targets. We have discovered that adaptor strands can improve hybridization not only by means of
increase in local concentration, but additionally can serve as unwinding arms for structured
analytes, making them more accessible for binding. By using combination of adaptor strands and
unwinding arm for HK gene PSMA3, we were able to activate selective cleavage of PSMA3 with
low concentration of nanodevice (20 nM) under near physiological conditions.
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CHAPTER 6: CONCLUSIONS
This work contributed to the development of DNA nanomachines for treatment of diseases
by addressing and improving three main functions of nanomachines: computational, therapeutic
(actuating) and sensing. Operation of DNA nanomachines is based on DNA computation and DNA
logic gates. We have optimized design principles for tile-associated NAND logic gates, a universal
logic. Our design exhibited fast (within 5 minutes) response using DNA or RNA molecules as
inputs, with low concentration of computing units (10 nM) and perfect digital behavior. We have
optimized protocol for manufacturing computing units using click chemistry, which would allow
for generation of stable computing units, that could be used under a variety of conditions. We were
able to integrate two NAND gates for processing of three inputs, showing that our approach can
be used to generate complex functions.
We have developed Dz-based DNA nanomachine DOCTR, that is capable of achieving
selective activation of therapeutic function in response to cancer marker RNA. Therapeutic
function is achieved by cutting out a fragment of cancer marker RNA and using it as activator for
cleavage of another RNA for housekeeping gene. This nanoconstruct is able to operate under near
physiological conditions with relatively low requirement for DNA nanodevice concentration (10
nM) with high efficiency and high selectivity.
DNA cephalopod construct contributed to improvement in sensing function of DNA
nanomachines. With the use of analyte-specific adaptors and unwinding arms we were able to
improve hybridization of tile-associated MB probe with the fragment of 16S rRNA of E.coli. This
approached increased kinetic constant for hybridization 465 times for nanoconstruct, while
reducing detection time from 5 hrs to 1.25 min, compared to MB probe in solution. The use of
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unwinding arms and adaptors can be applied to operation of DNA nanomachines in vivo to
improve their sensing functions with targets exhibiting stable secondary structures.
Finally, we have shown that we can combine multiple functions within single DNA
nanomachine scaffold. In the design of Dz-based nanomachine DOCTR-2 we have combined
computation (based on OR logic gates), therapeutic (actuator) and enhanced sensing function. This
DNA nanomachine was able to process two SNP-containing sequences of Kras gene as inputs, and
produce activator sequence in both cases, while sparing the WT Kras, in perfect agreement with
designed OR logic. Addition of adaptor sequences and unwinding arms had improved interaction
of binary actuator with PSMA3 target, although optimization of this function of DOCTR-2 is not
yet completed.
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Permission is granted to reproduce the article as part of the thesis.
CCC Terms and Conditions
Description of Service; Defined Terms. This Republication License enables the User to
obtain licenses for republication of one or more copyrighted works as described in detail on the
relevant Order Confirmation (the "Work(s)"). Copyright Clearance Center, Inc. ("CCC") grants
licenses through the Service on behalf of the rightsholder identified on the Order Confirmation
(the "Rightsholder"). "Republication", as used herein, generally means the inclusion of a Work, in
whole or in part, in a new work or works, also as described on the Order Confirmation. "User", as
used herein, means the person or entity making such republication.

The terms set forth in the relevant Order Confirmation, and any terms set by the
Rightsholder with respect to a particular Work, govern the terms of use of Works in connection
with the Service. By using the Service, the person transacting for a republication license on behalf
of the User represents and warrants that he/she/it (a) has been duly authorized by the User to accept,
and hereby does accept, all such terms and conditions on behalf of User, and (b) shall inform User
of all such terms and conditions. In the event such person is a "freelancer" or other third party
independent of User and CCC, such party shall be deemed jointly a "User" for purposes of these
terms and conditions. In any event, User shall be deemed to have accepted and agreed to all such
terms and conditions if User republishes the Work in any fashion.

Scope of License; Limitations and Obligations.
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All Works and all rights therein, including copyright rights, remain the sole and exclusive
property of the Rightsholder. The license created by the exchange of an Order Confirmation
(and/or any invoice) and payment by User of the full amount set forth on that document includes
only those rights expressly set forth in the Order Confirmation and in these terms and conditions,
and conveys no other rights in the Work(s) to User. All rights not expressly granted are hereby
reserved.

General Payment Terms: You may pay by credit card or through an account with us payable
at the end of the month. If you and we agree that you may establish a standing account with CCC,
then the following terms apply: Remit Payment to: Copyright Clearance Center, 29118 Network
Place, Chicago, IL 60673-1291. Payments Due: Invoices are payable upon their delivery to you
(or upon our notice to you that they are available to you for downloading). After 30 days,
outstanding amounts will be subject to a service charge of 1-1/2% per month or, if less, the
maximum rate allowed by applicable law. Unless otherwise specifically set forth in the Order
Confirmation or in a separate written agreement signed by CCC, invoices are due and payable on
"net 30" terms. While User may exercise the rights licensed immediately upon issuance of the
Order Confirmation, the license is automatically revoked and is null and void, as if it had never
been issued, if complete payment for the license is not received on a timely basis either from User
directly or through a payment agent, such as a credit card company.

Unless otherwise provided in the Order Confirmation, any grant of rights to User (i) is
"one-time" (including the editions and product family specified in the license), (ii) is non-exclusive
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and non-transferable and (iii) is subject to any and all limitations and restrictions (such as, but not
limited to, limitations on duration of use or circulation) included in the Order Confirmation or
invoice and/or in these terms and conditions. Upon completion of the licensed use, User shall either
secure a new permission for further use of the Work(s) or immediately cease any new use of the
Work(s) and shall render inaccessible (such as by deleting or by removing or severing links or
other locators) any further copies of the Work (except for copies printed on paper in accordance
with this license and still in User's stock at the end of such period).

In the event that the material for which a republication license is sought includes third party
materials (such as photographs, illustrations, graphs, inserts and similar materials) which are
identified in such material as having been used by permission, User is responsible for identifying,
and seeking separate licenses (under this Service or otherwise) for, any of such third party
materials; without a separate license, such third party materials may not be used.

Use of proper copyright notice for a Work is required as a condition of any license granted
under the Service. Unless otherwise provided in the Order Confirmation, a proper copyright notice
will read substantially as follows: "Republished with permission of [Rightsholder's name], from
[Work's title, author, volume, edition number and year of copyright]; permission conveyed through
Copyright Clearance Center, Inc. " Such notice must be provided in a reasonably legible font size
and must be placed either immediately adjacent to the Work as used (for example, as part of a byline or footnote but not as a separate electronic link) or in the place where substantially all other
credits or notices for the new work containing the republished Work are located. Failure to include
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the required notice results in loss to the Rightsholder and CCC, and the User shall be liable to pay
liquidated damages for each such failure equal to twice the use fee specified in the Order
Confirmation, in addition to the use fee itself and any other fees and charges specified.

User may only make alterations to the Work if and as expressly set forth in the Order
Confirmation. No Work may be used in any way that is defamatory, violates the rights of third
parties (including such third parties' rights of copyright, privacy, publicity, or other tangible or
intangible property), or is otherwise illegal, sexually explicit or obscene. In addition, User may not
conjoin a Work with any other material that may result in damage to the reputation of the
Rightsholder. User agrees to inform CCC if it becomes aware of any infringement of any rights in
a Work and to cooperate with any reasonable request of CCC or the Rightsholder in connection
therewith.

Indemnity. User hereby indemnifies and agrees to defend the Rightsholder and CCC, and
their respective employees and directors, against all claims, liability, damages, costs and expenses,
including legal fees and expenses, arising out of any use of a Work beyond the scope of the rights
granted herein, or any use of a Work which has been altered in any unauthorized way by User,
including claims of defamation or infringement of rights of copyright, publicity, privacy or other
tangible or intangible property.

Limitation of Liability. UNDER NO CIRCUMSTANCES WILL CCC OR THE
RIGHTSHOLDER BE LIABLE FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL OR
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INCIDENTAL DAMAGES (INCLUDING WITHOUT LIMITATION DAMAGES FOR LOSS
OF BUSINESS PROFITS OR INFORMATION, OR FOR BUSINESS INTERRUPTION)
ARISING OUT OF THE USE OR INABILITY TO USE A WORK, EVEN IF ONE OF THEM
HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. In any event, the total
liability of the Rightsholder and CCC (including their respective employees and directors) shall
not exceed the total amount actually paid by User for this license. User assumes full liability for
the actions and omissions of its principals, employees, agents, affiliates, successors and assigns.

Limited Warranties. THE WORK(S) AND RIGHT(S) ARE PROVIDED "AS IS". CCC
HAS THE RIGHT TO GRANT TO USER THE RIGHTS GRANTED IN THE ORDER
CONFIRMATION DOCUMENT. CCC AND THE RIGHTSHOLDER DISCLAIM ALL OTHER
WARRANTIES RELATING TO THE WORK(S) AND RIGHT(S), EITHER EXPRESS OR
IMPLIED,

INCLUDING

WITHOUT

LIMITATION

IMPLIED

WARRANTIES

OF

MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. ADDITIONAL
RIGHTS MAY BE REQUIRED TO USE ILLUSTRATIONS, GRAPHS, PHOTOGRAPHS,
ABSTRACTS, INSERTS OR OTHER PORTIONS OF THE WORK (AS OPPOSED TO THE
ENTIRE WORK) IN A MANNER CONTEMPLATED BY USER; USER UNDERSTANDS
AND AGREES THAT NEITHER CCC NOR THE RIGHTSHOLDER MAY HAVE SUCH
ADDITIONAL RIGHTS TO GRANT.

Effect of Breach. Any failure by User to pay any amount when due, or any use by User of
a Work beyond the scope of the license set forth in the Order Confirmation and/or these terms and
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conditions, shall be a material breach of the license created by the Order Confirmation and these
terms and conditions. Any breach not cured within 30 days of written notice thereof shall result in
immediate termination of such license without further notice. Any unauthorized (but licensable)
use of a Work that is terminated immediately upon notice thereof may be liquidated by payment
of the Rightsholder's ordinary license price therefor; any unauthorized (and unlicensable) use that
is not terminated immediately for any reason (including, for example, because materials containing
the Work cannot reasonably be recalled) will be subject to all remedies available at law or in equity,
but in no event to a payment of less than three times the Rightsholder's ordinary license price for
the most closely analogous licensable use plus Rightsholder's and/or CCC's costs and expenses
incurred in collecting such payment.
Miscellaneous.
User acknowledges that CCC may, from time to time, make changes or additions to the
Service or to these terms and conditions, and CCC reserves the right to send notice to the User by
electronic mail or otherwise for the purposes of notifying User of such changes or additions;
provided that any such changes or additions shall not apply to permissions already secured and
paid for.
Use of User-related information collected through the Service is governed by CCC's
privacy policy, available online here:https://marketplace.copyright.com/rs-ui-web/mp/privacypolicy
The licensing transaction described in the Order Confirmation is personal to User.
Therefore, User may not assign or transfer to any other person (whether a natural person or an
organization of any kind) the license created by the Order Confirmation and these terms and
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conditions or any rights granted hereunder; provided, however, that User may assign such license
in its entirety on written notice to CCC in the event of a transfer of all or substantially all of User's
rights in the new material which includes the Work(s) licensed under this Service.
No amendment or waiver of any terms is binding unless set forth in writing and signed by
the parties. The Rightsholder and CCC hereby object to any terms contained in any writing
prepared by the User or its principals, employees, agents or affiliates and purporting to govern or
otherwise relate to the licensing transaction described in the Order Confirmation, which terms are
in any way inconsistent with any terms set forth in the Order Confirmation and/or in these terms
and conditions or CCC's standard operating procedures, whether such writing is prepared prior to,
simultaneously with or subsequent to the Order Confirmation, and whether such writing appears
on a copy of the Order Confirmation or in a separate instrument.
The licensing transaction described in the Order Confirmation document shall be governed
by and construed under the law of the State of New York, USA, without regard to the principles
thereof of conflicts of law. Any case, controversy, suit, action, or proceeding arising out of, in
connection with, or related to such licensing transaction shall be brought, at CCC's sole discretion,
in any federal or state court located in the County of New York, State of New York, USA, or in
any federal or state court whose geographical jurisdiction covers the location of the Rightsholder
set forth in the Order Confirmation. The parties expressly submit to the personal jurisdiction and
venue of each such federal or state court.If you have any comments or questions about the Service
or Copyright Clearance Center, please contact us at 978-750-8400 or send an e-mail to
support@copyright.com.
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and Conditions which are included below.
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below.
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CCC Terms and Conditions
Description of Service; Defined Terms. This Republication License enables the User to obtain
licenses for republication of one or more copyrighted works as described in detail on the relevant
Order Confirmation (the "Work(s)"). Copyright Clearance Center, Inc. ("CCC") grants licenses
through the Service on behalf of the rightsholder identified on the Order Confirmation (the
"Rightsholder"). "Republication", as used herein, generally means the inclusion of a Work, in
whole or in part, in a new work or works, also as described on the Order Confirmation. "User", as
used herein, means the person or entity making such republication.
The terms set forth in the relevant Order Confirmation, and any terms set by the Rightsholder with
respect to a particular Work, govern the terms of use of Works in connection with the Service. By
using the Service, the person transacting for a republication license on behalf of the User represents
and warrants that he/she/it (a) has been duly authorized by the User to accept, and hereby does
accept, all such terms and conditions on behalf of User, and (b) shall inform User of all such terms
and conditions. In the event such person is a "freelancer" or other third party independent of User
and CCC, such party shall be deemed jointly a "User" for purposes of these terms and conditions.
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if User republishes the Work in any fashion.
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All Works and all rights therein, including copyright rights, remain the sole and exclusive property
of the Rightsholder. The license created by the exchange of an Order Confirmation (and/or any
invoice) and payment by User of the full amount set forth on that document includes only those
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General Payment Terms: You may pay by credit card or through an account with us payable at the
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our notice to you that they are available to you for downloading). After 30 days, outstanding
amounts will be subject to a service charge of 1-1/2% per month or, if less, the maximum rate
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allowed by applicable law. Unless otherwise specifically set forth in the Order Confirmation or in
a separate written agreement signed by CCC, invoices are due and payable on "net 30" terms.
While User may exercise the rights licensed immediately upon issuance of the Order Confirmation,
the license is automatically revoked and is null and void, as if it had never been issued, if complete
payment for the license is not received on a timely basis either from User directly or through a
payment agent, such as a credit card company.
Unless otherwise provided in the Order Confirmation, any grant of rights to User (i) is "one-time"
(including the editions and product family specified in the license), (ii) is non-exclusive and nontransferable and (iii) is subject to any and all limitations and restrictions (such as, but not limited
to, limitations on duration of use or circulation) included in the Order Confirmation or invoice
and/or in these terms and conditions. Upon completion of the licensed use, User shall either secure
a new permission for further use of the Work(s) or immediately cease any new use of the Work(s)
and shall render inaccessible (such as by deleting or by removing or severing links or other
locators) any further copies of the Work (except for copies printed on paper in accordance with
this license and still in User's stock at the end of such period).
In the event that the material for which a republication license is sought includes third party
materials (such as photographs, illustrations, graphs, inserts and similar materials) which are
identified in such material as having been used by permission, User is responsible for identifying,
and seeking separate licenses (under this Service or otherwise) for, any of such third party
materials; without a separate license, such third party materials may not be used.
Use of proper copyright notice for a Work is required as a condition of any license granted under
the Service. Unless otherwise provided in the Order Confirmation, a proper copyright notice will
read substantially as follows: "Republished with permission of [Rightsholder's name], from
[Work's title, author, volume, edition number and year of copyright]; permission conveyed through
Copyright Clearance Center, Inc. " Such notice must be provided in a reasonably legible font size
and must be placed either immediately adjacent to the Work as used (for example, as part of a byline or footnote but not as a separate electronic link) or in the place where substantially all other
credits or notices for the new work containing the republished Work are located. Failure to include
the required notice results in loss to the Rightsholder and CCC, and the User shall be liable to pay
liquidated damages for each such failure equal to twice the use fee specified in the Order
Confirmation, in addition to the use fee itself and any other fees and charges specified.
User may only make alterations to the Work if and as expressly set forth in the Order Confirmation.
No Work may be used in any way that is defamatory, violates the rights of third parties (including
such third parties' rights of copyright, privacy, publicity, or other tangible or intangible property),
or is otherwise illegal, sexually explicit or obscene. In addition, User may not conjoin a Work with
any other material that may result in damage to the reputation of the Rightsholder. User agrees to
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inform CCC if it becomes aware of any infringement of any rights in a Work and to cooperate with
any reasonable request of CCC or the Rightsholder in connection therewith.
Indemnity. User hereby indemnifies and agrees to defend the Rightsholder and CCC, and their
respective employees and directors, against all claims, liability, damages, costs and expenses,
including legal fees and expenses, arising out of any use of a Work beyond the scope of the rights
granted herein, or any use of a Work which has been altered in any unauthorized way by User,
including claims of defamation or infringement of rights of copyright, publicity, privacy or other
tangible or intangible property.
Limitation of Liability. UNDER NO CIRCUMSTANCES WILL CCC OR THE
RIGHTSHOLDER BE LIABLE FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL OR
INCIDENTAL DAMAGES (INCLUDING WITHOUT LIMITATION DAMAGES FOR LOSS
OF BUSINESS PROFITS OR INFORMATION, OR FOR BUSINESS INTERRUPTION)
ARISING OUT OF THE USE OR INABILITY TO USE A WORK, EVEN IF ONE OF THEM
HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. In any event, the total
liability of the Rightsholder and CCC (including their respective employees and directors) shall
not exceed the total amount actually paid by User for this license. User assumes full liability for
the actions and omissions of its principals, employees, agents, affiliates, successors and assigns.
Limited Warranties. THE WORK(S) AND RIGHT(S) ARE PROVIDED "AS IS". CCC HAS THE
RIGHT TO GRANT TO USER THE RIGHTS GRANTED IN THE ORDER CONFIRMATION
DOCUMENT. CCC AND THE RIGHTSHOLDER DISCLAIM ALL OTHER WARRANTIES
RELATING TO THE WORK(S) AND RIGHT(S), EITHER EXPRESS OR IMPLIED,
INCLUDING WITHOUT LIMITATION IMPLIED WARRANTIES OF MERCHANTABILITY
OR FITNESS FOR A PARTICULAR PURPOSE. ADDITIONAL RIGHTS MAY BE
REQUIRED TO USE ILLUSTRATIONS, GRAPHS, PHOTOGRAPHS, ABSTRACTS,
INSERTS OR OTHER PORTIONS OF THE WORK (AS OPPOSED TO THE ENTIRE WORK)
IN A MANNER CONTEMPLATED BY USER; USER UNDERSTANDS AND AGREES THAT
NEITHER CCC NOR THE RIGHTSHOLDER MAY HAVE SUCH ADDITIONAL RIGHTS TO
GRANT.
Effect of Breach. Any failure by User to pay any amount when due, or any use by User of a Work
beyond the scope of the license set forth in the Order Confirmation and/or these terms and
conditions, shall be a material breach of the license created by the Order Confirmation and these
terms and conditions. Any breach not cured within 30 days of written notice thereof shall result in
immediate termination of such license without further notice. Any unauthorized (but licensable)
use of a Work that is terminated immediately upon notice thereof may be liquidated by payment
of the Rightsholder's ordinary license price therefor; any unauthorized (and unlicensable) use that
is not terminated immediately for any reason (including, for example, because materials containing
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the Work cannot reasonably be recalled) will be subject to all remedies available at law or in equity,
but in no event to a payment of less than three times the Rightsholder's ordinary license price for
the most closely analogous licensable use plus Rightsholder's and/or CCC's costs and expenses
incurred in collecting such payment.
Miscellaneous.
User acknowledges that CCC may, from time to time, make changes or additions to the Service or
to these terms and conditions, and CCC reserves the right to send notice to the User by electronic
mail or otherwise for the purposes of notifying User of such changes or additions; provided that
any such changes or additions shall not apply to permissions already secured and paid for.
Use of User-related information collected through the Service is governed by CCC's privacy
policy, available online here:https://marketplace.copyright.com/rs-ui-web/mp/privacy-policy
The licensing transaction described in the Order Confirmation is personal to User. Therefore, User
may not assign or transfer to any other person (whether a natural person or an organization of any
kind) the license created by the Order Confirmation and these terms and conditions or any rights
granted hereunder; provided, however, that User may assign such license in its entirety on written
notice to CCC in the event of a transfer of all or substantially all of User's rights in the new material
which includes the Work(s) licensed under this Service.
No amendment or waiver of any terms is binding unless set forth in writing and signed by the
parties. The Rightsholder and CCC hereby object to any terms contained in any writing prepared
by the User or its principals, employees, agents or affiliates and purporting to govern or otherwise
relate to the licensing transaction described in the Order Confirmation, which terms are in any way
inconsistent with any terms set forth in the Order Confirmation and/or in these terms and
conditions or CCC's standard operating procedures, whether such writing is prepared prior to,
simultaneously with or subsequent to the Order Confirmation, and whether such writing appears
on a copy of the Order Confirmation or in a separate instrument.
The licensing transaction described in the Order Confirmation document shall be governed by and
construed under the law of the State of New York, USA, without regard to the principles thereof
of conflicts of law. Any case, controversy, suit, action, or proceeding arising out of, in connection
with, or related to such licensing transaction shall be brought, at CCC's sole discretion, in any
federal or state court located in the County of New York, State of New York, USA, or in any
federal or state court whose geographical jurisdiction covers the location of the Rightsholder set
forth in the Order Confirmation. The parties expressly submit to the personal jurisdiction and
venue of each such federal or state court.If you have any comments or questions about the Service
or Copyright Clearance Center, please contact us at 978-750-8400 or send an e-mail to
support@copyright.com.
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APPENDIX B: CHAPTER 2 SUPPLEMENTAL MATERIALS
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Reproduced in part with permission from Molden, T. A., Grillo, M. C., & Kolpashchikov,
D. M.: Manufacturing reusable NAND logic gates and their initial circuits for DNA
nanoprocessors. Chemistry – A European Journal, 2020, 27(7), 2421–2426.
. Copyright 2020 Wiley-VCH Verlag GmbH & Co. KGaA.
Experimental Section
Materials and Methods. DNase/RNase free water was purchased from Boston BioProducts
(Ashland, Ma), and used for all buffers and for the stock solutions of oligonucleotides. 1M MgCl2
solution was purchased from Teknova (Hollister, CA), HEPES, NaCl, KCl, CuSO4, and DMSO
were purchased from Fisher Scientific (Fair Lawn, NJ). Urea, sodium ascorbate, Tris (3
hydroxypropyltriazolylmethyl)amine, and Triton X 100 were purchased from Sigma Aldrich
(St.Louis, MO), acrylamide and N,N’-methylenebisacrylamide were purchased from Acros
Organics (Morris Planes, NJ). RNAse H (5000 U/mL) was obtained from New England Biolabs
(Ipswich, Ma). F sub was custom-made by TriLink Biotechnologies, Inc. (San Diego, CA). All
other oligonucleotides were obtained from Integrated DNA Technologies, Inc. (Coraville, IA).
Concentrated solutions of oligonucleotides in water were prepared at room temperature and stored
at

20 °C until use. The concentrations of oligonucleotides in stock solutions were determined

from the absorptions of these solutions at 260 nm, measured with Thermo Scientific NanoDrop
One UV-Vis Spectrophotometer, while the corresponding extinction coefficients were determined
by using OligoAnalyzer 3.1 software (Integrated DNA Technologies, Inc.). Fluorescent
experiments were performed using Perkin Elmer LS55 Fluorescent Spectrometer with Xenon lamp
(Waltham, Ma), excitation and emission were at 485 nm and 517 nm, respectively. Fluorescence
for kinetics experiments was recorded continuously using kinetics program on Gary Eclipse
Fluorescence Spectrophotometer with Xenon flash lamp (excitation at 485 nm, emission at 517
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nm). Gel electrophoresis experiments were performed using BioRad electrophoresis equipment
(Hercules, Ca), and visualized using BioRad Gel Doc XR+.
Assembling of DNA tiles. Prior to all experiments, DNA tiles were assembled by annealing
as follows. All strands (100 nM) each were combined in Buffer 1 (50 mM HEPES, 150 mM NaCl,
20 mM KCl, 50 mM MgCl2, 1% DMSO, 0.03 % w/v Triton X 100 pH 7.4.), heated at 95oC for 5
min, and allowed to cool down to room temperature (22oC) during 20 h.
Fluorescent experiments. Sixty microliters of a master mix containing 200 nM F_sub and
10 nM of the DNA tile in Buffer 1 (50 mM HEPES, 150 mM NaCl, 20 mM KCl, 50 mM MgCl2,
1% DMSO, 0.03 % w/v Triton X 100 pH 7.4) were aliquoted in separate microcentrifuge tubes, to
which desired combinations of 100 nM DNA or RNA inputs were added. Fluorescence at 517 nm
(excitation 485 nm) of each sample, and fluorescence of 200 nM F_sub in Buffer 1, were recorded
following incubation at 22 °C for 1, 5, 15, 30, 90 or 180 min. All experiments were performed in
triplicate.
RNAse H experiments. A sixty microliter-solution containing 10 nM NAND 1 tile, 200
nM F_sub, 100 nM of RNA inputs I1 and I2 in Buffer 1 was allowed to incubate for 30 min at 22
oC, and its fluorescence was recorded using the kinetics function of the Gary Eclipse Fluorescence
Spectrophotometer with Xenon flash lamp (excitation at 485 nm, emission at 517 nm) for 5 min.
Kinetics program was paused to add RNase H to the final concentration 0.01 U/μL. Fluorescence
of the system was recorded using the kinetics function, pausing every 13 min to add fresh portion
of RNA inputs (to increase the input concentration by100 nM after each addition).
6. “Click chemistry”. NAND1 (500 nM) tile containing modified strands (FS-alkyne, 1aazide, 1b-azide, BS-biotinylated) was annealed in Buffer 2 (50 mM MgCl2 50 mM HEPES-NaOH,
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pH

7.4).

To
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Tris
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hydroxypropyltriazolylmethyl)amine (THPTA) and sodium ascorbate were added to the final
concentrations of 0.1 mM, 0.5 mM, and 5 mM, respectively. The “click” reaction was incubated
for 16 h at 22oC. Purification of the reaction mixture proceeded as follows. The reaction mixture
was added to 300 μL of streptavidin-agarose beads, 400 μL of Buffer 2, and allowed to react for
30 min at 22oC, after which the flow-through was discarded. Next, 400 μL of 300 mM NaCl
solution was added to the column, and the flow-through was discarded. The product was collected
from the column upon addition of 400 μL of 0.2 M NaOH with centrifugation. Collected solution
was neutralized with 1M HCl, and the DNA tile was precipitated using sodium acetate/ethanol
precipitation. The precipitate was collected, re-suspended in Buffer 1, and analyzed using 10 %
denaturing PAGE.
Table 7: Oligonucleotides used in study
Name
F sub
NAND1_I2
NAND1_I1
NAND1_I2
NAND1_I1
NAND1_FS
NAND1_1a
NAND1_1b
NAND1_BS
NAND1_FS (Click
chemistry)
NAND1_1a (Click
chemistry)
NAND1_1b(Click
chemistry)
NAND1_BS(Click
chemistry)

Sequence, 5’ → 3’
AAG GTTFAM TCC TCg uCCC TGG GCA-BHQ1
CGT TGG AGT GGC TGC
GAA TGG TTG CGT ACG
cgu ugg agu ggc ugc
gaa ugg uug cgu acg
TGTTC ATCTA ATCGC CGAGTC GAGTC GTCTAC
CGT ACG CAA CCA TTC /iSp9/ GCG ATT AGA TGA ACA GGT CAT GTC TC
TACGA TCAGC GACTCG /iSp9/ GAGTG ACAACGA GAGGAAAC
CCA GGG AGGCTAGCT GTTGC/iSp9/GACTC GCATA CAGTCC GTAGAC
/iSp9/GCACG CACTC CAACG
GGACTG TATGC GCTGA TCGTA GAGAC ATGACC
/55OctdU/TGTTC ATCTA ATCGC CGAGTC GAGTC GTCTAC-/35OctdU/
CGT ACG CAA CCA TTC /iSp9/ GCG ATT AGA TGA ACA/iAzideN/ GGT CAT
GTC TC TACGA TCAGC GACTCG /iSp9/ GAGTG ACAACGA GAGGAAAC
CCA GGG AGGCTAGCT GTTGC/iSp9/GACTC GCATA CAGTCC/iAzideN/
GTAGAC /iSp9/GCACG CACTC CAACG
Bio-GGACTG TATGC GCTGA TCGTA GAGAC ATGACC
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Name
NAND2_FS
NAND2_2a
NAND2_2b
NAND2_BS
MB_2
NAND2_I3
NAND2_I4
Linker 1+2

Sequence, 5’ → 3’
AGTTG ATCTT ATCGG CGTGTC CAGTG GTGTAC
CCGTG CTCTG GAGTC /iSp9/ CCGAT AAGAT CAACT GGACTT GTCTC
AACGT TCAGC GACACG /iSp9/AT GGCTC TGGCTGC
CGTTGGAGCAGAGGA/ iSp9/ CACTG GCTTA GAGACC GTACAC / iSp9/
TTCTG GAGCC ATAGG
GGTCTC TAAGC GCTGA ACGTT GAGAC AAGTCC
FAM-CGCGCAGCCA CTCCAACGCG-BHQ
GACTCCAGAGGACGC
CCTATGGCTCCAGAA
GGACTG TATGC GCTGA TCGTA GAGAC ATGACCTTTTTTTTTT AGTTG
ATCTT ATCGG CGTGTC CAGTG GTGTAC

RNA nucleotides are in low case; /iSp9/ triethylene glycol spacer; FAM-fluorescein label

Figure 30: Design of NAND1 with sequences. NAND 1 is generated by association of
NAND1_BS, NAND1_1a, NAND1_1b, and NAND1_FS strands. 5’ 3’ direction of the strands
is indicated by the arrows; single-stranded portions of the gate are connected to the Dx-tile via
triethylene glycol linkers, represented by the dotted lines. The 15-nt “bridge” sequence of
NAND1_1a is complimentary to the NAND1_I1 input, while the “bridge” sequence of
NAND1_1b is complimentary to NAND1_I2 input. Base pairs formed between the “bridge” of
NAND1_1b strand and arms of split Dz (BiDz-a and BiDz-b) are indicated by the dashes. The
„bridge“ sequences of the tile-forming strands NAND1_1a and NAND1_1b can hybridize to the
Dz arms or to the inputs, when present. The complex that each ‘bridge‘ forms with the Dz arms
contains less base pairs than with the correspondent input. Additionally, it has one G-T Wobble
base pair, compared to the Watson-Crick A-T pair in the complex formed with the inputs. The
nucleotides of the “bridge” sequences forming the G-T Wobble base pairs with the arms of split
Dz are marked in red.
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Figure 31: Time-dependence of the fluorescent signal for the NAND1 gate. NAND1 (10 nM) in
Buffer 1 was mixed with 100 nM of DNA inputs and 200 nM of F_sub. Fluorescence of the
samples containing no inputs, 100 nM of I1, 100 nM of I2, or 100 nM each of both I1 and I2 was
recorded after incubation at 22 °C for 1 min, 5 min, 15 min, and 30 min intervals. Signal produced
by F_sub in solution (in the absence of NAND1) upon incubation at 22 °C for the same time points
is provided as a reference. Data represents an average of three trials, and the initial increase in the
0 signal occurs most likely in the time required to manually add both inputs to the system.
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Figure 32: Performance of NAND 1 without being assembled on the tile. The functional stands
NAND_1a and NAND_1b do not respond in the absence of DNA tile-forming stands NAND_FS
and NAND_BS. Strands NAND_1a and NAND_1b (10 nM each) were incubated in Buffer 1 in
the presence of 200 nM F_sub and 100 nM input combinations as indicated on the abscissa axis.
Fluoresce was measured 30 min after incubation ate 22oC.

Figure 33: Design and performance of the NAND2 gate. A. NAND2 is generated by association
of NAND2_BS, NAND2_2a, NAND2_2b, and NAND2_FS strands. 5’
3’ direction of the
strands is indicated by the arrows, single-stranded portions of the gate are connected to the DX tile
via triethylene glycol linkers, represented by the dotted lines. A 15-nt “bridge” sequence of
NAND2_2a is complimentary to input 3 (I3),“bridge” sequence of NAND2_2b is complimentary
to input 4 (I4). High output of the gate results in formation of the “input” sequence complimentary
to a molecular beacon MB_2. The portion of the MB_2 sequence complimentary to the “input”
sequence is underlined. B. 10 nM of NAND 2 tile in Buffer 1 was mixed with 100 nM of DNA
inputs and 20 nM of MB_2. Fluorescence of samples containing no inputs, 100 nM of I3, 100 nM
of I4, or 100 nM of each of I3 and I4 was recorded following incubation at 22 °C for 30 min. The
signal produced by MB_2 in solution after incubation at 22 °C for the same time intervals is
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provided as a reference. Data represents an average of three trials, with standard deviations shown
as error bars. A threshold dashed line represents the upper boundary of the 0 output and separates
the high and low signals.

Figure 34: NAND1 and NAND2 integrated gates were generated with addition of tile strands as
before, except for strands NAND1_BS and NAND2_FS, which were substituted by linker 1+2
strand, connecting the two tiles. NAND2 tile is processing Inputs I3 and I4, where I3 and I4 are
complimentary to the ‘bridge’ sequences of tile-forming strands 2a and 2b respectively; NAND1
tile is processing input I1, that is complimentary to ‘bridge’ sequence of strand 1a. NAND2 gate
produces output of “1” in the absence of I3 and I4 or in the presence of only one of these inputs,
which results in the formation of the ‘input’ sequence complimentary to the ‘bridge’ sequences of
1b strand of NAND1 gate. The fluorescent response of integrated gates is produced when split Dz
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sequences of NAND1 are stabilized by ‘bridge’ sequences of NAND 1, which occurs in the
absence of Input 1 or in the absence of the ‘input’ sequence formed by NAND2.
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APPENDIX C: CHAPTER 3 SUPPLEMENTAL MATERIAL
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Reproduced in part with permission from Molden, T. A., Niccum, C. T., &
Kolpashchikov, D. M. (2020). Cut and paste for cancer treatment: A DNA nanodevice that
cuts out an RNA marker sequence to activate a therapeutic function. Angewandte Chemie
2020, 132(47), 21376–21380. Copyright 2020 Wiley-VCH Verlag GmbH & Co. KGaA.
Experimental Section
Materials and Methods. DNase/RNase-free water was purchased from Boston BioProducts
(Ashland, Ma), and used for all buffers and for the stock solutions of oligonucleotides. 25 mM
MgCl2 solution was purchased from Teknova (Hollister, CA), HEPES, NaCl and KCl were
purchased from Fisher Scientific (Fair Lawn, NJ). Urea was purchased from Sigma Aldrich
(St.Louis, MO), acrylamide and N,N’-methylenebisacrylamide were purchased from Acros
Organics (Morris Planes, NJ), SeaKem LE agarose was purchased from Lonza (Rockland, ME). F
sub was custom-made by TriLink Biotechnologies, Inc. (San Diego, CA). All other
oligonucleotides were obtained from Integrated DNA Technologies, Inc. (Coraville, IA).
Concentrated solutions of oligonucleotides in water were prepared at room temperature and stored
at

20 °C until use. The concentrations of oligonucleotides in stock solutions were determined

from the absorptions of these solutions at 260 nm, measured with Thermo Scientific NanoDrop
One UV-Vis Spectrophotometer, while the corresponding extinction coefficients were determined
by using OligoAnalyzer 3.1 software (Integrated DNA Technologies, Inc.). Fluorescent
experiments were performed using Perkin Elmer LS55 Fluorescent Spectrometer (Waltham, Ma),
excitation and emission were at 485 nm and 517 nm, respectively. Gel electrophoresis experiments
were performed using BioRad electrophoresis equipment (Hercules, Ca), and visualized using
BioRad Gel Doc XR+.
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Assembling DNA nanodevices. Prior to the fluorescent and cleavage experiments, DNA
nanodevices were assembled by annealing as follows. Two oligonucleotide strands T1 and T2 (100
nM each) for each of DOCTR-1, DOCTR-2, DOCTR-3 or DOCTR-PA (see Table S1 for the
sequences) were combined in 1×Buffer 1 (50 mM HEPES, 15 mM NaCl, 150 mM KCl, 2 mM
MgCl2, pH 7.4.) followed by heating at 95oC for 5 min and allowed to cool down to room
temperature (22oC) during 20 h. The formation of DNA nanodevices of the correct size was
confirmed each time by 2.5 % agarose gel electrophoresis (run at 60 V for 1.5 h) or by 8 % native
PAGE electrophoresis (run at 120 V for 2 h). Gels were visualized using GelRed nucleic acid stain
(Biotium). The size of the DNA nanodevices was compared to the fragments of 25 bp dsDNA step
ladder (Promega).
Fluorescent experiments. Sixty microliter aliquots of a master mix containing 200 nM F
sub and 10 nM of assembled DOCTR constructs in Buffer 1, or 200 nM F sub and 10 nM of the
tile-free Dz-a and Dz-b strands in Buffer 1 spiked with 50 mM MgCl2 were distributed to the
individual microcentrifuge tubes. RNA activator sequences K-58G, K-58A, K-21G or K-21A
(Table S1) were added to each tube to the final RNA concentration of 10 nM. A sample containing
200 nM F sub and 10 nM DOCTR or 200 nM F sub and 10 nM of tile-free Dz-a and Dz-b
represented negative control. All samples were incubated at 30oC. In this proof-of-concept study,
the fluorescent experiments were carried out at 30oC, because binding arms of F sub have low
melting temperatures (12.3 °C and 14.2 °C for Dz-a and Dz-b respectively). However, these
sequences can be easily redesigned to bind and cleave an actual housekeeping gene at 37oC.
Fluorescence at 517 nm (excitation 485 nm) was recorded at 4 hrs time points. All experiments
were performed in triplicate.
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Cleavage of K-58 RNA. Fifty microliter aliquots of a master mix containing 500 nM of K58G, K-58G-FAM, K-58A, K-58A-FAM RNA (see Table S1) were distributed to the individual
microcentrifuge tubes, to which DOCTR-1 or tile-free Dza and Dzb were added to the final
concentrations of 10 nM. The remainder of the master mix was incubated without addition of any
DNA. All samples were incubated at 37oC. Cleavage at each tube was assessed at multiple time
points. Following the required incubation period, 10 µL of the reaction mixture was collected from
the tube and added to the 2× denaturing PAGE loading buffer (2×TBE, 8 M urea). Following the
removal of the 10 µL aliquot, microcentrifuge tubes were placed back into 37oC incubator.
Aliquoted samples were then placed into the

20oC freezer and stored there until analyzed. The

analysis of the cleavage products was performed using 12.5 % denaturing PAGE (80 V, 2 h). If
fluorescently labeled RNA was used, gels were visualized first without staining. The nonfluorescent cleavage products were visualized by staining with GelRed. In case of non-fluorescent
RNA, staining of gels with GelRed was performed after electrophoresis. To quantify percent
cleavage, Adobe Photoshop was used. The band intensity of RNA K-58A (non-cleaved RNA), F40 and F-19 (FAM- labeled fragments generated by Dz1 and Dz2, respectively) were determined
after subtracting the average background directly above and below each band. Fraction of RNA
cleaved was determined as a ratio of the sum of band intensities of F-40 and F-19) to the sum of
band intensities of F-40, F-19, and K-58-FAM. All cleavage experiments were performed in
triplicates.
Cleavage of PA-55-FAM RNA. Fifty microliters of a master mix containing 100 nM
concentration of DOCTR-PA and 500 nM of a 55-nt synthetic analog of PSMA3 RNA (PA-55FAM) fluorescently labeled at the 5’-end wer distributed into individual microcentrifuge tubes, to
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which WT or mutant long RNA (K-58G or K-58A) or WT or mutant short RNA (K-21G or K21A) were added to the final concentration of 100 nM or 500 nM each as indicated in the figure
legends. Control sample contained 500 nM of PSMA3 RNA in Buffer 1. Cleavage at each tube
was assessed after 5 hr and 24 hr incubation at 37 °C. Following the required incubation period,
10 µL of the reaction mixture was collected from the tube and added to the 2×denaturing PAGE
loading buffer (2× TBE, 8M urea). Following the removal of the 10 µL aliquot, microcentrifuge
tubes were placed back into 37oC incubator. Aliquoted samples were then placed into the

20oC

freezer and stored there until analyzed. The analysis of cleavage products was performed using
12.5 % denaturing PAGE (80 V, 2 h). Gels were visualized using GelDoc (BioRad, USA).
Competition experiments with NF-21-Alexa RNA. One hundred nM of K-58A with FAM
at the 5’-end or 100 nM RNA NF-21-Alexa were added to Buffer 1, or to a solution containing
100 nM of DOCTR-1. Additionally, 100 nM of NF-21-Alexa was added to a solution of 100 nM
DOCTR-1 preincubated with K-58_FAM for 2 hrs at 37°C. Samples were incubated at 37°C for 2
h followed by mixing with 6×Blue-Orange dye (Promega) and analyzed using 10% native PAGE
containing either 2 mM or 50 mM MgCl2 (120 V, 1 h). Gels were first visualized using a UV
Transiluminator (Spectroline) and then stained with GelRed and visualized using GelDoc.
DOCTR design. Prior to the design of DOCTR-1, the optimal length for binding arms of
Dz1 and Dz2 (the recognition/processing function) were determined for each deoxyribozyme
separately in the solution. Variants of each Dz with binding arms increasing in one nucleotide
increments were tested in terms of efficiency of K-58A cleavage. The optimal binding arms for
Dzs operating in solution were determined to be 10/9 for Dz1 and 10/13 for Dz2 (Figure S2), with
the melting temperatures for the binding of each Dz arm about 30oC (Table S1). This length of the
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binding arms, optimal for efficient substrate binding and product release to achieve maximum
multiple turnover rates of the tile-free Dz, was, however, too high for the cooperative action of
Dzs in the context of DOCTR structure. The arms needed to be shortened to 9/8 for Dz1 and 9-13
for Dz2.
We designed DOCTR-1 with RNA-binding arms for Dz1 and Dz2 containing 9/8 and 9/13
nucleotides, respectively. The binding arms had melting temperatures around 21°C, except for the
13 nt binding fragment on Dz2, which had a melting temperature around 29° C. This fragment
needed to be longer to efficiently bind the stem structure formed at the 5’-end of K-58 (Figure S1).
Table 8: Oligonucleotides used in study
Name
DZ1 (9/8)
DZ1 (9/9)
DZ1 (10/9)
DZ1 (10/10)
DZ1 (10/11)
DZ1 (11/10)
DZ1 (11/11)
DZ2 (9/9)
DZ2 (9/11)
DZ2 (9/12)
DZ2 (9/13)
DZ2 (9/14)
DZ2 (10/13)
DZ2 (10/14)
DZ2 (11/13)
K-58G
K-58A
K-58Ad
K-58A-FAM
NF21G
NF21A
K-21-Alexa
PA-FAM
DOCTR-1 (T1 9/8)

Sequence, 5’ → 3’
TCTTGCCTAGGCTAGCTACAACGAGCCATCAG
TCTTGCCTAGGCTAGCTACAACGAGCCATCAGC
CTC TTG CCT A GGCTAGCTACAACGA GC CAT CAG C
CTC TTG CCT A GGCTAGCTACAACGA GC CAT CAG CT
CTC TTG CCT A GGCTAGCTACAACGA GC CAT CAG CTC
ACTC TTG CCT A GGCTAGCTACAACGA GC CAT CAG CT
ACTC TTG CCT A GGCTAGCTACAACGA GC CAT CAG CTC
CAACTACCA GGCTAGCTACAACGA AAGTTTATA
CAACTACCA GGCTAGCTACAACGA AAGTTTATATT
CAACTACCA GGCTAGCTACAACGA AAGTTTATATTC
CAACTACCA GGCTAGCTACAACGA AAGTTTATATTCA
CAACTACCA GGCTAGCTACAACGA AAGTTTATATTCAG
CCAACTACCA GGCTAGCTACAACGA AAGTTTATATTCA
CCAACTACCA GGCTAGCTACAACGA AAGTTTATATTCAG
TCCAACTACCA GGCTAGCTACAACGA AAGTTTATATTCA
aug acu gaa uau aaa cuu gug gua guu gga gcu ggu ggc gua ggc aag agu gcc uug a
aug acu gaa uau aaa cuu gug gua guu gga gcu gau ggc gua ggc aag agu gcc uug a
ATG ACT GAA TAT AAA CTT GTG GTA GTT GGA GCT GAT GGC GT A
GGC AAG AGT GCC TTG A
/FAM/aug acu gaa uau aaa cuu gug gua guu gga gcu gau ggc gua ggc aag agu gcc uug a
ugguaguugga gcugguggcg
ugguaguugga gcugauggcg
/Alexa Fluor 594/ugguaguugga gcugauggcg
/FAM/aca gcu auu gga auc aga ugc aaa gau ggu guu guc uuu ggg gua gaa aaa uua g
CCA GGG A GGC TAG CT TCC AAC TAC CA /iSp9/GA CTT GCG TGC GGT CG
/iSp9/ T CTT GCC TA GGC TAG CTA CAA CGA GCC ATC AG
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Sequence, 5’ → 3’

Name
DOCTR-1 (T1 9/9)

CCA GGG A GGC TAG CT TCC AAC TAC CA /iSp9/GA CTT GCG TGC GGT CG
/iSp9/ CT CTT GCC TA GGC TAG CTA CAA CGA GCC ATC AG
DOCTR-1 (T2 9/13) GCCATCAGC ACAACGA GAGGAAAC /iSp9/CGACC GCACG CAAGTC /iSp9/
CAACTACCA GGCTAGCT ACAACGA AAGTTTATATTCA
DOCTR-1 (ttt_T1 9/8) CCA GGG A GGC TAG CT TCC AAC TAC CA TTT GA CTT GCG TGC GGT CG
TTT T CTT GCC TA GGC TAG CTA CAA CGA GCC ATC AG
DOCTR-1 (ttt_T1 9/9) CCA GGG A GGC TAG CT TCC AAC TAC CA TTT GA CTT GCG TGC GGT CG
TTT C T CTT GCC TA GGC TAG CTA CAA CGA GCC ATC AG
GCCATCAGC ACAACGA GAGGAAAC TTT CGACC GCACG CAAGTC TTT
DOCTR-1 (ttt_T2
CAACTACCA GGCTAGCT ACAACGA AAGTTTATATTCA
9/13)
DOCTR-2 (T1 9/8 ) GACTT GCGTG CGGTCG /iSp9/TCTTGCCTA GGCTAGCT ACAACGA
GCCATCAG
DOCTR-2 (T2 9/13) CGACC GCACG CAAGTC/iSp9/ CAACTACCA GGCTAGCT ACAACGA
AAGTTTATATTCA
GCCATCAGCACAACGAGAGGAAAC
Dz-a
CCAGGGAGGCTAGCTTCCAACTACCA
Dz-b
CAA AGA CAA CAG GCT AGC TTC CAA CTA CCA TTT GAC TTG CGT GCG
DOCTR-PA (T1)
GTC G
GCCATCAGCACAACGACATCTTTGCAT TTT CGACCGCACGCAAGTC
DOCTR-PA (T2)
AAG GTTFAM TCC TCg uCCC TGG GCA-BHQ1
F sub
DOCTR1_PSAM3-T1 CAAAGACAACAGGCTAGCTTCCAACTACCA /iSp9/GA CTT GCG TGC GGT CG
/iSp9/ T CTT GCC TA GGC TAG CTA CAA CGA GCC ATC AG

DOCTR1_PSAM3-T2 GCCATCAGCACAACGACATCTTTGCAT /iSp9/CGACC GCACG CAAGTC /iSp9/
CAACTACCA GGCTAGCT ACAACGA AAGTTTATATTCA
RNA nucleotides are in low case; /iSp9/ triethylene glycol spacer; FAM-fluorescein label; Alexa
Fluor 594, name of a read fluorophore, Dz cleavage sited are highlighted yellow.

Structure and free energy of RNA K-58A, NF-39 and F-40.
Tile-free Dz1 and Dz2 produced little or no NF-21 fragment (Figure 2, Lane 3). This
observation could be explained by the combination of the following factors. First, the rate of K58A cleavage by Dz2 was about 14 times greater than that by Dz1 (Figure 37). Second, the
cleavage site in the full-size K-58A was easier accessible by Dz1 than in the Dz2 cleavage product
NF39 (Figure 35B). Under this scenario, Dz2 quickly cleaves K58A to produce F-18 and NF-39
(Figure 35A). NF-39 folds into a hard-to-bind NF-39 structure. To test this hypothesis, we made
computational comparison of Dz1/NF-39 and Dz1/K58A stability using NUPACK software. We
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found only insignificant difference in the stability of the two complexes. For example, all DNA
K58A (NUPACK does not allow analysis of DNA/RNA hybrids) forms only 5% more complex
with a Dz1 mimic (Dz1 (9/8)-T15, TCTTGCCTA TTT TTT TTT TTT TTT GCCATCAG) than
NF-39. An alternative explanation is dimerization of the NF-39 soon after its release by Dz2
(Figure 35C). Indeed, NUPACK predicts 72% NF-39 existing as a dimer under the experimental
concentration as opposed to only 5.6% for K58A.
Under this scenario, when K58A was cleaved by Dz2 within DOCTR-1/ K58A complex,
NF-39 did not have time to be released for dimerization before it gets cleaved by the closely
positioned Dz1 thus producing NF-21 (Figure 2, Lane 3).

This example illustrates the

cooperativity of Dz1 and Dz 2 co-localized within a single association in comparison with free Dz
sequences acting from solution.
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Figure 35: Structure of RNA K-58A and its cleavage products. A) Primary structure of K-58A
with FAM label at its 5’ end. The 5 possible fragments produced after cleavage by Dz1 and Dz2
are indicated by arrows. B) Secondary structure of RNA K-58A (ΔG = 10.10 kcal/mol), NF39
( 7.70 kcal/mol) and F40 ( 4.7 kcal/mol) fragments as predicted by Mfold software. Binding
sites of Dz1 (9/8), Dz2(9/13) are indicated by green and blue dashed lines, respectively. Dz
cleavage sites are highlighted yellow. C) Predicted complex between 500 nM K58A (all DNA
sequence) or 500 nM NF39 (all DNA sequence) and 10 nM Dz1 (9/8)-T15 (TCTTGCCTA TTT
TTT TTT TTT TTT GCCATCAG) under 215 mM Na+, 2 mM Mg2+, 37oC calculated by
NUPACK; D) Dimerization of 500 nM K58A or 500 nM NF39 calculated by NUPACK.
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Discrimination between K-58A and K-58G

Figure 36: Discrimination between WT (K-58G) and mutant target (K-58A) by nanodevice or tilefree Dzs. Cleavage of 500 nM mutant K-58A (Panel A) or 500 nM WT K-58G (Panel B) by 10
nM DOCTR-1 or 10 nM tile-free Dz1 and Dz2 after 20 hrs incubation at 37oC. Cleavage of RNA
target by DOCTR-1, DOCTR-1 (ttt), DOCTR-1 (9/9), DOCTR-1 (9/9 ttt) (lanes 2-5) or by tilefree Dzs 9/8, 9/13 (lane 6) or 10/9, 10/13 (lane 7). Lane 8 contains 10/60 ss DNA oligo standard.
The samples were analyzed in 12.5 %, 7 M urea PAGE. Position of NF-21 activator fragment is
indicated by magenta arrow.
DOCTR-1 with Dz1 9/8 and Dz2 9/13 binding arms shows the best selectivity, generating
21-nt activator sequence (magenta arrow) only in the presence of K-58A and not K-58G (lane 2
Panels A and B). DOCTR-1 with 9/9 binding arms for Dz1 is not selective: it generates NF21
fragment for both K-58 A and K-58G (lane 4, panels A and B). In the case of K-58A, DOCTR-1
9/9 shows almost complete cleavage of RNA by cooperative action of Dz1 and Dz2 that results in
generation of NF-18, F-19, and NF-21 cleavage fragments. In the case of the wild type RNA
cleavage (panel B), lane 4 additionally contains a 40-nt fragment F-40, one of the cleavage
products of Dz1. Accumulation of Dz1 products indicates less cooperativity between the Dzs,
possibly due to slower hybridization of Dz1 with the mismatched target. Lanes 3 and 5 in both
panels contain DOCTR-1 variants, where Dz units are attached to the dsDNA platform via
thymidine linkers and not by PEG linkers, and show increased activity of Dz2 and decreased
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activity of Dz1, which is indicated by accumulation of a 39-nt fragment NF-39, the cleavage
product of Dz2, and absence of NF21 activator sequence or Dz1 cleavage products. Attachment of
the single-stranded Dzs and Dz-a/Dz-b fragments to the dsDNA platform by thymidine linkers
decreases flexibility of these fragments and can generate an additional base pair between Dz2 and
RNA target, therefore decreasing cooperativity between two Dzs. From the different mixtures of
tile-free Dzs, only the Dz1/Dz2 pair with elongated RNA-binding arms (10/9 and 10/13) showed
complete cleavage of K-58A into NF-18, F-19 and NF-21 fragments (Panel A, lane 7), while a
mixture of Dzs 9/8 and 9/13 (lane 6) failed to produce the NF-21 activator.
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Figure 37: Fraction of cleaved RNA K-58A-FAM as a function of binding arms’ length for Dz1
(A) and Dz2 (B) (see Table 2 for the Dz sequences). Cleavage efficiencies were determined after
5-hr incubation at 37oC in Buffer 1. Cleaved K-58A RNA was quantified as described in Materials
and Methods. The data is an average of three independent experiments.
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Table 9: Sequences and characteristics of RNA binding arms of Dz1 and Dz2.
Dz

Sequence, 5’ → 3’

DZ1 (9/8)

TCT TGC CTA GGC TAG CTA CAA CGA GCC ATC AG

9/8

Melting
temperature
Arm1/Arm2, ⁰C*
22.5/20.5

DZ1 (9/9)

TCT TGC CTA GGC TAG CTA CAA CGA GCC ATC AGC

9/9

22.5/31.4

DZ1 (10/9)

CTC TTG CCT A GGC TAG CTA CAA CGA GCC ATC AGC

10/9

29.1/31.4

DZ1 (10/10) CTC TTG CCT A GGC TAG CTA CAA CGA GCC ATC AGC T
DZ1 (10/11) CTC TTG CCT A GGC TAG CTA CAA CGA GC CAT CAG CTC
DZ1 (11/10) ACTC TTG CCT A GGC TAG CTA CAA CGA GC CAT CAG CT

10/10
10/11
11/10

29.1/36.1
29.1/40.4
34.5/36.1

DZ1 (11/11) ACTC TTG CCT A GGC TAG CTA CAA CGA GC CAT CAG
CTC
DZ2 (9/9)
CAA CTA CCA GGC TAG CTA CAA CGA AAG TTT ATA
DZ2 (9/11) CAA CTA CCA GGC TAG CTACA ACGA AAG TTT ATA TT

11/11

34.5/40.4

9/9
9/11

21.0/7.2
21.0/18.8

DZ2 (9/12)

CAA CTA CCA GGC TAG CTA CAA CGA AAG TTT ATA TTC

9/12

21.0/24.9

DZ2 (9/13)

CAA CTA CCA GGC TAG CTA CAA CGA AAG TTT ATA TTC
A
CAA CTA CCA GGC TAG CTA CAA CGA AAG TTT ATA TTC
AG
CCA ACT ACC A GGC TAG CTA CAA CGA AAG TTT ATA
TTC A
CCA ACT ACC A GGC TAG CTA CAA CGA AAG TTT ATA
TTC AG
TCC AAC TAC CA G GCT AGC TAC AAC GA AAG TTT ATA
TTC A

9/13

21.0/29.8

9/14

21.0/33.9

10/13

29.4/29.8

10/14

29.4/33.9

11/13

34.2/29.8

DZ2 (9/14)
DZ2 (10/13)
DZ2 (10/14)
DZ2 (11/13)

Length
Arm1/Arm2, nt

*Arm 1 and 2 (underlined) flank the catalytic core sequence (italic) from 5’ and 3’ sides, respectively.
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Comparison of processing efficiency of DOCTR-1 with that of DOCTR-2 lacking actuating
portion

Figure 38: Comparison of processing efficiency of DOCTR-1 with that of DOCTR-2 lacking
actuating portion (Dz-a and Dz-b), and free Dz1 and Dz2 (9/8, 9/13 or 10/9, 10/13). RNA K-58A
(500 nM) was incubated with 10 nM of each of the cleaving agents for 5 hrs at 37oC. The cleavage
products were separated in 12.5 % urea PAG. The level of RNA cleavage was calculated as a ratio
of the band intensities of the fluorescent cleavage products (F-40 and F-19) to the intensities of all
fluorescent species in the sample (F-40, F-19 and K-58A-FAM), where F-40, F-19, and K-58 is
the fluorescence of the corresponding fragments. The data are average of 3 independent
experiments.
Processing efficiency of DOCTR-1 was also compared with a variation of DOCTR lacking
Dz-a and Dz-b actuating portion (DOCTR-2). DOCTR-2 had the same cleavage efficiency as the
tile-free pair of Dz1 and Dz2. This data indicates that the two Dzs attached to DOCTR-1 dsDNA
platform become less efficient in RNA binding/cleaving presumably due to less favorable
formation of the multi-strand associations (Figure 6B) in comparison with simpler Dz1/K58A/Dz2 or DOCTR-2/K-58A complexes. Additionally, there might be some competition for
RNA K-58A binding sites between recognition and actuating functions of DOCTR-1.
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Analysis of the NF-21 exchange with the solution through competition with RNA NF-21-Alexa

Figure 39: Transfer of the 21-nt activator fragment from the recognition to actuating module of
DOCTR-1. RNA K-58A or NF-21_Alexa were incubated with DOCTR-1 (lanes 4 and 5,
respectively), or RNA NF-21-Alexa was added to DOCTR-1 pre-incubated with K-58A (lane 6).
Lanes 1, 2, 3 contained RNA K-58A, RNA NF-21-Alexa or DOCTR-1 controls, respectively.
Reaction mixtures were analyzed following 2 h of incubation at 37 °C by non-denaturing PAGE
in gel supplemented with 2 mM (A) or 50 mM Mg2+ (B and C). The gel images were obtained
either after excitation of intrinsic FAM and Alexa fluorescence (B) or after staining with GelRed
(A and C). Green arrows indicate DOCTR-1/NF21 and DOCTR-1/NF-21-Alexa complexes.

The difference in migration of DOCTR-1 and DOCTR-1/NF-21 complex is not obvious in
Figure 8B of the main text. Figure 19 depicts the image of a similar gel that was run for a prolonged
period. It demonstrates that even at 2 mM MgCl2, the band corresponding to DOCTR1was shifted
upward when either K-58A-FAM or K-58A-FAM together with NF-21-Alexa was added. At the
same time, the samples containing DOCTR-1 incubated with only RNA NF-21-Alexa, the lowmobility band containing DOCTR-1 had the same mobility as the band of the sample containing
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just DOCTR-1 (Figure 19, compare lanes 3 and 5). This data indicates that at 2 mM MgCl2,
DOCTR-1 cannot efficiently bind the 21-nt fragment from solution. Therefore, for efficient
binding of the 21-nt fragment to DOCTR, it needs to be cut out from K-58A first and then
transferred to Dz-a and Dz-b portion of the nanodevice. On the contrast, when the same reaction
mixtures were analyzed in the gel containing 50 mM Mg2+, we could see NF-21-Alexa in complex
with DOCTR-1, as indicated by a high molecular weight red fluorescent band (Figure S6B, lane
5, green arrow). The same shift of the red-fluorescent band was apparent when NF-21-Alexa was
added to the reaction mixture that was pre-incubated with K-58A (Figure S5B, lane 6). This data
suggests that at 50 mM Mg2+ both NF-21-Alexa and the NF-21 cut out from K-58A are bound to
DOCTR-1.

F sub cleavage by the tile-free Dz-a/ Dz-b or DOCTR-3

Figure 40: F sub cleavage by the tile-free Dz-a and Dz-b or DOCTR-3. A) Fluorescence of F sub
(200 nM) in the presence of Dz-a and Dz-b (10 nM each) and 10 nM of K-58A, K-58G, NF-21A
or NF-21G at 517 nm following incubation in buffer 1 supplemented with 50 mM Mg2+ for 20 h
at 30⁰C. The data represents an average of three trials. B) Fluorescence of F sub (200 nM) in the
presence of DOCTR-3 (10 nM) lacking the recognition/processing function and containing only
Dz-a and Dz-b attached to the dsDNA platform via thymidine linkers, in the presence of 10 nM of
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K-58A, K-58G, NF-21A or NF-21G at 517 nm following incubation in buffer 1 at 30oC for 4 h
incubation. Data represents an average of three trials.

Figure 41. Activation of DOCTR-PA by RNA K-58A or RNA K-21A. A) Secondary structure of
RNA PA-55. B,) DOCTR-PA in complex with K58A-DNA and PA-FAM. Triethylene glycol
linkers are shown as dashed lines.
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Cleavage efficiency of DOCTR for PA-FAM

PA-FAM

DOCTR + K-58A + K-58G + K-21A + K-21G + K-58A
(500 nM) (500 nM) (500 nM) (500 nM) (100 nM)

+ K-58G + K-21A + K-21G
(100 nM) (100 nM) (100 nM)

Figure 42. Cleavage of PA-FAM by DOCTR-1. 100 nM DOCTR following 24 hrs incubation with
PA-FAM (500 nM) and either 5X excess or 100 nM of activators (58-A,%8-G, 21-A, 21-G).
Observed cleavage was produced only by fully matched activator (58-A and 21-A). Best cleavage
observed in the presence of 100 nM of K-58A activator. Unstained gel.

Table 10. % Cleavage of PA-FAM by DOCTR-1 (24 hrs)
Activator

% Cleavage

58-A

(500 58-A

(100 21-A

(100 58-G

(100 21-G

nM)

nM)

nM)

nM)

nM)

16.4

37.2

18.3

5.0

0.96
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Table 11. Oligonucleotides used in study
Name

Sequence 5‘  3‘a-,f

Purification
g

An-16

CCG GTA CAT TGT TGA G

An-S4

CCG GTA CAT TGT TGA GACCG

An 16S-60

guc gaa cgg uaa cag gaa gca gcu ugc ugx uuc gcu gac gag ugg cgg acg
ggu gag uaa
GTC GAA CGG TAA CAG GAA GCA GCT TGC TGC TTC GCT GAC
GAG TGG CGG ACG GGT GAG TAA
GTC GAA CGG TAA CAG GTA GCA GCT TGC TGC TTC GCT GAC
GAG TGG CGG ACG GGT GAG TAA
GTC GAA CGG TAA CAG CAA GCA GCT TGC TGC TTC GCT GAC
GAG TGG CGG ACG GGT GAG TAA
ACG TCA CTT CAC /iFluorT/CG CC T CAA CAA TGT ACC G GC
G/3BHQ_1/
/FAM/CG CC T CAA CAA TGT ACC G GC G/3BHQ_1/

An 16S-60, DNA
An 16S-60 DNA
(A/T mut)
An 16S-60 DNA
(G/C mut)
MB-1
MB-1,solution
MB-2

HPLC

MB-2, solution

ACG TCA CTT CAC /iFluorT/cc GTC AGC GAA GCA GCA cgg
/3BHQ_1/
/FAM/ cc GTC AGC GAA GCA GCA cgg /3BHQ_1/

MB holder_bio

GTG AAG TGA CGT/Bio/

SD

T1

CTC TAC TGA CGT TTT CCT CCA TAC CAT GCA GTA CTG TCC
CAT TTT TGC AGT CAT CTC
CTC TAC TGA CGT TTT AGC TGA TCA CAT CCG GGC GTT CTG
TGC ATG GTA TGG AGG TTT TGC AGT CAT CTC
CTC TAC TGA CGT TTT ATG GGA CAG TAC TTG TAG GTC ATG
AGC ACC TAA CT TTT TGC AGT CAT CTC
AGC TGC T /iSp18/ ATG GGA CAG TAC TTG TAG GTC ATG AGC
ACC TAA CT TTT TGC AGT CAT CTC
CTC TAC TGA CGT TTT GT AAC GAC CGA TGG ATG TGA TCA
GCT TTT TGC AGT CAT CTC
CTC TAC TGA CGT TTT GT AAC GAC CGA TGG ATG TGA TCA
GCT /iSp18/ CGTC CGC CAC
GTG AAG TGA CGT /iSp9/ GCCCG CCATC CAGATG ACCTG
AGACT AGACC TACAA CAGAAC
CTC TAC TGA CGT TTT AG TTA GGT GCT CA GC ATC ATC GAG
CCT GA TTT TGC AGT CAT CTC
CCTG TTA CCG TT /iSp18/ AG TTA GGT GCT CA GC ATC ATC
GAG CCT GA TTT TGC AGT CAT CTC
CTC TAC TGA CGT TTT AGA CCG TGA GCA TTG ACA TCT GGA
TGG CAT CGG TCG TTA C TTT TGC AGT CAT CTC
CTC TAC TGA CGT TTT TCA GGC TCG ATG ATGC AGTCT
CAGGT CACT GAA CTG GTA GCG TAC C TTT TGC AGT CAT CTC
CTC TAC TGA CGT TTT GGTAC GCTAC CAGTT CAG TG TCAAT
GCTCA C GGTCT TTT TGC AGT CAT CTC
/Bio/TTT TTT TTT GGTAC GCTAC CAGTT CAG TG TCAAT
GCTCA C GGTCT TTT TGC AGT CAT CTC

SD

T2
T3
16S_T3
T4
16S_T4
T5
T6
16S_T6
T7
T8
T9
T9-bio
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HPLC
HPLC

SD
SD
SD
SD
SD
SD
SD
SD
SD
SD
SD
SD

Sequence 5‘  3‘a-,f

Name

Purification
g

16S_Adpt-3’ 6/9 (47)

ACG TCA GTA GAG TTT TTT TTT TT TTACTCACC T TTT TTT
TTT TTT TTT TTT TT TTACTC

SD

BHQ-1 – Black Hole Quencher1
iSp9, internal triethylene glycol spacer (IDT)
c
Ribonucleotides are in low case
d
oligo thymidine linkers are in italic
e
nucleotides in red are mismatched to the analyte
f
Bio, biotinylated oligo
g
SD, standard desalting
a
b

Table 12. Adaptors used in study
Adaptora,b

Sequencec,d

Melting
Temp, °C

5' 5-8 (26)

5’-TC AAC T TTT TTT
TTT TCA ACA AT
TTT GAG ATG ACT
GCA
5’-TC AAC T TTT TTT
TTT TTT TTT TTT TT
TCA ACA AT TTT
TTT TTT TT GAG
ATG ACT GCA
5’-TC AACA T TTT
TTT TTT TTT TTT
TTT TT TCA ACA AT
TTT TTT TTT TT GAG
ATG ACT GCA
5’-TC AACAA T TTT
TTT TTT TTT TTT
TTT TT TCA ACA AT
TTT TTT TTT TT GAG
ATG ACT GCA
5’-TC AACAA TTTTT
T TTT TTT TTT TTT
TTT TTT TT T TTT
TTT TTT TCA ACA
AT T TTT TTT TTT
TTT TTT TTT TT
TTTTT GAG ATG
ACT GCA
5’- CTCA ACA AT
TTT T TTT TTT TTT
TTT TTT TTT TT T

0; 13.2

Distance
between
analyte
binding
fragments (nt)
10

0; 13.2

5' 5-8 (45)

5' 6-8 (46)

5' 8-8 (47)

5' 8-8 (77)

5' 9-9 (79)

Single
stranded
length of
adaptor (nt)

Rate Increase
(average)

26

5.90

21

45

5.41

0,13.2

21

46

5.99

13.2, 13.2

20

47

6.00

13.2, 13.2

35

77

10.48

22.6, 22.6

35

78
15.1
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Adaptora,b

5' 9-9 (68)

5' 9-9 (88)

5' 9-9 (188)

5
' 9-10 (80)

5' 10-10 (81)

Sequencec,d

TTT TTT TTT CTCA
ACA AT T TTT TTT
TTT TTT TTT TTT TT
TTTTT GAG ATG
ACT GCA
5’- CTCA ACA AT
TTT T TTT TTTTTT
TTTT TT T TTT TTT
TTT T CTCA ACA AT
TT TTT TTT TT
TTTTTTT TTT GAG
ATG ACT GCA
5’- CTCA ACA AT
TTT TTT TTT TTT
TTT TTT TTT TTT
TTT TT T TTT TTT
TTT TCTCA ACA AT
TT TTT TTT TTT TTT
TTT TTT TTT TTT
TTT T GAG ATG ACT
GCA
5’- CTCA ACA AT
TTT TTT TTT TTT
TTT TTT TTT TTT
TTT TT T TTT TTT
TTT TTTT TTT TTT
TTTT TTT TTT TTTT
TTT TTT TTTT TTT
TTT TTTT TTT TTT
TCTCA ACA AT TT
TTT TTT TTT TTT
TTT TTT TTT TTT
TTT TTTT TTT TTT
TTTT TTT TTT TTTT
TTT TTT TTTT TTT
TTT TTTT TTT TTT T
GAG ATG ACT GCA
5’- CTCA ACA AT
TTTT T TTT TTT TTT
TTT TTT TTT TT T
TTT TTT TTT CTCA
ACA ATG T TTT TTT
TTT TTT TTT TTT TT
TTTTT GAG ATG
ACT GCA
5’- CTCA ACA ATG
TTTT T TTT TTT TTT

Melting
Temp, °C

Distance
between
analyte
binding
fragments (nt)

Single
stranded
length of
adaptor (nt)

22.6, 22.6

30

68

22.6, 22.6

40

88

22.6, 22.6

90

188

22.6, 28.4

33

77

Rate Increase
(average)

10.3

28.4, 28.4

32

77
4.0
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Adaptora,b

5' 8-9 (49)

5' 7-8-8 (77)

5' 8-8-9 (57)

5' 8-8-9 (77)

5' 6-8-8-9
(104)

3' 5-8 (26)

Sequencec,d

TTT TTT TTT TT T
TTT TTT TTT CTCA
ACA ATG T TTT TTT
TTT TTT TTT TTT TT
TTTTT GAG ATG
ACT GCA
5’-TCA ACA AT T
TTT TTT TTT TTT
TTT TTT TT TCA
ACA ATG TTT TTT
TTT TT GAG ATG
ACT GCA
5’- CA ACA AT T TTT
TTT TTT TTT TTT
TTT TT TCA ACA AT
T TTT TTT TTT TTT
TTT TTT TT TCA
ACA AT TTT TTT TTT
TT GAG ATG ACT
GCA
5’- TC AACAA TTT
TTT TTT TT TCA
ACA AT TTT TTT TTT
TT TCA ACA ATG
TTT TTT TTT TT GAG
ATG ACT GCA
5’- TC AACAA T TTT
TTT TTT TTT TTT
TTT TT TCA ACA AT
T TTT TTT TTT TTT
TTT TTT TT TCA
ACA ATG TTT TTT
TTT TT GAG ATG
ACT GCA
5’- TCAACAT TTT
TTT TTT TTT TTT
TTT TT TC AACAA T
TTT TTT TTT TTT
TTT TTT TT TCA
ACA AT T TTT TTT
TTT TTT TTT TTT TT
TCA ACA ATG TTT
TTT TTT TT GAG
ATG ACT GCA
5’-ACG TCA GTA
GAG TTT TCA ACA

Melting
Temp, °C

Distance
between
analyte
binding
fragments (nt)

13.2, 22.6C

21

49

9.52

4.1,
13.2,13.2

21, 21

77

7.70

13.2,13.2,
22.6

10, 11

57

8.66

13.2,13.2
22.6

20,21

77

8.57

21, 20, 21

93

7.02

10

26

2.74

0, 13.2, 13.2,
22.6

0,13.2
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Single
stranded
length of
adaptor (nt)

Rate Increase
(average)

Adaptora,b

3' 5-8 (45)

3' 5-8 (73)

3' 7-8 (45)

3’ 7-9 (26)

3’ 8-10 (26)

3’ 6-7-8 (69)

3’ 7-8-9 (72)

3’ 5-8-10
(45)

Sequencec,d

AT TTT TTT TTT T TC
AAC
5’-ACG TCA GTA
GAG TTT TTT TTT TT
TCA ACA AT TTT
TTT TTT T TTT TTT
TTT TT TC AAC
5’-ACG TCA GTA
GAG TTT TTT TTT T
TTT TTT TTT TTT
TTT TTT TT TCA
ACA AT TTT TTT TTT
T TTT TTT TTT TTT
TTT TTT TT TC AAC
5’-ACG TCA GTA
GAG TTT TTT TTT TT
TCA ACA AT TTT
TTT TTT T TTT TTT
TTT TT TC AACAA
5’-ACG TCA GTA
GAG TTT TCA ACA
AT G T TTT T TT TC
AAC AA
5’- ACG TCA GTA
GAG TTT TCA ACA
AT GT T TTT T TC
AAC AAT
5’-ACG TCA GTA
GAG TTT TTT TTT T
TCA ACA AT TTT
TTT TTT T TTT TTT
TTT TCA ACAA TTT
TTT TTT T TTT TTT
TTT TC AAC A
5’- ACG TCA GTA
GAG TTT TTT TTT T
TCA ACA AT G TTT
TTT TTT T TTT TTT
TTT TCA ACA AT
TTT TTT TTT T TTT
TTT TTT TCA ACAA
5’- ACG TCA GTA
GAG TTT TCA ACA
AT GT TT TTT TTTT
TC AAC AAT TTT
TTT TTT TTC AAC

Melting
Temp, °C

Distance
between
analyte
binding
fragments (nt)

Single
stranded
length of
adaptor (nt)

Rate Increase
(average)

0,13.2

21

45

3.71

0,13.2

21

73

3.13

5.4, 13.2

21

45

2.08

5.4, 22.6

7

26

3.27

13.2, 28

5

26

5.77

0, 5.4,13.2

19, 19

69

4.24

5.4, 13.2,
22.6

19, 19

72

4.09

0, 13.2, 28

9, 10

45

4.10
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Adaptora,b

Sequencec,d

Melting
Temp, °C

3’-5-8,
21oCe

5’-TCA GTA GAG
TTT TCA ACA AT
TTT TTT TTT T TC
AAC
5’-TCA GTA GAG T
TT T CAA CAA T G
5’-TCA GTA GAG T
TT TCA ACA AT
5’- ACG TCA GTA
GAG TTT TTT TTT TT
TTT TTT T TT TTT
TTT

0,13.2

3’-9, 21oCe
3’-8, 21oCe
3’ ttt (26)

Distance
between
analyte
binding
fragments (nt)
10

Single
stranded
length of
adaptor (nt)

Rate Increase
(average)

15

0.8

22.6

3

15

0.8

13.2

3

15

0.7

N/A

N/A

N/A

0.6

a

Dashed numbers represent length of the fragment complimentary to the analyte
number in parenthesis indicates total single stranded length of adaptor.
c
Blue letters represent oligonucleotides complimentary to the tile strands
d
red letters represent oligonucleotides complimentary to the analyte.
e
Indicates melting temperature of adaptors attachment to the tile
b

Experimental Section
Materials and Methods. DNase/RNase free water was purchased from Boston BioProducts
(Ashland, Ma), and used for all buffers and for the stock solutions of oligonucleotides. All
experiments were performed in Buffer 1 containing 50 mM Tris-HCl, 50 mM MgCl2, pH 7.4.
MgCl2 solution was purchased from Teknova (Hollister, CA). Acrylamide and N,N’methylenebisacrylamide were purchased from Acros Organics (Morris Planes, NJ), SeaKem LE
agarose was purchased from Lonza (Rockland, ME). LB agar was purchased from Fisher Scientific
(Fair Lawn, NJ. MB and all other oligonucleotides were obtained from Integrated DNA
Technologies, Inc. (Coraville, IA). Streptavidin silica particles (1.31 μm) were obtained as a 1 %
w/v suspension from Spherotech (Lake Forest,IL). E.coli K12 cells and Monarch Total RNA
Miniprep Kit were obtained from New England Bio labs (Ipswich,Ma). Concentrated solutions of
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oligonucleotides in DNASe free water were prepared at room temperature and stored at 20 °C until
use. The concentrations of oligonucleotides in stock solutions were determined from the
absorptions of these solutions at 260 nm, measured with Thermo Scientific NanoDrop One, while
the corresponding extinction coefficients were determined by using OligoAnalyzer 3.1 software
(Integrated DNA Technologies, Inc.). Fluorescent experiments were performed using Cary Eclipse
Fluorescence Spectrophotometer (Santa Clara, CA) equipped with RX2000 Rapid Kinetics
Spectrometer Accessory (Surrey, UK), excitation, and emission at 485 nm and 517 nm,
respectively. Gel electrophoresis experiments were performed using BioRad electrophoresis
equipment (Hercules, CA), and visualized using BioRad Gel Doc XR+.
Assembling of DNA Cephalopod Tile. Prior to the fluorescent experiments, tiles were
generated by annealing as follows. Oligonucleotide strands T1-T9 (100 nM each) in 1×Buffer 1
were heated at 95oC for 5 min, and allowed to anneal by cool down to room temperature (22oC)
during 20 hours. The formation of tile and assembly with adaptors was visualized by 7 % native
PAGE electrophoresis. Individual samples containing only tile, tile with analyte, tile with adaptors
or tile with adaptors and analyte were allowed to incubate for 30 mins prior to analysis, and run at
2.5 oC for 8h at 100V. Gels were visualized using GelRed nucleic acid stain (Biotium). The size
of the DNA nanodevices were compared to the fragments of 25 bp DNA step ladder (Promega).
Fluorescent assays. Adaptor selection. 60 microliter aliquots containing tile (10nM) and
varieties of 5’or 3’ adaptors (80nM) of varying lengths were allowed to hybridize in Buffer 1 for
15 min prior to analysis, after which they were transferred to a cuvette and 20 nM of An-S4 was
added. Immediately following the addition, the change in fluorescent intensity at 517 nm
(excitation 485 nm) was recorded continuously for 10 minutes using the Cary Eclipse
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spectrometer. A sample with 10 nM tile and 80 nM adaptors consisting of polythymine sequence
represented the control. The fluorescence produced by the tile was compared to the fluorescent
increase produced by MB in solution. Specifically, to 60 μL solution containing MB (10 nM), 20
nM of An-S4 was added and fluorescence was recorded continuously for 10 min. All experiments
were performed in triplicate. 5’ and 3’ variations were tested separately to determine the most
efficient variations. These were used for subsequent experiments.
Effects of adaptor stoichiometry. 60 microliter aliquots containing tile (10nM) and different
concentration of adaptor 5’ 8-8 (77) (0 – 100 nM) were allowed to hybridize in Buffer 1 for 15
min prior to analysis, after which they were transferred to a cuvette and 20 nM of An-S4 was
added. Immediately following the addition, the change in fluorescent intensity at 517 nm
(excitation 485 nm) was recorded continuously for 10 minutes using the Cary Eclipse
spectrometer. A sample containing 0 nM adaptors represented negative control, sample with 100
nM adaptors represented a stoichiometric excess of adaptors. All experiments were performed in
triplicate.
Detection of 16S rRNA (61-120 nt). 60 microliter aliquots containing tile (20nM) and
analyte-specific adaptor 5’6-9(47) or polythymine control adaptor (140 nM) were allowed to
hybridize in Buffer 1 for 15 min prior to analysis, after which they were transferred to a cuvette
and synthetic fragment of 16S rRNA (61-120 nt) was added (20 nM). Immediately following the
addition, the change in fluorescent intensity at 517 nm (excitation 485 nm) was recorded
continuously for 15 minutes using the Cary Eclipse spectrometer. The fluorescence produced by
the tile with adaptors was compared to the fluorescent increase produced by tile in the absence of
adaptors and to the MB in solution. Measurement of fluorescent increase for tile without adaptors
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was performed in similar manner as above. 60 μL solution, containing 20 nM of MB and 20 nM
of analyte 16S (61-120 nt) didn’t produce increase in fluorescence within 15 min. Fluorescence of
the solution was measured until the change in fluorescence was detected (5 h). All experiments
were performed in triplicate.
Detection of 16S rRNA from E.coli. The concentration of total RNA extracted was
measured using the NanoDrop One and concentration of 16S rRNA was determined. 60 microliter
aliquots containing tile (40nM) and analyte-specific adaptor 5’6-9(47) or polythymine control
adaptor (280 nM) were allowed to hybridize in Buffer 1 for 15 min prior to analysis, after which
they were transferred to a cuvette and 16S rRNA was added to the final concentration of 98 nM.
Immediately following the addition, the change in fluorescent intensity at 517 nm (excitation 485
nm) was recorded continuously for 60 minutes using the Cary Eclipse spectrometer. The
fluorescence produced by the tile with adaptors was compared to the fluorescent increase produced
by tile in the absence of adaptors and to the MB in solution. Measurement of fluorescent increase
for tile without adaptors was performed in similar manner as above for 60 min. 60 μL solution of
MB (40 nM) and 16S rRNA extract (98 nM) didn’t produce increase in fluorescence within 60
min, fluorescence of the solution was measured until the change in fluorescence was detected (20
h). All experiments were performed in triplicate.
Total RNA extraction. E. coli cells were grown in 5 mL of LB agar broth in a15 mL cell
culture tube overnight. The RNA extraction was performed using Monarch Total RNA Miniprep
kit (NEB), according to the manufacturer’s protocol. RNA was eluted using 50 μL of RNAse free
water and total RNA concentration was determined using Nanodrop One. Following the extraction,
integrity and quality of RNA was assessed by 1 % agarose gel electrophoresis (110 min at 100V).
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Gels were visualized using GelRed nucleic acid stain (Biotium). The size of the RNA fragments
were compared to with Riboruler High Range RNA ladder (Thermo Scientific).
Heterogeneous experiments. Prior to all experiments, biotinylated tiles (400 nM in Buffer
1) were as previously described by addition of T1-T9 strands, where T9 strand contained biotin on
its 5’end. MB was hybridized with MB-holder strand, containing biotin on its 3’ end. MB-holder
contained the same sequence complimentary to the MB as tile strand T5. Final concentration of
the complex was 400 nM. Next, 10 mg/mL suspension of streptavidin coated silica beads in Buffer
1 was prepared by washing and centrifuging the beads 2X at 10000 rpm for 3 min. Following this
step, 90 μL of 400 nM tile with stoichiometric amounts of adaptors 5’ 8-8 (77) or adaptors 5’ ttt,
90 μL of 400 nM of tile without adaptors or 90 μL of 400 nM of MB-holder complex were
incubated with 30 μL (10 mg/mL) beads suspension in Buffer 1 for 30 min. After incubation
period, samples were centrifuged and washed with Buffer 1 (2X at 6526 rpm for 3 min). Samples
were diluted with 120 μL of Buffer 1 and 60 μL aliquot from each were analyzed. Immediately
following addition of An-16 or An-S4, the change in fluorescent intensity at 517 nm (excitation
485 nm, excitation and emission slits=10 nm) was recorded continuously using the Cary Eclipse
spectrometer until fluorescent signal reached the plateau. All experiments were performed in
triplicate.
Calculations of kinetic constants. For the following reaction MB + An ⇆ MB/An, second
order kinetics and negligible rate of the reverse reaction were assumed. Hybridization constant
was determined as k= Rate/([MB/An]). To calculate the rate (d[MB/An]/dt), initial rate of the
reaction (linear portion of the curve) was used as time, and the change in fluorescence was related
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to the change in concentration of fluorescent duplex by constructing calibration curve with various
concentrations of MB/An duplex.
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Figure 43. Calibration curves for determination of MB-analyte duplex concentrations. Calibration
curves were constructed for concentration of MB with An-16 (A), An-S4 (B) and analyte 16S (C)
in solution and attached to the beads. For all experiments, 100 nM stock of MB-analyte duplex
was generated by heating up and slowly cooling stoichiometric amounts of each. From the stock
solution, serial dilution was prepared to generate MB-analyte concentrations of 0 – 100 nM.
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Fluorescence of each solution was determined (λex=485 nm, λem=517 nm, 20 nm ex/em slits for
solution-based assay, 10/10 slits for beads were used). Each point of the curve generated by an
average of three independent trials. Equation of best fit line was generated using Excel function.
[D] represents concentration of fluorescent duplex.

Figure 44. Effects of adaptors on hybridization of MB with An-S4. Hybridization of MB was
related to the rate of fluorescent increase, which was determined for tile-associated MB in the
presence of An-S4 with stoichiometric amounts of various 5’ adaptors (A) or 3’ adaptors (B) as a
slope of fluorescence vs time over the linear portion of the increase. The measurement represents
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an average of three independent trials. The dashed numbers represent the number of analyte
binding fragments and the number of base pairs complimentary to the analyte in each fragment.
The number in parentheses indicates total length of the adaptor. MB indicates rate of fluorescence
increase of MB in solution in the presence of An-S4. Adaptor ttt represents control adaptor
consisting of polythymine sequence.

Figure 45. Effects of 3’ tentacle strands on the rates of fluorescent increase. A. Effects of melting
temperature increase of analyte-binding fragments on hybridization rate kinetics (determined as
change in fluorescence of MB per second).B. . Effects of number of analyte-binding fragments on
hybridization kinetics (determined as change in fluorescence of MB per second).C. Effects of the
single nucleotide portion length of the tentacle strands on hybridization kinetics (determined as
change in fluorescence of MB per second). D. Effects of addition of best performing 5’, 3’ or a
combination of 5’ and 3’ adaptors on hybridization kinetics (determined as change in fluorescence
of MB per second). All slopes represent an average fluorescent increase of 3 independent trials
and were determined for the first 120 seconds after addition of the analyte. Hybridization rates of
tile-associated MB were compared with free MB in solution (MB). Change in fluorescent intensity
of 10 nM MB in the presence of 20 nM An-S4 was measured for tile associated MB with
stoichiometric amounts of different variations of 5’ adaptors. The number of nucleotides
complimentary to the analyte in each fragment is indicated by the numbers separated by dashes;
number in parenthesis indicates total adaptor length in nucleotides. 5’ ttt represents control adaptor,
that consists of polythymine sequence.
170

Figure 46. Adaptor stoichiometry and LOD.A. Determination of adaptor stoichiometry on
hybridization of tile-associated MB with An-S4. Determined as increase in fluorescence of 10 nM
tile-associated MB in the presence of 20 nM An-S4 and 0-80 nM adaptor 5’ 8-8 (77). B. LOD for
An-16S-60. 10 nM of MB-2 probe in solution or tile-associated MB with 70 nM of adaptor 5’ 6-9
(47) or 5’ ttt was incubated with 0 – 5 nM An-16S-60 for 15 min and fluorescence of each
concentration was determined in triplicate. LOD was determined as concentration that produced
signal equal to the background plus three standard deviations. 5’ ttt represents control adaptor, that
consists of polythymine sequence. Red line represents threshold fluorescence above which An16S-60 is detected by tile with adaptor 5’ 6-9. Adaptor 5’ ttt had LOD tile with adaptor 5’ 6-9 can
detect Orange, grey, and blue lines represents thresholds, Tile with adaptor 5’ ttt had LOD = 0.44
nM, while MB_2 probe wasn’t able to detect analyte in the within the experimental conditions. C.
LOD for An-S4. 10 nM of MB-1 probe in solution or tile-associated MB with 80 nM of adaptor
5’ 8-8 (77) or 5’ ttt was incubated with 0 – 5 nM An-S4 for 15 min and fluorescence of each
concentration was determined in triplicate. LOD was determined as concentration that produced
signal equal to the background plus three standard deviations. 5’ ttt represents control adaptor, that
consists of polythymine sequence. Orange, grey, and blue lines represents thresholds, fluorescence
above which indicates detection of An-S4 by-tile-associated MB with the adaptors 5’ ttt, 5’ 8-8
(77) or by solution MB-1 probe respectively.
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Figure 47. Secondary structures of analyte 16S variants and hybridization kinetics.
A. Structure of 61-120 nt fragment of 16S rRNA and alignment of sequences complimentary to
T3, T4,T6 arms, MB and adaptor 5’ 6-9. Red dashed fragment indicates sequence with
complementarity to control adaptor 5’ ttt. B. Secondary structure of 61-120 nt fragment with DNA
bases. Red circle indicates base that was changed to generate A-T variant with less stable stem,
black circle indicates base that was changed to generate G-C variant, that loses string of bases
complementary to 5’ ttt adaptor. C. Secondary structure of A-T variant. D. Secondary structure of
G-C variant. All secondary structures were generated using mFold software. E. Increase in
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fluorescence in the presence of 61-120 nt RNA fragment, DNA fragment, A-T variant, and G-C
variant, in the presence of tile-free MB (blue bar), tile-associated MB without adaptors (orange
bar), with adaptor 5’ ttt (grey) and with adaptor 5’ 6-9 (yellow). Increase in fluorescence was
determined over 5 min time period.
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APPENDIX E: CHAPTER 5 SUPPLEMENTAL INFORMATION
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DOCTR-2 designs summary
1. Design # 1

Figure 48. DOCTR-2 design consists of 5 tile-forming strands, Dz-1 has 9/8 and Dz-2 has 9/13
binding arms. Additionally T3 and T5 tile-forming strands have PSMA3-unwinding arms. Strand
T4 contains activator-binding and PSMA3 binding sequences with Dz-a and Dz-b containing 11
nt binding sequences. Melting temperature of each fragment with PSMA3 are indicated. This
design didn’t produce 21-nt activator fragment and had no PSMA3 cleavage under low tile
conditions (10 nM), but produced some cleavage with 100 nM tile, 500 nM PSMA3 and 100 nM
58-A activator in 5 hrs.
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2. Design # 2

KRAS unwinding arm
TCAAGGCA

CT AC
AG
A
T Dz-2 A
C
C
GG
AG

CT AC
AG
A
T Dz-1 AC
C
GG
AG

TCTTGCCTA GCCATCAG

CAACTACCA AAGTTTATATTCA

AGUUCCGUGAGAACGGAUGCGGUAGUCGAGGUUGAUGGUGUUCAAAUAUAAGUCAGUA-5’
T2-Dz2
T1-Dz1
GCTGCTAGACCACCGTGGTAC CGGTTCGACGC CGCTGCAGCTGTGCCGCAGGCA
CGACGATCTGGTGGCACCATG GCCAAGCTGCG GCGACGTCGAC ACGGCGTCCGT
34.6C

Dz-a (12)

A A CG A

T3-Arm1 (12)

AC

5’-GCCATCAGC

35.3

Dz-b (12)

T5-Arm2 (14)

CGATAACCTTAG CTACGTTTCTAC ACAACAGAAACC-5’
CCATCTTTTTAATC
32.9 C

34.7C

28.5 C

34.7 C

5’-ACAGCUAUUGGAAUCAGAUGCAAAGAUGGUGUUGUCUUUGGGGUAGAAAAAUUAG

PSMA3 mRNA

Figure 49. DOCTR-2 design consists of 5 tile-forming strands, Dz-1 has 9/8 and 8 nt unwinding
arm for Kras, Dz-2 has 9/13 binding arms. T3 and T5 tile-forming strands have PSMA3-unwinding
arms, but attachment of T3 unwinding arm was changed for more flexibility. Strand T4 contains
Dz-a ( 12 nt), while Dz-b (12 nt) as well as PSMA3 unwinding arm are attached to T5. Tile
produced 2w1 nt activator sequence, but failed to cleave PSMA3 under 10 nM tile conditions (14
% in 32 hrs, 500 nM PSMA3, 100 nM Tile, 100 nM 58-A activator).
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3. Design # 3

Figure 50. DOCTR-2 design # 3. Same as design # 1, but different attachment of T3-unwinding
arm (same as design #2). When tested for cleavage of PSMA3, tile with both Arm-1 and Arm-2 or
with just Arm-1 didn’t produce cleavage, while the tile containing only Arm-2 had cleavage in the
presence of Kras-58A (10 nM tile, 20 nM 58-A activator, 500 nM PSMA3-FAM, 24 hrs, 37C, 10
mM MgCl2).
Optimization of Dz-a and Dz-b length
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Figure 51. Cleavage of PSMA3-FAM by DOCTR-2 or tile-free Dz-a/Dz-b in the presence of
adaptors. A. Cleavage of PSMA3 by DOCTR-2 with or without adaptors. Lanes 2-5 show reaction
mixture of 10 nM of DOCTR-2 with 500 nM PSMA3-FAM, in the presence of Kras-58-A, -58-G
or -58-U activators added (lanes 3-5 respectively). Lane 5-8 show reaction mixture of DOCTR-2
with PSMA3 adaptors with addition of Kras-58A, -58-G or-58U activators (lanes 6-8
respectively). Lane 1 shows PSMA3-FAM without addition of any cleaving agents. Position of
intact RNA on the gel is indicated by purple arrow, position of cleaved product is indicated by
green arrow. Reaction mixtures were analyzed following 2 hrs incubation by 12.5 % dPAGE.
Unstained gel. B. Cleavage of PSMA3 by tile-free Dz-a/Dz-b pair in the presence of adaptors.
Lanes 2-4 contain reaction mixture of Dz-a (10 nt binding)/Dz-b (12 nt binding) with PSMA3FAM, with addition of 21A or 21G activators (lanes 3 and 4). Lanes 5-7 contain reaction mixture
of Dz-a (13 nt binding)/Dz-b (12 nt binding) with PSMA3-FAM, with addition of 21A or 21G
activators (lanes 6 and 7). ). Lanes 8-10 contain reaction mixture of Dz-a (9 nt binding)/Dz-b (8 nt
binding) with PSMA3-FAM, with addition of 21A or 21G activators (lanes 9 and 10). Lane 1
shows PSMA3-FAM without addition of any cleaving agents. Position of intact RNA on the gel
is indicated by purple arrow, position of cleaved product is indicated by green arrow. Reaction
mixtures were analyzed following 2 hrs incubation by 12.5 % dPAGE. Unstained gel.
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